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SUMMARY 
Disruption of gap junctional intercellular communication and/or Connexins (the 
channel proteins of gap junctions) is frequently reported in malignant cell lines and 
tumours. Many tumor cells exhibit aberrant gap junctional intercellular 
communication (GJIC), which can be restored by transfection with Connexin genes. 
Of the Connexin family, Connexin 43 has attracted the most attention as it is widely 
expressed in many tissues and Connexin 43 gap junctions correlate with various 
physiological functions. Connexin 43 is a short-lived protein (half-life of 1-3 h in 
cultured cells), both lysosomes and proteasomes having been reported to be involved 
in its degradation. 
Certain human papillomaviruses (HPV) associated with the development of cancers, 
especially of the cervix, have been reported to downregulate GJIC in vitro. There is 
also evidence for reduced gap junctions in cervical dysplasia. The association 
between HPV and GJIC, and the mechanism and consequence of deregulated GJIC in 
cervical tumour progression, remains unclear. In HPV-16 associated cervical cancer, 
the viral oncogene E6 inactivates the tumour suppressor p53, but also has p53-
independent functions in tumour progression. One of these may involve interaction 
with hDlg (the human homologue of Drosophila Discs Large), a tumour suppressor 
present in epithelial cells at sites of cell-cell contact and which regulates cell polarity 
and attachment. hDlg contains three PDZ protein-protein interaction domains, the 
second PDZ domain of which binds E6. Connexin 43 also has a PDZ binding domain 
in its C-terminus. 
Previously, it was demonstrated that Connexin 43 relocates from the membrane to the 
cytoplasm in a novel HPV-16 E6-containing cervical epithelial cell line (named 
WI2GPXY) that is fully transformed and invasive and deficient in gap-junctional 
intercellular communication (Aasen T et aI., 2003 Oncogene 22, 7969- 7980). 
The overall aim of this project was to investigate the relationship of loss of gap 
junctions to malignant progression by comparing the properties of W12GPXY with 
those of the non-malignant parental cell line, WI2G, from which W12GPXY was 
derived. 
First, microarray was used to identify global differences in RNA expression between 
the two cell lines, large differences were seen in expression of angiogenesis-related 
genes and they were confirmed by Real-Time RT-PCR for three genes, IL-8, VEGF 
and FGF-2. No significant differences were noted for connexin genes but there were 
differences in MAGUK family members including hDlg. 
However, protein expression studies by western blot and immunofluorescence 
staining showed a significant increase (2.9 fold) of HPV-16 E6 in W12GPXY cells, 
which co-localises with hDlg in the cytoplasm. Connexin 43 also binds hDlg. 
Treatment ofW12GPXY cells with Leptomycin B to trap E6 in the nucleus or siRNA 
knockdown of E6 abrogate the relocation and co-location of hDlg and endogenous 
wild type Connexin 43 and restore Connexin 43 gap junction at points of cell-cell 
contact. Further, when C33a cells (HPV -negative cervical tumour cells which 
normally retain large Connexin 43 gap junctions) are transfected with HPV -18 wild 
type E6, changes in localisation of Connexin 43 and hDlg are consistent with those in 
W12GPXY cells. However, C33a cells transfected with a mutant E6 lacking the hDlg 
? 
binding site retain Connexin 43 gap junction plaques. Finally, Connexin 43 associates 
with hDlg through its PDZ-binding domain and this is required for its relocalisation to 
the cytoplasm in W12GPXY cells. The results suggest that increased cytoplasmic E6 
associated with malignant progression of W12GPXY cells redistributes Connexin 43 
from membrane junctions into the cytoplasm by a mechanism involving binding of 
hDlg to the Connexin 43 C-tenninal tail. The findings have uncovered a new role for 
hDlg in trafficking of Connexin 43. It also provides a novel mechanism for the loss 
of gap junctional intercellular communication during malignant progression of 
squamous epithelial cells. 
The specific roles played by lysosomes and proteasomes in the degradation of 
Connexin 43 in W12GPXY cells were also studied. The results suggest the 
involvement of both proteolytic pathways, although the lysosome seems to be the 
major compartment for Connexin 43 degradation. Association with HPV-16 E6 and 
hDlg together with proteasome activity seems to be required for Connexin 43 
redirection from the cell membrane and transport into the lysosomal degradation 
pathway. Taken together, these results suggest that Connexin 43 gap junction 
intercellular communication was lost from the cell membrane requiring maintenance 
of E6 and hDlg complexes for proteasomal internalization and consequently transport 
into lysosomal compartment for degradation in W12GPXY cells. 
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1. Introduction 
CHAPTER 1. INTRODUCTION 
1.1 Papillomavirus 
The viral etiology of warts was discovered around 100 years ago when McFadyan and Hobday in 
1898 transmitted dog warts by ultrafiltered wart lysates. Nine years later, Ciuffo in Italy used 
the same method to produce warts successfully after self-inoculation of similar filtrates from 
human papillomas (zur Hausen, 1994, 1996). Papillomaviruses (PVs) were firstly described in 
cottontail rabbits in 1933 by Shope, these viruses were originally classified as members of the 
papovavirus family which was named using the first two letters of the major genera: papilloma, 
polyoma and simian vacuolating virus 40 (Howley, 1995). However, papillomaviruses (e.g. 
bovine, cottontail rabbit, and human papillomaviruses) and polyomaviruses (e.g. murine 
polyomavirus and simian virus 40) differ in diameter, genome size, protein composition and size, 
and capsomere morphology and size (Baker et aI., 1983 and 1989); recently, papillomaviruses 
and polyomaviruses were divided into two DNA tumor virus subgroups. The more researchers 
studied them, the more PV subtypes have been widely defined throughout the animal kingdom 
such as in birds, mammals and human. PV infections have been proven to cause wart generation 
in squamous epithelia. Furthermore, human papillomavirus (HPV s) infection in the basal layers 
of mucosal and cutaneous epithelium causes benign hyperproliferative lesions (de Villers, et aI., 
1981; Kizyzek, et aI., 1980). During the last two decades, HPVs were detected in genital warts 
leading to cervical cancer and PV s have been proved to be the most important oncogenic 
pathogenically associated virus group (Lowy, et aI., 1994; zur Hausen, 1991). All the PV types 
possess a common structure: they are small nonenveloped viruses with 55nm-diameter 
icosahedral protein capsids containing double stranded DNA genomes of approximately 8,000 bp 
(Bunney et at, 1992). Most of the phylogenetic studies on HPVs are based on their genotype 
properties. More than 200 HPV s have been identified and at least 78 HPV genomes are 
16 
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completely characterised Figure (1) (Chen et aI., 1995). Different types ofHPVs are associated 
with warts or cancers in the cervix and anogenital tract sites, oral cavity and skin (Melbye and 
Frisch, 1998; de Villiers et aI., 1999; Harwood et aI., 1999). It is clear that HPVs are prevalent 
and are transmitted through sexual activities and infections rates are high in both male and 
female population (Bosch et aI., 2002). A number of epidemiology studies demonstrated the 
close linkage between HPV infection and development of cervical cancer. The association of 
HPVs with different diseases is presented in Table (1). 
17 
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Site HPV -associated disease HPV types 
1,2,3,4,1,10,26,27,28, 
Wart 29,41,48,60,63,65,75, 
Skin 76, 77, ..... 
5,8,9,12,14,15,17,19, 
EVwart 20,21,22,23,24,25,36, 
37,38,46,47,50, ... '" 
Oral Cavity FER 13,32,57,72,73 
Larynx Papilloma 6,11 
Genital warts 6,11 
Anogenital tract 
34,40,42,43,44,53,54, 
Intraepithelial neoplasia 55,59,61,62,64,67,68, 
71, 74 
Intraepithelial neoplasia 16,18,31,33,35,38,45, 
and cancer 51,52,56,58,69, ..... 
---- -- --
- -- --- ----
Table 1: HPVs and their associated diseases. HPV 16, 18 and 31 were classified as high risk 
HPVs. 
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Figure 1: Phylogenetic tree of PV types. There are 5 supergroups in PV phylogenetic tree, 
subgroup A contains the most members including high risk HPVs (taken from Chan et aI., 1995). 
1.2 HPV s and cancer 
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Following Shope's discovery, Rous confirmed papillomavirus infection could link to cancer 
initiation and promotion and suggested PV s could be the first identified DNA tumor virus (Rous 
and Kidd, 1936; Kidd and Rous, 1940). Although HPV infections had been identified as the 
most common sexually transmitted disease producing common epidermal warts in the 
anorectum, hands, feet, and knees; it was only in 1980s that a clear connection was elucidated 
between HPV infection and 99.7% cervical cancer cases, and leading to the discovery of the first 
identified viral oncogenes that constituted a risk factor for widespread human cancer (Gissmann 
et aI, 1983; 1984; Munoz, 2000). HPV DNA sequences found in cervical carcinoma cell lines 
were the first clue to the role that high-risk types 16 and 18 play in altered cell growth (Schwarz 
et aI., 1985; Schneider-Gadicke and Schwarz, 1986). Further studies in cervical cancer cell lines 
have demonstrated many of the harmful effects of HPV in terms of cellular mutations (Havre et 
aI., 1995; Liu et aI., 1997) and genomic integrity (Hashida and Yasumoto, 1991). Additionally, 
since then HPV infections have also been found associated with some cases of oral cancer, other 
anogenital cancer, oesophageal cancer, non-melanoma skin cancer and lung cancer (Munger et 
aI., 2004). The association between HPV and various cancers is presented in Table (2). Cervical 
cancer is the second most common cancer among women worldwide, each year more than 
450,000 women are diagnosed with cervical cancer and over 200,000 women die of this disease 
(Daley, 1998). The mean incidence of cervical cancer in developing countries (19.2 cases per 
100,000 women) was approximately twice more than in developed countries (10.6 cases per 
100,000 women), which also happened for cervical cancer mortality (Drain et ai., 2002). 
The progress and outcome of an HPV infection depends on HPV type, anatomical features of the 
infection, location and the timing of cellular differentiation (Bosch et aI., 2002). Starting in 
1976, thereafter rapidly fostered by technological advances, the puzzling complexity of the HPV 
group became evident. These viruses can be divided in to two clinical groups, the mucosal 
20 
1. Introduction 
infecting and cutaneous infecting HPVs; within each subfamily, individual virus can be defined 
as high risk or low risk according to the propensity for malignant progression of the lesion that 
they cause (Jenson et aI., 1991). HPV genotypes 6, 11,40,42-44, 53-55, 57, 59,61,67,69, 71, 
74 and 82 only cause gential warts (condyloma, acuminata); HPV types 31,33,35,39,51,52 
and 58 carry an intermediate risk; and HPV type 16, 18, 45 and 56 are a high risk subfamily 
which are associated with squamous intraepthelial lesions leading to high-grade dysplasias and 
malignant cervical cancer (Roman and Fife, 1989; Park et aI., 1995). HPV 16 is the most 
prevalent virus to infect the cervix and is associated with the entire range of intraepithelial 
lesions to invasive squamous cell carcinoma, followed in prevalence by HPV -18, HPV -31 and 
the others (zur Hausen, 2002). 
Infection by HPV s is believed to occur through microwounds of the epithelium by attachment to 
a cell surface receptor such as a6f34-integrin or heparin and entry into the basal layer cell 
nucleus. Cells in the basal layers consist of stem cells and transit-amplifying cells that are 
continuously dividing and provide a reservoir of cells for the suprabasal region (Hummel et aI., 
1992). During HPV maintenance and progression, the productive life cycle of the virus is 
directly linked to the differentiation program of the infected epithelial host cells (Howley and 
Lowy, 2001; Stubemauch & Laimins, 1999), Figure (2). Following HPV entry, there is a viral 
gene expression cascade activated to establish around 50 copies of viral DNA episomes per cell 
that are stably maintained in the undifferentiated basal layer cells through the infection course 
and that replicate in synchrony with host cell division (LaPorta & Taichman, 1982; Howley and 
Lowy, 2001). In the HPV -infected differentiating cell, the viruses maintain the correct 
environment to stimulate the host cells in G 1 into S-phase and to reactivate the host replicative 
machinery to allow virus vegetative replication for the virus to thrive (McMurray et aI., 2001). 
21 
Cancer type 
Cancer of the cervix 










Cancer of the oropharyngeal region . 20% 
Cancer of the esophagus 10%-20% 
Squamous cell carcinoma of the skin 70%-80% 
Basal cell carcinoma of the skin 50% 
1. Introduction 
Table 2. Approximate percentage of HPV-positive human cancers (Adapted from zur Hausen, 
1999) 
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Figure 2: The differentiation-dependent changes in normal and HPV-infected epithelial cells 
(taken from Stubenrauch and Laimins, 1999). 
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1.3 The HPV Genome and Its Contribution to Malignancy 
The HPV genome typically consists of eight open-reading frame sequences, located on only one 
of the strands of DNA, and is divided into a ~ 4 kb region encoding six early-phase genes (E) 
(E1-E7), a ~3 kb region encoding two late-phase genes (L1 and L2) and a ~ 1 kb viral noncoding 
long control region (LCR) which regulates E and L gene expression. The HPV16 viral genome 
also has the P97 early promoter, immediately upstream of E6 ORF; and the P670 late 
differentiation induced promoter, locating in the E7 ORF (Grassmann et aI., 1996; Desaintes & 
Demeret, 1996). The open reading frames of the HPV 16 genome are shown in Figure (3). 
1.3.1 HPV El and E2 
The early genes serve to regulate the transcription of DNA, while the late genes encode the 
capsid proteins involved in viral spread (Stoler et aI., 1989). The El and E2 proteins play 
important roles in regulating the transcription and replication of the viral genome, E2 is 
especially involved in regulating the transcription from the viral long control region. El protein 
is essential for viral replication; it is a DNA-dependent, ATP-dependent helicase which is 
responsible for recruiting the cellular DNA replication initiation machinery via E2 which binds 
to specific sequences at the origin of replication (Richman et aI., 1997). The El binding site is 
an AT rich region which lies between the E2 binding sites. El binds weakly to DNA but the 
affinity is increased in the presence of E2 (Desaintes & Demeret, 1996). E2 is a DNA binding 
transcription factor interacting with an ACCN6GGT/ACCN6GTT motif in the viral LCR (Rirt et 
aI., 1996; Marshall et aI., 1989). E2 binds to the motifs as a dimer through a domain in its C-
terminal part, where E2 demonstrates the function of both a replication initiator and an E61E7 
transcriptional modulator. In morphologically normal, but HPV -infected basal cells, HPV gene 
expression is inhibited by E2 at normal levels (Cripe et aI., 1987). HPV DNA is frequently 
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integrated into the host genome in cancer cells where the break point in the viral genome occurs 
consistently within the E11E2 region, and once the E2-controlled regulation ofE61E7 expression 
is lost, E6 and E7 will be inappropriately expressed (Hubert & Laimins, 2002). 
1.3.2 HPV El A E4 and E5 
The HPV E4 and E5 ORFs are expressed during the early phases of the viral life cycle but only 
as the third and fourth ORFs on polycistronic transcripts and little E4 and E5 proteins are 
sythesized (Remm et aI., 1999). In contrast, on epithelial cell differentiation, E4 and E5 are 
expressed as the first and second ORFs of late transcripts. Actually, E4 is the virus protein most 
abundantly transcribed and highly expressed in a wart (Howley, 1996). The E4 ORF lacks an 
initiator AUG codon and translates with the first 5 amino acids of El to generate El AE4 fusion 
proteins using the El sequence for translation initiation (Holey, 1996). High risk E1AE4 proteins 
bind and disrupt the cytoplasmic keratin networks in differentiated cells and interact with an 
RNA helicase, E4-DBD, which is a member of a helicase family involved in mRNA splicing, 
transport as well as initiation of translation (Doorbar et ai., 1991; Yoshioka et ai., 2000). 
Another character of HPV -18 and HPV -16 E 1 AE4 is they can induce a G2 arrest in a variety of 
cell types, but how this happens is still not clear (Davy et ai., 2002; Nakahara et ai., 2002). 
The HPV -16 E5 protein is a small 84 amino acid hydrophobic protein localized to the 
endoplasmic reticulum and Golgi apparatus but also found on cellular membranes (Conrad et ai., 
1993). It acts as a ligand for membrane proteins, including growth factor receptors, interacts 
with and also modulates ERK1I2 and p38 MAP kinase activation by an EGFR-independent 
pathway (Crusius et aI., 2000). E5 can also stabilize and inhibit the degradation of the complex 
between epidermal growth factor (EFG) and its receptor (EGFR), resulting in enhanced MAP 
kinase activity (Gu & Matlashewski, 1995). The binding between E5 protein and ductin, a 
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16kDa subunit of the vacuolar ATPase, results in down- regulation of gap junction intercellular 
communication and disturbance of the H+ transport function of vacuolar ATPase to inhibit 
endosomal acidification, prolonging the active signal from the EGFR and interfering the 
endosomal compartments pH (Conrad et aI., 1993; Straight et aI., 1995; Briggs et aI., 2001). The 
effects of E5 on cell growth have been difficult to study due to its low (usually non-detectable) 
level of expression in stable cell lines. The E5 gene is frequently deleted during the viral 
integration, although it is thought to play an important role in malignant transformation. Recent 
studies showed HPV E5 had an important activity in late gene amplification and expression in 
differentiated suprabasal epithelial cells suggesting that E5 had a role in the late phase of the 
viral life cycle (Longworth & Laimins, 2004). 
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1.3.3 HPV E6 and E7 
High risk HPV E6 and E7 emerge as most important for growth stimulation and cell 
transformation. Both represent related proteins that even individually can immortalize a variety 
of human cell types. Their cooperation synergistically exerts overlapping effects on cell cycle 
control, and in combination, they efficiently immortalise human keratinocytes (Gissmann, 1992). 
During the progression from the premalignant to malignant phase of high-risk HPV -associated 
disease, the viral DNA genome is integrated into the host chromosome, resulting in over 
expression of the viral oncoproteins E6 and E7 (Jeon and Lambert, 1995). 
HPV E6 protein is a 151 amino acid (18 kDa) polypeptide in which there are four Cys-x-x-Cys 
motifs forming two zinc-finger domains, one highly conserved C-terminal PDZ (PSD-
95/DIg/ZO-l)-binding domain, and one LD-rich site (Kiyono et aI., 1997; Tong et aI., 1997). A 
schematic representation of high risk HPV E6 and its binding proteins is shown in Figure (4). E6 
is one of the earliest expressed genes during the HPV infection. Although E6 is small, it is a 
multifunctional oncoprotein that induces several important effects upon the viral life cycle and 
host cell maturation processes, involving gene transcription, cell proliferation, apoptosis and 
immortalization (McMurray et aI., 2001). The first insights into the action of E6 have come by 
studying its interactions with p53. p53 is a well-characterized tumor suppressor that regulates the 
expression of proteins involved in cell cycle control, including the cyclin dependent kinase 
inhibitor, p21. In the nucleus, E6 binds to the tumor suppressor p53 via an interaction with E6-
associated protein (E6-AP), a cellular E3-ubiquitin protein ligase, and targets p53 for 
ubiquitination and degradation (Huibergtse et aI., 1991). The cellular p53 protein is a 
transcription factor for cell cycle arrest and apoptosis related gene expression by which cells 
respond to environmental stress. In response to DNA damage, p53 is activated and detains the 
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cell in G 1, presumably to allow time for DNA repair; pS3 mediates this G 1 arrest by inducing 
high levels of the cdk inhibitor p21 cip1 (cdk interacting protein-I) and p14ARF resulting in either 
Gl or G2 arrest (DeWeese et aI., 1997; Samuel et aI., 2002), as well as apoptosis (Hawleyet aI., 
1989). E6 also inhibits p53 function by retaining p53 in the cytoplasm to block its entrance into 
the nucleus, independently of the degradation pathway (Thomas et aI., 1999). It was identified 
that in human cervical carcinoma-derived malignant cell lines (CaSki and SiHa) the whole HPV 
16 genome was harboured and HPV 16 E6 with E7 can induce morphologic transformation in 
mouse 3T3 cells as well as the immortalization of human mammary epithelial cells (Androphy et 
aI., 1987; Kyono et aI., 1998). Unlike E7, E6 alone was not efficient at immortalizing human 
keratinocytes, the process requires the expression of both E6 and E7 (Howley et aI., 1989). Only 
high-risk HPV E6 directs ubiquitin degradation of p53, low risk HPV E6 protein has relatively 
low binding affinity for p53, which may partly account for the less aggressive functional 
properties (Kehmeier et aI., 2002). 
Recent studies have identified p53-independent activities of E6 that are important for 
immortalization of human cells. E6 mutants of HPV -16 have been identified that are unable to 
degrade p53 but retain the ability to immortalize mammary epithelial cells; consistently, other E6 
mutants retain the ability to degrade p53 but have lost the ability to immortalize (Liu et aI, 1999). 
One of the important onco-functions that appears to improve E6 transforming ability is its 
association with the PDZ family of proteins. PDZ proteins contain a conserved domain 
associated with the PSD-95, DIg, and ZO-l proteins (hence the name PDZ, the detail of this 
protein family will be described in Charpter 1.4.). The PDZ domain is often found in proteins 
localized at areas of cell-cell contact, such as tight junctions in epithelial cells. The PDZ proteins 
probably act as molecular scaffolds to aid in signal transduction (Graven and Bredt, 1998; 
Gompert, 1996). High risk HPV E6 containing a carboxyl terminal PDZ protein binding motive 
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X-(S/T)-X-(V/I/L)-COOH also has been reported to interact physically with several cytoplasmic 
proteins including the PDZ domain-containing proteins MAGI-I, ZO-I, MUPP-l, hScrib and 
hDlg. Such interactions might alter cell signalling cascades or cause changes in cell structure 
(Chen et aI., 1995; Tong & Howley, 1997; Nakagawa and Huibregtse, 2000; Gao et aI., 2001; 
Thomas et aI., 2002; Watson et aI., 2003). Binding of these PDZ proteins and high risk HPV E6 
results in E6AP mediated ubiqitination and proteolysis (Gardiol et aI., 1999; Nakagawa and 
Huibregtse, 2000). The PDZ binding sites in low risk HPV E6 proteins have much lower 
binding affinity than high risk HPV s and since most of these PDZ containing proteins are 
involved in negatively regulating cellular proliferation, it is conceivable that these PDZ 
interactions may contribute to hisk HPV E6 transformation activity. The importance of this 
interaction has been confirmed in experiments with transgenic mice expressing E6 proteins that 
lack the PDZ binding domain. These mice retain the ability to inactivate p53 but do not develop 
the epidermal hyperplasias that are frequently seen in wild-type E6 transgenics (Nguyen et aI., 
2003). It is not clear which signalling pathways are impacted by E6 binding to PDZ proteins or 
which PDZ family members are most important for these phenotypes. The elucidation of these 
pathways is of great importance for our understanding of HPV pathogenesis. 
Another major function of the high-risk E6 proteins that is important for immortalization is their 
ability to activate the expression of the catalytic subunit of telomerase, hTERT which results in 
cell immortalization in early-passage human keratinocytes and mammary epithelial cells 
(Klingelhutz et aI, 1996; Nakamura et aI., 1997; Munger et aI., 2002). Telomerase is a four-
subunit ribonucleoprotein enzyme that synthesizes telomere hexamer repeat sequences by 
reverse transcript an RNA template and maintains the telomeric DNA at the ends of linear 
chromosomes (Lustig, 2004). Telomerase activity is usually restricted to embryonic cells and is 
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absent in somatic cells. The lack of telomerase activity results in a shortening of telomeres, with 
successive cell divisions eventually leading to senescence. In contrast, in most cancers, 
reactivation of hTERT expression occurs and leads to reconstitution of telomerase activity (Liu, 
1999). E6 appears to activate hTERT transcription through the combined action ofMyc and Sp-
1 (Greenberg et aI., 1999; Key et aI., 2000). Recent studies have shown that E6 can bind to both 
Myc and its cofactor Max, leading to transcriptional activation of the hTERT promoter (Veldman 
et aI., 2003). Analysis ofE6 mutants that discriminate between the ability to degrade p53 and to 
activate hTER T demonstrated that the latter activity is most important for immortalization. 
As described, E6 is a multifunctional protein. The high-risk E6 proteins interact with a number 
of other cellular proteins, such as p300/CBP, and the interferon regulatory factor IRF-3, which 
'are important for normal cell differentiation and cell cycle progression to alter cellular gene 
expression (Wemess et at, 1990; Patel et aI., 1999; Zimmermann et aI., 1999; Ronco et aI., 
1998). They can enhance the expression of the oncogene product c-myc (Hurlin et aI., 1995). A 
number of additional cellular protein targets of high risk HPV E6 have been identified, including 
paxillin, a focal adhesion protein, which appears to be involved in bovine papillomavirus E6 
transformation by disturbing the actin cytoskeleton; E6BP protein (also known as ERC-55), a 
calcium-binding protein, suggesting the interaction might affect calcium-induced differentiation 
ofE6 expressing cells; and Bak, a member ofBcl-2 family. 
Among E6 oncofunctions, it appears that p53 degradation is most important for full 
transformation and that binding of PDZ proteins and activation of hTERT expression are 
necessary for immortalization. 
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The high risk HPV E7 like other oncoproteins encoded by DNA viruses, also associates with and 
modifies the functions of cellular protein complexes. There are two Cys-X-X-Cys motifs 
separated by a 29 amino acid spacer in the C-terminus via which E7 dimerizes as a zinc binding 
protein (McIntyre et aI., 1993). E7 protein is a 98 amino acid nuclear protein with casein kinase 
II phosphorylation sites at serine residues 31 and 32 (Barbosa et ai., 1990; Storey et aI., 1990). 
Many of the interactions between E7 and cellular proteins involve the factors that regulate cell 
growth, especially the transition from the G 1 of the mitotic cycle into S phase (Munger & 
Howley, 2002). The HPV-16 E7 binds to the tumor suppressor retinoblastoma protein (pRb) and 
other members of the pRb family proteins e.g. p105 and p130; and regulates their 
phosphorylation state to affect the cell cycle via a region analogous to the conserved region 2 of 
adenovirus E1A. This is critical for E7-induced cell transformation (Phelps et ai., 1992). E7 
preferentially interacts with hypophosphorylated pRb, resulting in the cell entering S phase. 
Hypophosporylated pRb normally represses E2F transcription factors, in GO/G 1 phase. The 
sequestering of pRb by E7 results in stimulation of expression of genes involved in cell cycle 
progression and DNA synthesis such as DNA polymerase-a and thymidine kinase (Chittende et 
ai., 1991; Martin et aI., 1998). The binding between pRb and high risk HPV E7 also induces the 
destabilisation of pRb via promoting pRb proteolytic degradation, which contributes to HPV E7 
induced cellular transfonnation and cell apoptosis (Jone et aI., 1997; Boyer et aI., 1996). Low 
risk HPV E7 binds to pRb with a lower affinity and has less phosphorylation by casein kinase II 
than high risk HPV E7. Consistent with these differences, low risk HPV E7 is not thought 
sufficient to transform cells (Gage et aI., 1990; Barbosa et aI., 1990). 
In addition to pRb binding and degradation, like other viral oncoproteins, high risk HPV E7 also 
targets inhibitors of cyclin-dependent kinase that are critical regulators of cell cycle arrest during 
keratinocyte differentiation. As previously discussed, HPV must force the host cell to provide 
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DNA replication components and activities to amplify the viral genome in the absence of normal 
growth signals. For that, E7 targets cyclinE-cdk2 (which regulates initiation of S phase) and 
cyclinA-cdk2 (which regulates the progression of S phase) to extend the duration of replicative 
competence in the host cells. The binding and abrogation of inhibitors such as p21 CIPl and 
p27KIPl by E7 may contribute to maintenance of a replication-competent cellular environment in 
differentiated epithelial cells (Cheng et aI., 1995~ Missero et aI., 1996~ Zerfass-Thome et aI., 
1996; Jones et aI., 1997). p21CIPlfWAFl/SDIl binding with E7 can block the inhibition of both 
cyclinlcdk activity and PCNA-dependent DNA replication (Funk et ai., 1997 Jones et ai., 1997); 
p27KlP1 is a regulator of TGF-f3 induced cell growth inhibition in keratinocytes, its binding with 
E7 may result releasing from TGF-f3-associated growth arrest (Pietenpol et aI., 1990). 
The E7 protein also recruits histone deacetylases to repress the transcription of E2F factors 
involved in regulating transcriptional cell cycle progression and/or cellular differentiation 
(Brehm et aI., 1998). Additionally, E7 interacts with members of the AP-1 family of 
transcription factors, including c-Jun, JunE, JunD and c-Fos, which are found to regulate early 
mitogenic effects on cell differentiation (Antinore et aI., 1996). Finally, E7 targets the 
interferon-inducible signal cascade by inhibiting the IRF-1 and NFkappaB function and this 
could lead to the impairment of the IFN response in HPV-infected cells (Perea et aI., 2000). 
1.4 MAGUK proteins 
All the members of membrane-associated guanylate kinase homologue (MAGUK) family are 
scaffold proteins that recruit different molecular components into localized macromolecular 
complexes with their protein partners, which are thought to be involved in cell signalling 
cascades and cell morphology organisation. These proteins are associated with the plasma 
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membrane typically at cell-cell contact sites in multicellular animals from Drosophila to 
mammals (Dimitratos et aI., 1997; 1999). Our current knowledge ofMAGUK activity, includes 
two overlapping functions: 1) to localize, recruit, and organise other proteins at the plasma 
membrane in order to allow extracellular signals to initiate a response from intracellular 
signalling transduction pathways; 2) to act as a molecular scaffold or anchoring proteins crucial 
in controlling cytoarchitecture and maintaining cell junction structure. In some cases, the PDZ 
domains are even involved in clustering of Shaker-type K+ ion channels in cell membrane 
specialization (Kim et aI., 1995). 
MAGUKs appear to be critical in allowing the efficient transduction of extracellular signals via 
localised biochemical interaction (Spiro et aI., 1999). MAGUK proteins have a multidomain 
organisation (from N- to C-terminus) including one or three PDZ domains, an SH3 domain and a 
region homologous to guanylate kinase (GUK). All these domains are involved in protein-
protein interactions; in some MAGUKs there is also a HOOK domain and a Lin-7 bindinglVeli-
binding domain as well as the CaM kinase and calmodulin-binding domains in Lin-2-like 
MAGUKs. All these motifs can be associated with specific targets (Fanning & Anderson, 1996; 
Dimitratos et aI., 1997). PDZ domains are 80-100 amino acid domains named for their presence 
in the MAGUK proteins: post-synaptic density protein-95 kDa (PSD-95), the Drosophila tumor 
suppressor Disc-large (DIg) and ZO-l (Doyle et aI., 1996; Dimitratos et aI., 1997) and they are 
the best characterized protein binding domains in MAGUK proteins. Data from X-ray 
crystallography and from binding specificity assays using the oriented peptide library technique 
show that PDZ domains can bind to three different types of targets: 1) to a specific (S/T)-X-(V/I) 
C-terminus motif, 2) to another PDZ domain, and 3) to an internal target motif (Morais etal., 
1996; Songyang et aI., 1997; Tsunoda et at, 1997; Shieh & Zhu 1996). GUK domains in 
MAGUKs, excluding DIg-like and ZO-l like proteins, contain a GMP binding site and an ATP 
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binding site similar in structure and GUK activity to the guanylate kinase that converts GMP to 
GDP using ATP as the phosphate donor (Dimitratos et aI., 1997; Anderson, 1996; Stehle & 
Schulz, 1990); SH3 domains (src homology 3) have been described in numerous cytoskeletal and 
signalling proteins, where they mediate direct protein-protein association and direct subcellular 
localisation and formation of multiprotein complexes. Unfortunately, interactions between the 
GUK domains of the MAGUKs and other proteins are not well characterised (Mayer, 2001). 
1.5 Dig and hDlg 
Several MAGUK proteins are important components of junctional complexes. The DIg protein 
is localised in various Drosophila epithelia at both smooth and septate junctions. They are 
specialised apicolateral cell junctions necessary for normal epithelial cell polarity and are 
considered to be the equivalent of mammalian tight junctions (Hough et aI., 1997; Woods et aI., 
1997). In epithelia, cell proliferation is partly controlled by local cell-cell interactions and lost of 
hDlg in epithelial cells indicated increased cell proliferation and caused neoplastic growth 
(Dimitratos et aI., 1997). A detailed study of mice transgenic for DIg protein lacking individual 
domains (as detailed below) has shown the essential functions of the domains by rescuing of the 
wild type from the mutant background (Woods et aI., 1996; Hough et at, 1997; Lue et at, 1996): 
1) Both PDZ1 and PDZ2 domains are sufficient for DIg association with a 30-kDa NH2-terminal 
domain of the cytoskeleton actin-binding family protein 4.1 that is conserved in 
ezriniradixinimoesin (ERM) proteins, although the link between DIg and the cytoskeleton is 
not very clear. 
2) The PDZ2 domain is necessary for restricting DIg membrane localisation to the septate 
junctions. In its absence the protein is localised over the entire plasma membrane. 
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3) Both PDZ2 and PDZ3 are required for cell proliferation control but not for epithelial 
structure. In the absence of either domain the protein rescued normal epithelial structure, but 
the rescued imaginal discs failed to support normal cell proliferation. This confirms that DIg 
may have a direct role in proliferation control signalling pathways. 
4) The SB3 domain is required for both growth control and maintenance of the epithelial 
structure. 
5) The HOOK domain is essential for DIg attaching to the plasma membrane and maintaining 
epithelial structure. In the absence of this domain, the protein is mainly found in the nucleus. 
6) The GUK domain is not directly involved in cell proliferation regulation but rather serves for 
DIg stabilisation. 
Mammalian DIg family members display similar structural characteristics to Drosophila DIg. 
Absence of DIg in Drosophila or of mammalian DIg in neuromuscular junctions indicates that 
this protein is involved in loss of synaptic bouton integrity (Lahey et aI., 1994). Other studies 
have shown the loss of DIg can disrupt both microfilaments and the microtubule networks 
(Woods et aI., 1996). Therefore, DIg plays a vital role in cell junction component organisation 
and cell-cell interactions. Another MAGUK protein member, ZO-I, which also has a C-terminal 
proline rich extension is a major component of tight junctions and may be involved in organising 
these junctions by recruiting a complex with occludin and binding with both actin 
microfilaments and a-catenin (Baskins et aI., 1998; Itoh et aI., 1997; Furuse et aI., 1994). This 
suggests that the MAGUK family is closely linked to the recruitment and function of cell 
junctions. Although most mammalian DIg homologues were first identified in neuronal tissues, 
all of these proteins are expressed in a variety of non-neuronal cell types including epithelial 
cells. In epithelial cells, recruitment of DIg to cell-cell contact sites is regulated by E-cadherin, 
furthermore, DIg binds to E-cadherin and localises together at adherens junctions (Reuver & 
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Gamer, 1998; Ide et aI., 1999). hDlg is located at intercellular contact sites in epithelial cells 
where it can bind to other cellular proteins including adenomatous polyposis coli (APC), a 
tumour suppressor, involved in the Wnt signalling pathway (Matsumine et aI., 1996; Goode and 
Perrimon, 1997). hDlg like other MAGUKs proteins also contains the protein interaction 
domains SH3, HOOK, guanylate kinase homologue and three PDZ domains (Matsumine et aI., 
1996; Marfatia et aI., 1996; Craven and Bredt, 1998). The PDZ domains in hDlg have 80-90 
amino acids, which bind with high affinity to C- terminal 4-amino acid motifs in partner proteins 
ending with carboxyl-terminal valine, isoleucine or leucine (V, I or L) (Harris and Lim, 2001). 
Previous studies have identified several viral oncoproteins including high-risk HPV E6 and 
Adenovirus 9 E4-0RFl and the Tax oncoprotein of HTLV-1 (Lee et aI., 1997; Suzuki et aI., 
1999) as proteins that can target hDlg, and in some cases E6 has been shown to target these 
proteins for proteasome-mediated degradation (Gardiol et aI., 1999; Kuhne et aI., 2000; Massimi 
et aI., 2004). Therefore, hDlg is proposed to be involved in the oncogenic transformation 
processes of diverse viruses (Kiyono et at, 1997; Lee et at, 1997). Importantly, only high risk 
HPV E6 can lead to hDlg degradation, and PDZ binding motifs are only present in high risk 
HPV E6 (Gardiol et aI., 1999). In addition, hDlg degradation is independent of high risk HPV 
E6 induced p53 degradation, highlighting hDlg as a viral oncoprotein target tumor suppressor for 
HPV cervical carcinoma pathogenesis (Gardiol et aI., 1999). High risk HPV E6 first interacts 
with the second PDZ domain of hDlg through a consensus PDZ-binding motif (X-S/T-X-V/I) 
located at the E6 C-terminus, subsequently recruiting endogenous ubiquitin ligase for 






Figure 5: Schematic diagram showing the location of hDlg at the membrane-cytoskeleton 
interface of epithelial cells at regions of cell-cell contact. Here hDlg co-localizes with E-cadherin 
and binds the APC tumour suppressor, which in turn regulates ~-catenin. The interaction 
between hDlg and APC is via PDZ domain 2 and this is the same domain targeted by the high 
risk HPV E6 proteins. Also shown is the interaction with protein 4.1 , which connects hDlg to the 
actin cytoskeleton (adapted from Mantovani and Banks, 2001). 
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1.5.1 hDlg cellular trafficking and degradation 
Previous studies found MAGUKs are associated with the cytoskeleton network. Microtubules 
were also found binding to PSD-93 in vivo, a member of MAGUKs, via its guanylate kinase 
(GK) domain binding to microtubule-associated protein lA; GK domain truncations were found 
to disrupt the GKIMAP-1A interaction in another member of MAGUKs, Drosophila discs-large 
(DIg) (Bremnan et aI., 1998; Kloker et aI., 2002). Moreover, with its GK domain, hDlg was 
found binding to GAKIN, a microtubule-interacting protein, in the cytoplasm of human T 
lymphocytes. The interaction suggested GAKIN acted as a cargo vesicle which facilitated hDlg 
coupling to the microtubule-based cytoskeleton and was vital for intercellular trafficking ofhDlg 
and its associated protein complexes (Hanada et aI., 2000; Asada et aI., 2003). The detail of the 
association between hDlg and the cytoskeleton and trafficking of hDlg to specialized cellular 
sites are still under investigation. 
Besides the association with the microtubule network, hDlg has also shown to be connected with 
the actin cytoskeleton through binding with hCASK and the 4.1/ERM cytoskeletal proteins to 
organsize cell membrane junctions and extracellular matrix (Lue et aI., 1996; Nix et aI., 2000). 
Although the details of hDlg degradation are not completely clear at this stage, the discovery of 
its binding to high risk HPV E6 elucidated an important route for its degradation. Previously, 
hScribble, a MAGUKs protein family member expressed at epithelial tight junctions, was shown 
to be a substrate for E6/EAP ubiquitin degradation (Nakagawa and Huibregtse, 2000). hDlg was 
also recently found to be degraded via the proteasomal pathway, by binding to high risk HPV E6 
but independent ofE6-AP (Mantovani et aI., 2001; Grm and Banks, 2004). It was proposed that 
the degradation mechanism of hDlg was complicated differed according to various cellular 
condition. This still has to be further clarified. 
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1.6 Gap junctions, connexon and connexins 
Cells in tissues and organs co-ordinate their activity by communicating directly with each other. 
Among the various cell contact mediated processes, gap junctions allow direct communication 
between adjacent cells (Fleming et aI., 2000). Gap junctions were firstly defined 
morphologically as special cell-cell contacts with narrow 2-3nm gaps that allowed direct 
intercellular exchange of critical regulatory ions and small molecules (e.g Ca++, C-AMP, 
glutathione), as well as macro-molecular materials of less than 1 kDa (amino acids; sugars, 
nucleotides, but not nucleic acids), between the opposing cells, providing direct coordination of 
electrical and metabolic functions, proliferation and differentiation (Cocle and Carfield, 1986; 
Churchchill and Louis, 1998; Evans and Martin, 2002). For example, the skin has numerous gap 
junctions involved in the co-ordination of keratinocyte growth and differentiation, whereas the 
abundance of gap junctions is thought to regulate the recycling of potassium ions during auditory 
transduction in the sensory inner ear epithelia (Choudhry et aI., 1997; Kikuchi et aI., 1995). 
GJIC is found in all multicellular animals (Bargiello et aI., 1987; Warner, 1988) and GJIC 
function is regulated by the number of intercellular channels present in the plasma membrane 
and the functionally permeable states of the channels. 
Gap junction numbers on cell membranes are regulated by several means: 1) connexin gene 
transcription regulation; 2) gap junction protein amount synthesised in the endoplasmic 
reticulum; 3) gap junction protein delivery to either the cell membrane or the lysosomes for 
degradation directly from the trans-Golgi network (Qin et aI., 2003); 4) connexins can be 
endocytosed via clathrin-coated pits; 5) from the endosome, connexins can be either recycled to 
the cell membrane or diverted to the plasma membrane or to lysosome for targeted degradation. 
Gap junction channels are typically open at rest and only close under specific circumstances; 
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however, the gating mechanism of gap junctions is the most complex of any ion channel. The 
elementary gating of the gap junction channel is controlled by multiple factors including calcium 
concentration, pH, voltage difference between the cells, phosphorylation of connexin C-terminus 
and a number of physiological stimuli, typically associated with increased cell division, such as 
growth factors and oncogenes (Harris, 2001; Lampe and Lau, 2000). The component proteins of 
gap junctions also have significant impacts on the selective permeability properties of the 
junctions (Steinberg et aI., 1994; Brissette et aI., 1994). 
Gap junction channels are intercellular structures formed of two "hemi-channels" or connexons. 
The connexons reside on the plasma membrane of cells and have three conserved cysteines in 
each extracellular loop to form the intramolecular disulfide bridges, so that connexons can dock 
end-to-end to another one on the neighbouring cell, forming a continuous aqueous pore through 
the lipid bilayer. A number of connexons cluster into supramolecular domains forming the 
familiar gap junction plaques between the adhesive cells (Zampighi et aI., 1980; Sikerwar et ai., 
1981; Kumar and Gilula, 1994). The hexameric connexon is formed by six identical connexins 
(homologous connexons) or some combination of expressed connexins (hybrid or heterologous 
connexons) (Rook et ai., 1992; Trosko and Ruch, 1998). An image of gap junction intracellular 
communication structure is shown in Figure (6). 
The gap junction proteins, connexins, have a common topology: four hydrophobic 
transmembrane a helices anchored into the lipid bilayer of the cell membrane; two extracellular 
loops allowing channels to couple with the opposing connexon; one cytoplasmic loop; and a N-
and C-terminal region located on the cytoplasmic membrane face. The connexin sequences are 
most conserved in the transmembrane and extracellular domains and the key functional 
differences between connexins are determined by amino acid differences in these domains; while 
the most sequence variation happens in the cytoplasmic loop and C-terminus (Bruzzone et aI., 
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1994; White et aI., 1995). A schematic diagram of a general connexin is shown in Figure (7). 
Various functional properties have been assigned to specific linear domains in connexins. Site-
directed mutation analyses have shown the second extracellular domain and the middle of 
cytoplasmic portion are responsible for heterotypic compatibility and facilitating docking 
between opposing connexins, whereas the first extracellular loop might be part of a voltage 
sensing mechanism (White et aI., 1994; 1995; Bruzzone et aI., 1994). The third transmembrane 
domain is suspected to contribute to the channel wall formation (Unwin, 1989; Rubin et aI., 
1992). It has been reported that the sequence and the length of the connexin cytoplasmic loop 
and C-terminus serves as a gating control particle like a "ball and chain" model, where the 
carboxyl tail swings around to interact with the intracellular loop. This may be critical in 
regulating connexin chemical gating and pH sensitivity (Anumonwo et aI., 2001, Moreno et aI., 
2002). The deletion of some connexin C-termini seems to have little effect on assembly of gap 
junctions, yet several residues in most connexin (except connexin 26) C-terminal domains are 
phosphorylation targets for more than one protein kinase, suggesting connexins could have 
functions independent of the gap junction exchange channel (Morley et aI., 1996; Homma et aI., 
1998; Kadle et aI., 1991; Kanemitus et aI., 1997; Martin et aI., 2000). Functional studies on 
connexin carboxyl tails also suggested they can interact with other cell junctional proteins and a 
number of cytoplasmic partners (Furuse et aI., 1993; Singh and Lampe 2003). Finally, the N-
terminus behaves as a calmodulin-binding domain and plays an important part in connexin 
membrane targeting and insertion. Connexin N-terminus also plays an important role in 
controlling gap junction voltage gating mechanisms (Welsh et aI., 1982; Suchyna et aI., 1993; 
Martin et aI., 2000). Since the first cloned connexin gene was reported in 1986,20 mouse and 21 
human connexin genes have been identified. Connexins can be divided into three subgroups 
(a,/3 and y) with respect to their extent of sequence identity and length of cytoplasmic loop 
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(Table 3) (Eiberger et aI., 2001; Sohl and Willecke, 2004). Connexin 43 is regarded as the most 
widely expressed connexin and intensive investigations have been carried out to search for 
linkages between its mutations/cellular changes and human diseases. Several studies have 
shown that Connexin 43 is involved in regulating cell proliferation and cell signalling cascades 
independently of GJIC functions. For example, Connexin 43 can be phosphorylated on tyrosine 
residues in the C-terminus by Src and this can activate anti-apoptotic progression through the 
SrclERK signalling pathway (Plotkin et aI., 2002). Connexin 43 also promotes degradation of S 
phase kinase-associated protein 2 (Skp2), the human F-box protein that regulates the 
ubiquitination and degradation ofp27 (Zhang et aI., 2003). 
Gap junctions mediate cell coupling in almost all tissues, the size and number of gap junctions 
per cell depends on the cell cycle and physiological state of the organism/tissue and exposure to 
various environmental factors. Though evidence shows that expression of a single connexin in 
one cell is sufficient to establish gap junction intercellular communication, many cells contain 
more than one type of connexin. The observation of connexin expression in different organs or 
tissues suggests that the same connexin might be regulated distinctly in different cell types, some 
connexins are ubiquitously expressed but other connexin expression show restricted expression 
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Figure 6: Model of gap junctions, connexons and connexins. Six homomeric/heteromeric types 
connexin subunits in each plasma membrane dock to generate the gap junction channel 
connecting two cytoplasmic compartments (adapted from Richard, 2000). 
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Figure 7: A schematic diagram of a general connexin including the structural motifs and their 
presumed functions. M1-M4, transmembrane domains 1-4; E1IE2, extracellular domain1 and 2; 




a-Group connexins I3-Group connexins 
. 
mCx30.2 hCx31.9 mCx26 hCx25 
mCx33 hCx37 mCx30 hCx26 
mCx37 hCx40 mCx30.3 hCx30 
mCx40 hCx43 mCx31 hCx30.3 
mCx43 hCx46 mCx31 .1 hCx31 
mCx46 hCx50 mCx32 hCx31.1 
mCx50 hCx62 hCx32 
mCx57 hCx59 
-y-Group connexins Non-grouped connexins 
. 
mCx45 hCx45 mCx23 hCx23 
mCx47 hCx47 mCx29 hCx30.2 
mCx36 hCx36 
mCx39 hCx40.1 
Table 3: The connexin gene family and its subgroup distribution in mouse and human. This table 
reflects the current state of the sequence information available from the NCBI database 
(http://www.ncbi .nlm.nih.gov/genomes/static/euk _ g.html). 
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1.7 Connexin protein-protein interactions 
Connexins have been traditionally regarded as simple gap junction channel proteins, but more 
and more evidence suggests connexins can interact with plasma membrane and cytoplasmic 
proteins either directly or forming multi-protein complexes to regulate cell structure and/or 
function (Zimmer et aI., 1987; Fu et aI., 2004). Such interactions tend to regulate connexin 
function at several levels, including connexin assembly, trafficking, gating and degradation. 
Furthermore, these interactions are associated with other cellular mechanisms responsive to 
stimulation or pathological conditions (Thomas et aI., 2002; Moreno et aI., 2002). Connexins 
have similar sequence from the N-terminus to the fourth transmembrane domain but can vary in 
their carboxyl terminal domains. There are protein-protein interacting motifs in these C-terminal 
domains which suggests these regions might play an important role in individual connexin gap 
junction independent functions (Toyofuku et aI., 1998; Kausalya et al., 2001). Connexin 43 is 
the most studied gap junction protein, its C-terminus contains sm, SH3 and PDZ binding 
domains that may facilitate the association of Connexin 43 and its binding proteins. A schematic 
diagram of possible protein interactions between the connexin 43 C-terminal domain and 
potential partners is shown in Figure (8). It has been shown that via the C-terminal domains, 
Connexin 43 and other several connexin types can interact with adherens junction-associated 
proteins, tight junction-associated proteins, cytoskeletal proteins and some protein kinases, 
including: 
• ZO-I, a plasma membrane scaffolding protein belonging to the MAGUK family, which is an 
actin-binding, signal transduction molecule and cross linking protein that interacts with a 
large number of proteins involved in cell-cell contact. ZO-1 is specifically enriched at tight 
junctions of epithelial and endothelial cells (Stevenson et aI., 1986). The C-terminal domains 
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of Connexins 43, 46 and 50 possess similar residues, which interact with the PDZ2 motif in 
ZO-l via its PDZ domain in several cell types and these interactions are regulated by 
phosphorylation via Src tyrosine kinases (Giepmans et aI., 2001; Nielson et aI., 2003; 
Toyofuku et aI., 1998). The last four amino acids (DLEI) in the C-terminus of Connexin 43, 
especially the isoleucine site, were reported to be critical for binding with ZO-l (Giepmans et 
aI., 2001). The binding of ZO-l and connexins suggests ZO-l might serve as a scaffold in 
gap junction assembly and/or recruiting signal molecules for connexin mediated intracellular 
singalling. 
• At cell contact sites, gap junctions are often seen by electron microscopy very close to 
adherens junctions (Peters et aI., 1994). Functional inhibitors of Cadherin, (e.g.EDTA), can 
also disrupt gap junctions and inhibit cell coupling. Conversely, inhibition of Connexin 43 
also can block adherens junction formation (Meyer et aI., 1992; Hertig et aI., 1996). In 
adherens junctions, the cadherin cytoplasmic domain binds to a/~-Catenin (Piepenhagen and 
Nelson, 1993). Both E-cadherin and a-catenin were found co-localised with connexin 26 
and 32 during gap junction formation and ~-catenin was co-localised with connexin 43 to 
form connexin 43/Z0-l/~-catenin complex for connenxin 43 plasma membrane targeting 
(Fujimoto et aI., 1997; Wu et aI., 2003). 
• Previous work has shown connexin 43 gap junctions in a close association with cytoskeletal 
proteins. Several studies have shown connexin 43 binds to a- and ~-tubu1in via its C-
terminal domain (Giepmans et aI., 2001; Singh and Lampe, 2003). It seems the binding of 
connexin 43 to tubulin is involved in microtubule stabilisation and regulation of connexin 43 
recruitment and distribution; furthermore, disruption of microtubules with nocodazole can 
inhibit connexin 43 recruitment on plasma membranes in NRK cells (Giepmans et aI., 2001; 
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Guo et aI., 2003; Thomas et aI., 2001). Connexin 43 was found co-localised with F-actin in 
rat astrocytes in culture (Yamane et aI., 1999); recently, Connexin 43 was found 
immunuprecipitated and co-localised with the actin-binding protein, drebrin (Butkevich et 
al.,2004). The authors suggested that the binding might direct connexins into degradative 
cellular pathways. 
• All the known connexins, except Connexin 26 whose C-terminus is quite short, can be 
phosphorylated at their C-terminal domains (Herve and Sarrouilhe, 2002). Connexin 43 was 
found to be a substrate for more than 10 different protein kinases at different sites of its C-
terminal domain (Herve and Sarrouilhe, 2002). Among them, Src was shown to regulate the 
interaction of connexin and ZO-l (Toyofuku et aI., 2001); Src phosphorylation on tyrosine 
residues in the Connexin 43 C-terminus can activate anti-apoptotic progression through the 
SrclERK signalling pathway (Plotkin et aI., 2002); and Connexin 43 phosphorylation by 
protein kinase C (PKC) was linked to the cell cycle phases and a reduction in gap junction 
channel conductance (Lampe et aI., 2000; Solan et aI., 2003). Phosphorylation of connexin 
56 by PKC also caused decreased gap junction communication, whereas Connexin 32 
phosphorylation by cAMP-dependent PKA caused improved intercellular communication 
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Figure 8: Connexin 43 C-tenninal protein binding domains and their potential protein partners 
(Adapted from Herve et aI., 2002). 
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1.8 Connexin cellular trafficking and degradation 
The regulation of connexin assembly, trafficking and turnover may be important in the control of 
intercellular communication (Lampe et aI., 1998; Alford and Rannels, 2001; Paulson et aI., 
2000). Connexins follow the general secretory pathway for most membrane proteins that are 
synthesized by membrane-bound ribosomes and delivered by vesicular trafficking from the 
endoplasmic reticulum via the Golgi apparatus to the cell membrane, although connexins are not 
glycosylated in the Golgi (Musil and Goodenough, 1993). Trafficking of Connexin 43 among 
these compartments requires interactions with cytoskeletal elements, the biological mechanism 
and process of this association is poorly understood. 
Actin filaments and/or microtubules, could be involved in a number of aspects of gap junction 
assembly, such as restricting or facilitating the movements of connexins within the membrane, 
regulating or directing the transport of connexins from the cytoplasm to the plasma membrane, 
or affecting the recycling and turnover of connexins. There have been widely varying results in 
different system from previous studies addressing the relationship between gap junction 
assembly and actin filaments and/or microtubules (Martin et aI., 2001; Johnson et aI., 2002; Lauf 
et aI., 2002). 
Actin filaments have been observed closely associated with gap junctions although there is no 
evidence for their direct linkage (Woo-Kuen et aI., 1994; Yamane, 1999). However, connexin 
association with actin-associated cell junction proteins, cadherins and ZO-I, raises the possibility 
that Connexin 43 can be indirectly linked to a cell surface network that includes actin filaments 
(Van Vee et aI., 2002; Hernandez-Blazquez et aI., 2001; Taliana et aI., 2005). The role of 
cytoskeletal actin in gap junction assembly has been studied using cells treated with cytochalasin 
B to disrupt actin filaments. This has been reported to impair connexin 43 assembly and 
decrease GJIC (Wang and Rose, 1995; Theiss and Meller, 2002), or elongate gap junction 
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aggregates and a decrease the fonnation of plaque areas or not link gap junction assembly 
(Rassat et aI., 1982; Kidder et aI., 1987). Based on these varied studies, the precise role of the 
actin filaments in gap junction dynamics is not clear, particularly with regard to the assembly 
processes. 
Binding studies have suggested there is a direct association between microtubules and Connexin 
43 (Giepans et aI., 2001; Singh and Lampe, 2003; Paulson et aI., 2000; Lauf et aI., 2002). 
Nocodazole, an inhibitor oftublin polymerization, has been employed to examine the mechanism 
of microtubules in transport of connexin 43. These experiments have shown that abnonnal 
microtubule aggregation is accompanied by impeded translocation of connexin 43 from the cell 
interior to the plasma membrane, and a clear reduction of plasma-membrane-integrated 
Connexin 43 at cell contact points (Johnson et aI., 2002; Guo et aI., 2003; Giessmann et aI., 
2005). Furthennore, Nocodazole blocks the forskolin-enhanced increase in the expansion of gap 
junctions on the cell membrane and, in living MDCK cells, reduces the movement of transport 
intermediates containing green fluorescent protein-tagged connexion 43. Thus, microtubules 
appear to be necessary for enhanced GJ growth and likely for facilitating connexin trafficking 
under basal conditions (Jordan et aI., 1999; Johnson et aI., 2002). 
Failure of integral membrane proteins to assemble/associate correctly in the ER/Golgi leads to 
degradation by either ubiquitin- proteasome or endosome-lysosome degradation system (Hurtley 
and Helenius, 1989; Arvan et aI., 2002). The assembly of connexins into connexons has been 
reported to occur in the trans-Golgi network, but has been detected in the endoplasmic reticulum-
Golgi intermediate subcellular compartments (Diez et aI., 1999). Connexin transportation from 
the plasma membrane to the endosome is supposed to be mediated by the signals present from 
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connexin cytoplasmic domains like other membrane proteins (Thomas et aI., 2003; Segretain et 
aI., 2003). 
Connexin 43 composes highly mobile plasma membrane domains with rapid turnover rates 
ranging in half-life from 1.5-5 h, depending on the cell type studied (Fallon and Goodenough, 
1981; Laird et aI., 1991; Laird, 1996; Gaietta et aI., 2002). Previous work has shown both the 
lysosome and the ubiquitin-proteasome system to be involved in Connexin 43 degradation (Liang 
and Beyer, 1995; Laing et aI., 1997). Connexin 43 lysosomal turnover seems to be primarily 
involved in the destruction of internalized gap junctions and degradation of overexpressed 
protein or even some native Connexin 43 delivered from early secretory compartments (Naus et 
aI., 1993; Jordan et at, 1996; Qin et aI., 2003; Leithe and Rivedal, 2004). Connexin 43 
proteasomal turnover is mainly required for the degradation of mutantlmisfolded Connexin 43 in 
the endoplasmic reticulum-associated degradation pathway; furthermore, proteasomal activity 
mostly affects the stability of newly synthesized plasma Connexin 43 (VanSLyke et at, 2000; 
VanSLyke and Musil, 2002; Leithe and Rivedal, 2004). However, the mechanisms that lead 
Connexin 43 to one or both degradation pathway is not clear. 
1.9 Connexin and diseases 
Gap junction deficiency and connexin mutations have been long speculated as being associated 
with a wide spectrum of human diseases, with clinical and genetic evidence. The relationships 
between connexins and human genetic diseases/connexin-deficient mouse models are shown in 
Table (4). Several transgenic and knockout model systems have provided evidence that gap 
junctions play a vital role in embryonic development. For example, GJIC is linked to chick limb 
bud patterning and connexin 43 distribution can affect mouse heart myocyte differentiation 
(AlIen et aI., 1990; Fromaget et aI., 1992). Connexin 32 mutation is associated with a peripheral 
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neuropathy, X-linked Charcot-Marie-Tooth (CMTX) disease, which is a demyelinating 
syndrome with a progressive degeneration-induced defect in Schwann cells (Bergoffen et aI., 
1993; Nelis et aI., 1999). In addition, connexin 32 knockout mice are more susceptible to 
chemically induced liver carcinogenesis (Nelles et aI., 1996). As in skin, there are many 
connexins in the inner ear, and during auditory transduction through the inner ear, gap junctions 
supposedly precisely regulate ionic flow especially of potassium ions between the contacted 
sensory cells (Forge et aI., 1999). It has been reported that at least five types of connexins, 
including connexin 26,30,31,32 and 43, are involved in syndromic or nonsyndromic deafness 
(Kelsell et aI., 2001). Connexin 26 is essential for cochlear cell function and survival in the inner 
ear and mutations in Connexin 26 are leading causes for genetic hearing impairment, while 
epidemiological trials have proved 50% of inherited asymptomatic sensoneural deafness is 
linked to connexin 26 mutations (Kelsell et aI., 1997; Cohen-Salmon et aI., 2002). Mutations of 
connexin 26 are increasingly found associated with skin development and processes such as skin 
wound healing and cell differentiation (Rouan et aI., 2001; Brandner et aI., 2003). Another type 
of skin disorder termed as erythrorokeratoderma variabilis (EKV) is linked to connexin 31 and 
30.3 mutations (Richard et aI., 1998; 2003); in the lens, mutations of connexin 46 and 50 are 
linked to cataract abnormalities (Pal et aI., 2000). Connexin 43 mutations are involved with 
oculodentodigital dysplasia (ODDD), which is a human congenital disease characterised by 
abnormal face, eye, limb and dentition development (Paznekas et aI., 2003). Gap junctions are 
vital in cardiac development and functions, they mediate electrical impulse spread and actuate 
synchronous contraction of the cardiac chambers. Connexin 43 is the major connexin expressed 
in adult mammalian myocardium and essentially responsible for electrical synchrony conduction 
(Severs, 2001). Furthermore, the connexin 43 deficiency could cause arrhythmic heart failure or 
dysfunction (Gutstein et aI., 2001). 
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Mouse Cell and tissues with major Phenotype(s) of Cx- Human 




















n.s. n.s. n.s. hCx25 
breast, skin, cochlea, liver, lethal on E011 sensorineural hearing loss, hCx26 
placenta palmoplantar hyperkeratosis 
myelinated cells n.s. n.S. 
skin, brain, cochlea hearing Impairment nonsyndrornichearing loss, 
hydrotlc ectodermal dysplasia 
hair loss, nail defects and often 
mental deficiency 
n.s. n.s. n.s. 
skin n.s. erythrokeratoderma variabilis 
skin, cochlea uterus, transient placental hearing impairmen~ 
placenta dysmorp!1ogenesis erythrokeratoderma variabilis 
skin n.s. n.S. 
liver, Schwann cells, decreased glycogen CMTX, (one of the heredftary 
oligodendrocytes degradation, Increased liver peripheral neuropathies) 
carcinogenesis 
testis I1.S. 
neurons retina visual deficits n.s. 
endothelium, ovalias female slelilily, intensive n.s. 
bleeding 
n.s. n.s. n.s. 
heart, endothelium atrial arrhythmia n.s. 
many cel typas and tissues heart malformation and visceroatrial heleroataxia? 
ventricular arrhythmia 
heart, endothelia, neurons lethal on EO 10.5 n.s. 
lens zonular nuclear cataract congenital cataract 
brain, spinal cord n.s. n.s. 
lens microphthalmia, zonular zonular pulverulant cataract 
pulverulant and congenital 
cataract 
n.s. n.s. n.s. 



















0.5. not studied. EO, embryonic days. 
Table 4: Human inherited diseases associated with various connenxin mutations and the 




1.10 Connexins and cancer 
The hypothesis that gap junctional intercellular communication is involved in cancer progression 
arose from the observation that some types of cancer cells did not communicate through gap 
junctions (Loewenstein and Kanno, 1966; Kanno and Matsui, 1968). It seemed reduced gap 
junctional intercellular communication might be a general characteristic of cancer cells 
associated with uncontrolled cell growth (Loewenstein, 1979). It was postulated that lack of gap 
junctions (or lack of function) could prevent cell-to-cell diffusion of regulatory molecules or ions 
that was a prerequisite to cell growth control regulation (Loewenstein, 1979). A body of 
evidence has accumulated to show that GJIC may be lost during malignant progression, eg: 
HPV-positive cervical cancer (McNutt et aI., 1971; Krutovskikh and Yamasaki, 1997; King et 
aI., 2000; Aasen et aI., 2003). Connexin 43, the most widespread connexin and a major 
component of gap junctions in stratified epithelia, has been seen to be down-regulated in 
epithelial carcinoma cells (Carystinos et aI., 2001; Naus, 2002). Interestingly, several studies 
reported contradictory upregulation of gap junction in some cancer cells. For example: 
Connexin 26 is often upregulated in psoriatic epidermis and viral warts (Lucke et aI., 1999). At 
least four different types of solid tumors were well coupled (Sheridan, 1970) and a rat bladder 
carcinoma cell line exhibited a better intercellular communication than their normal counterparts 
(Asamoto et aI., 1994). 
The PKC activators, phorbol esters, which are tumor promoters, are powerful gap junction 
intercellular communication inhibitors in various cultured cell lines, suggesting that inhibition of 
gap junctions is a prerequisite for cancer expansion (Kwak et aI., 1995; Wagner et aI., 2002). 
From then on, many accumulated data has shown most tumor promoters and oncogenes (such as 
ras, raf, src et a1.) can inhibit gap junction intercellular communication in human or animal cell 
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lines at subtoxic doses (Beer et aI., 1988; Budunova and Williams, 1994; Rivedal et aI., 1996). 
Further evidence with specific connexin antibodies has shown in transformed cells, some tumor 
promoter agents not only decrease gap junction communication but also relocate connexins into 
cytoplasmic compartments (Bager et aI., 1994; Krutovskikh et aI., 1995), which suggests the 
cytoplasmic aberrant connexin was significantly associated with reduced gap junctions 
communication and increased cell hyperproliferation. Although there is no direct proof 
authenticating the lack of gap junctional intercellular communication as the cause of cell 
hyproliferation, it seems to favour cancer cell clonal expansion (Mesnil and Yamasaki, 1993). In 
vitro transformed fibroblast and epithelial cells either lack gap junction intercellular 
communication completely or are still able to communicate among themselves but are blocked 
from communication with surrounding normal counterparts (Enomoto and Yamasaki, 1984; 
Mehta et aI., 1986). This supports the hypotheses that loss of gap junctions has a role in cancer 
progression. It is important to note in some transformed cases the molecular processes affecting 
cell coupling are different in human and in rat. For example, Connexin 32 is relocated in 
cytoplasmic compartments in human liver tumors, but it is completely deleted in rat liver tumors 
(Fitzgerald et aI., 1989; Krutovskikh et at, 1994); while certain cancer cells still able to 
communicate through gap junctions despite their malignancy, show enhanced tumorigenicity 
after gap junctional intercellular communication abrogation which occurred in rat bladder 
squamous cell carcinoma cells (Asamoto et aI., 1998). These accumulated data suggest that 
although aberrant cell coupling is an extensive phenotype in a wide range of transformed cells 
independent of original tissues, organs and species, the situation is much more complex than 
suspected and dependent on the individual characteristic of the original cells and tissue. Since 
many transformed/tumorigenic cells have been reported to exhibit reduction of gap junctional 
intercellular communication, it is interesting to investigate whether restoration of gap junction 
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capacity could normalize or delay the tumorigenicity in these cells. Some known antineoplastic 
agents such as retinoids, vitamin D and cAMP were found to upregulate gap junctional 
intercellular communication (Trosko and Chang, 2001). More importantly, in vitro and in vivo 
evidence has shown that transformed or tumorigenic cell lines transfected with wild type 
connexin cDNAs such as Connexin 43 and 26, which are normally expressed in cells from the 
originating tissue, have proportionally decreased cell proliferation, restored cell differentiation, 
induced cell apoptosis, and gap junction intercellular communication (Yamasaki et aI., 1999; 
Mao et aI., 2000; Tanaka and Grossman, 2001). However, it was reported that Connexin 43-
transfected HeLa cells decrease invasive properties (Graeber and Hulser, 1998). These data 
suggest connexins might act as tumor suppressors affecting some cancer cells from certain types 
of tissue. So far, the role of gap junction intercellular communication and connexins in cell 
carcinogenesis is still unclear and under investigation. 
1.11 Connexins and HPV associated Carcinogenesis 
It was found that the number of gap junctions was decreased correlating with the severity of the 
morphological alteration in the dysplastic cervical epithelium and gap junction deficiency could 
occur during the development of HPV positive cervical malignant carcinomas (McNutt and 
Weinstein, 1969; McNutt et aI., 1971). During malignant progression in HPV positive cervical 
carcinogenesis, cancer cells only arise from limited individual colonies of the HPV-infected 
immortal cells. Consequently, it was proposed that there are several important molecular and 
cellular changes other than inhibition of p53 and pRb participating in HPV -associated cancer 
progreSSIOn. Gap junctional intercellular communication is abrogated in high-risk HPV-
associated cancer cells such as HeLa. It was reported that gap junctional intercellular 
communication is reduced in HPV -16 transformed rat myoblasts although these cells are not 
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normal a target for HPV infection (Ennaji et aI., 1995). BPV E5 was found to interact with 
16kDa ductinlsubunit c and was deemed responsible for the down-regulation of gap junction 
intercellular communication and the inhibition of acidification of endomembranes (Campo, 
2002). HPV-16 E5 was suggested to reduce cell coupling in transfected HaCaT cells (Oelze et 
aI., 1995). Connexin 43 which is the most common type in epithelia was found decreased in 
cervical dysplasia (King et aI., 2000). Recently, our group demonstrated that Connexin 43 is 
relocated from the membrane to the cytoplasm in a novel HPV -16-containing cervical epithelial 
cell line that is fully transformed and invasive and deficient in gap junction intercellular 
communication, in contrast to the parental cell line in which connexin 43 localises to cell 
junctions, providing extensive gap junction intercellular communication (Aasen et aI., 2003). 
HPV16 is the cause of over 60% of human cervical cancers. The high-risk HPV E6 proteins are 
found localized largely in the nucleus but also appear in the cytoplasm and HPV E6 is known to 
interact with several cytoplasmic proteins which could affect connexin assembly in the 
cytoplasm or gap junction targeting to the cell membrane which is believed to play a role during 
the initiation phase of invasion of cervical tumors. These results suggested that loss of gap 
junction intercellular communication may occur in a gradual fashion at a relatively late HPV-16 
associated cervical carcinogenesis stage. The exact role of connexins and gap junction 
intercellular communication in HPV -associated carcinogenesis is yet to be investigated. 
1.12 Project aim 
The overall aims of this project were: 
1) to identify gap junction related gene expression changes from immortal to invasive stage 
during the progression of HPV -16 positive cervical carcinogenesis; 
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2) to identify the relationship between the most common gap junction protein, Connexin 
43, and hDlg, a tumor suppressor in MAGUK protein gamily; 
3) investigation of the contribution of high risk HPV to loss of gap junction intercellular 
communication; 
4) to investigate the mechanism of transporting and degradation of Connexin 43 in HPV 
positive cervical cancer. 
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2.1 Materials 
2.1.1 Plasmids 
2. Materials & Methods 
p3XFLAG-CMV™-1O Expression Vector (E440l): For stable, cytoplasmic expression of 
N-terminal Met-3XFLAG fusion proteins. Stable expression is accomplished by 
neomycin selection (G 418 sulfate), ampicillin resistant. 
p3XFLAG-CMV™_14 Expression Vector (E490l): For stable, cytoplasmic expression of 
C-terminal 3XFLAG fusion proteins. Stable expression was accomplished by neomycin 
selection (G 418 sulfate), ampicillin resistant. 
Both of the plasmids were purchased from Sigma-Aldrich Company Ltd, UK. Map in 
Appendix 1&2. 
2.1.2 Enzymes and kits 
All the restriction enzymes and CIP were purchased from New England Biolabs, UK. 
Pfu polymerase, Taq polymerase, dNTPs, RNasin and RNase-free DNase 1 were 
purchased from Promega, UK. T4 DNA ligase, Oligo dT(12-18) primer and RNase H was 
purchased from Invitrogen, UK. 
RNeasy mini kit and QIAquick gel extraction kit were purchased from Qiagen Ltd, UK. 
Superscript™ II Reverse Transcriptase Kit was purchased from Invitrogen, UK. Wizard 
Plus SV Minipreps DNA isolation system was purchased from Promega, UK. 
2.1.3 Cell culture reagents 
Dulbecco's modified Eagle's medium (DMEM), fetal calf serum (FCS), L-glutamine and 
trypsin were purchased from Gibco BRL, UK. Keratinocyte growth medium (KGM) was 
purchased from Cambrex Bio Science Walkesville Inc, UK. 
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LipofectamineTM was purchased from Invitrogen, UK. G4l8, ALLN, MG 132, 
Phalloidin-TRITC and Leptomycin B were purchased from Sigma-Aldrich Company Ltd, 
UK. All the cell culture plastics were purchased from Coming Inc., UK; or Nunc A/S, 
UK. 
2.1.4 Common chemicals and buffers 
All the chemicals were purchased from Sigma Chemical Co. or BDH Chemicals, UK 
except the following: 
• 25nM MgCh, 10X PCR buffer, andlkb DNA ladder purchased from Promega, UK. 
• Protein A-Sepharose beads, the Rainbow marker, ECL Western blotting reagents and 
Hybond-P nitrocellulose membrane purchased from Amersham Biosciences Ltd, UK. 
• Agarose MP, protein inhibitor cocktail tablets, and ampicillin sodium BP purchased 




X -Omat film purchased from Kodak, UK. 
Formaldehyde, formamide from Fluka, UK. 
30% Acrylamide, glacial acetic acid, Butan-2-ol, glycerol and isopropanol from 
Prolab, UK. 
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All the buffers were prepared following the comments in Table (5). 
Table 5: Buffer comments. 
Solution Comment 




(prepared just prior to retrieving paraffin section antigen with 
the pressure cooker) mixed 18ml of solution A (9.6g citric 
acid in 500ml distilled water) with 82ml of solution B (14.7g 
Tris-Sodium-Citrate in 500ml distilled water) and made up to 
1000ml. 
Coomassie stain solution 0.02% (w/v) Coomassie Brilliant Blue™, 50% (v/v) 
methanol, 7% (v/v) acetic acid 
Diethyl Pyrocarbonate 200111 DEPC incubated with 500ml distilled water overnight 







5% (v/v) methanol, 10% (v/v) acetic acid 
20% sucrose (w/v), 5% formaldehyde (v/v) in PBS 
1% Triton X-lOO, 0.5% CHAPS, 0.1% SDS with 15% fresh 
protein inhibitor cocktail (Roche, UK) in PBS 
170mM NaCl, 3.4mM KCl, 10mM Na2HP04, 1.8mM 
KH2P04, pH7.2 
PBS containing 0.05% (v/v) Tween 20 
70% (v/v) acetone, 30% methanol (v/v) 
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7X protease inhibitor one tablet dissolved in 1.5ml distilled water 
cocktail 
2X protein loading 125 mM Tris (PH 6.8), 4% SDS, 20% glycerol, 10% 
buffer mercaptoethanol and 0.006% bromophenol blue, 15% (v/v) 
fresh protein inhibitor cocktail (Roche, UK) 







O.2M Tris base, 0.05 M EDTA (PH 8.0) 
890mM TRIS, 890mM boric acid, 10mM EDTA 
10mM Tris-HCl (PH 8.0), 1mM EDTA 
0.25% (w/v) trypsin in Tris-saline containing phenol red, 
adjusted to pH 7.5 with NaHC03 
0.6mM EDTA in PBS, 0.002% phenol red 




0.288mM p-Mercaptoethanol, 2% v/v SDS, 62.5mM Tris pH 
6.8 
65 
2. Materials & Methods 
2.1.5 Antibodies 
Table 6: List of antibodies, sources and dilutions. 
Antibodies Antibody Catalogue Western IFA Sources 
type or clone blotting dilution 
no. dilution 
----~-,~-~~.---.-~,-~--~~,,~-
l3-catenin MAM 610156 1:100 1: 1 00 . Transduction 
Laboratories 
E-cadherin MAR G-10 1 :100 1:100 Santa Cruz Biot. 
Cx26 MAM 138100 1:500 Zymed, UK 
Cx26 RAR 71-0500 1:500 Zymed, UK 
Cx30 RAM 71-2200 1:500 . Zymed, UK 
Cx43 RAR from aa 1 :1000 1:1000 gift from Dr E. Rivedal, 
363-382 Norway 
Cx43 MAR 13-8300 1:500 Zymed, UK 
Flag RAR F7425 1:320 1:160 Sigma, UK 
GAPDH MAR H86540M 1 :1000 Biodesign International 
hDlg MAR sc9961 1:400 1:25 Santa Cruz Biot. 
HPV-16 E6 RAG sc1583 1:200 1:100 Santa Cruz Biot. 
HPV-16E7 M ED17 1:100 Santa Cruz Biot. 
involucrin M SY5 1 :1000 1:1000 Sigma, UK 
Ki-67 MAR MIB-1 1:100 1:100 DAKO,UK 
p53 MAR 1:1000 gift from Prof R White 
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pRb RAR 1 :1000 gift from ProfR White 
tubulin MAR MCA77G 1:200 Serotec Ltd, UK 
ZO-l RAH 61-7300 1:250 1:100 Zymed, UK 
Anti-mouse FITC FI2000 1:100 vector labs, UK 
Ig TexasRed TI2000 1:100 vector labs, UK 
HRP 1:1000 Diagnostic Scot 
Anti-goat Ig FITC F1763 1:100 Sigma, UK 
Anti-rabbit Ig FITC FIIOOO 1:100 vector labs, UK 
TexasRed TIIOOO 1:100 vector labs, UK 
HRP 1:1000 Diagnostic Scot 
Anti-EEAl M Ab15846 1:500 AbcamLtd. 
Anti-EEAl RAR Ab2900 1:250 Abcam Ltd. 
Anti-MPR M Ab 2733 1:500 Abcam Ltd. 
Anti-MPR RAP Ab16417 1:200 AbcamLtd. 
Anti-Golgi RAR GM130 1:400 Gift from Dr. Xiaohong 
Shi 
• M, mouse monoclonal; R, rabbit polyclonal; AM, anti-mouse; AG, anti-goat; AH, anti-human; 
AR, anti-rat. 
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2.1.6 Cell lines 
HaCaT - HPV negative spontaneously immortalized aneuploid human keratinocyte cell 
line (Boukamp et aI., 1998) 
W12 - HPV 16 positive but non-malignant cervical epithelial cell line developed from a 
low-grade lesion (Stanley et aI., 1989) 
W12E - Subclone from parental W12 cell line harbouring extrachromosomal copies of 
HPV 16, known as 20863 (Jeon et aI., 1995). 
W12G - Subclone from parental W12 cell line harbouring integrated copies of HPV 16, 
known as 20861 (Jeon et aI., 1995). 
W12GPX - Feeder-independent sub clone established from W12G cell (Aasen et aI., 
2003) 
W12GPXY - Feeder and mitogen-independent malignant sub clone established from 
W12GPX cell, (Aasen et aI., 2003) 
W12GPXYwcx43 - W12GPXY cells stably transfected with the pC-terminus 3XFLAG-
fused wild-type human Connexin 43 plasmid (original from p3X FLAG-CMVTM-14 
plasmid) during this study. 
W12GPXY Tcx43 - W12GPXY cells stably transfected with the pC-terminus 3XFLAG-
fused last 5 amino acids truncated human Connexin 43 plasmid (original from p3X 
FLAG-CMVTM-14 plasmid) during this study. 
CaSki - HPV 16 positive cervical cancer cell line derived from cervical squamous cell 
carcinoma harbouring ~600 integrated viral copies (Pattillo et aI., 1997). 
C33a - HPV negative but p53 mutated cervical carcinoma cell line (Crook et aI., 1991). 
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C33aWHPV18E6 - C33a cells stably transfected with the pN-terminus 3XFLAG-fused 
HPV18 wild E6 plasmid (original from p3X FLAG-CMVTM-I0 plasmid) during this 
study. 
C33aMHPv18E6 - C33a cells stably transfected with the pN-terminus 3XFLAG-fused 
Thr156Glu mutant HPV18 E6 plasmid (original from p3X FLAG-CMVTM-I0 plasmid) 
during this study. 
HBF - Human breast primary fibroblasts cells from reduction tissue. 
2.2 Methods 
2.2.1 Small scale preparation of plasmid DNA (mini-preps) 
The small-scale extraction of plasmid DNA was prepared from the bacterial culture using 
Wizard Plus SV Minipreps DNA isolation system (A1330, Promega) following the 
manufacturer's protocol. Single colonies of transformed bacteria were dipped into 5 ml 
of L-broth containing 100/-1g/ml ampicillin and incubated with shaking overnight at 37 
QC. Overnight-cultured bacteria were centrifuged to pellet at 14000 rpm for 4 minutes. 
The supernatant was removed and the pellet was re suspended in 250 /-11 of cell 
resuspension solution and gently mixed with 250 /-11 lysis buffer. 10/-11 alkaline protease 
solution was added and the mixture was incubated for 5 minutes at room temperature; 
sbsequently, 350 /-11 of neutralization solution was added to the lysate and centrifuged to 
remove the cell debris at 14000 rpm for minutes at room temperature. The supernatant 
containing the plasmid DNA was transferred into a spin column and centrifuged at 14000 
rpm 1 minutes followed with two washes with the Wash Solution. The column was then 
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centrifuged at 14000 rpm for 2 minutes and the DNA eluted with 50 III of TE buffer and 
centrifuged for 1 minute. 
2.2.2 Large scale preparation of plasmid DNA (maxi-prep) 
CsCl gradient was used to obtain a preparation of large scale of plasmid DNA. 500 ml of 
overnight bacteria culture containing IOOllg/ml ampicillin was pelleted by centrifuging at 
8000 rpm for 10 minutes at 4 QC and the pellet was thoroughly resuspended in 10 ml 
solution I (0,5 M TriHCl pH 8,0, 10 mM EDTA, 1 mg lysozyme), The cells were lysed 
by swirling with 20 ml fresh solution II (1 % SDS, O,2N NaOH) and incubated at room 
temperature for 10 minutes; 15 ml of ice cold solution III (3M potassium acetate, 11.5% 
acetic acid) was added and inverted and incubated on ice for 15 minutes to precipitate the 
protein complexes, The solution was centrifuged at 8000 rpm for 10 minutes at 4 QC and 
the supernatant was filtered into a fresh tube through gauze, then 26 ml of isopropanol 
was added to the filtrate and the mixture was incubated at room temperature for 10 
minutes, The samples were centrifuged at 8000 rpm for 15 minutes at room temperature 
and the supernatant was decanted; the DNA pellet was air dried and re suspended in 5 ml 
of TE buffer, 5.4 g caesium chloride and 400 III ethidium chloride (1 Omg/ml) , The 
solution was centrifuged under vacuum at 48000 rpm for 16 hours at 4 QC, Following the 
centrifugation, the DNAlethidium chloride band was extracted using a syringe with 
needle, the ethidium chloride was removed from DNA by repeated extraction with butan-
2-01. The plasmid DNA was finally collected with ethanol precipitation and resuspended 
in TE buffer. 
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2.2.3 Phenol:chloroform extraction 
To purify the bulk nucleic acids solution, an equal volume of a 25:24:1 mixture of 
phenol:chloroform:isoamyl alcohol was added, mixed vigorously and centrifuged at 
I4000rpm for 5 minutes. The aqueous layer was transferred to a new tube and mixed 
with an equal volume of 24: 1 chloroform:isoamyl alcohol and centrifuged as before. 
Finally, the aqueous layer was removed to another new tube and concentrated with 
ethanol precipitation. 
2.2.4 Ethanol precipitation 
Nucleic acids were precipitated by adding 2.5 volumes v/v ice-cold 100% ethanol 
andllIO volume 3M sodium acetate, and incubated at -20°C for 30~60 minutes, after 
which the the precipitated nucleic acids were collected by centrifugation at I400rpm for 
10 minutes. The pellet was washed with 70% ethanol and centrifuged at I4000rpm for a 
further 5 minutes, and the pellet was then air-dried and re suspended in 10-50 !-LI TE 
buffer. 
2.2.5 DNA Agarose gel electrophoresis and recovery 
Agarose gel electrophoresis was used for the separation, size determination and relative 
quantitation of DNA fragments. 1% (w/v) analytical grade agarose was heated up with 
Ix TBE/IxTAE buffer in a microwave until all the agarose was dissolved and poured 
onto the gel support tray at about 60°C. The gel with an inserted comb was left to 
solidify, the comb was removed and the gel placed in the electrophoresis tank with 
enough buffer covering the gel surface. A 10 !-LI aliquot of each DNA sample was 
pipetted with 2.5 !-LI 6x DNA loading buffer into the wells along with the appropriate 
DNA molecular weight marker. After the electrophoresis was carried out at 80~ 100 volts 
71 
2. Materials & Methods 
for 1 hour, the gel was stained in ethidium bromide solution (1 Ilg/ml) and examined on a 
UV transilluminator, and photographs were taken with an Ultra Violet Products Gel 
Sytem, Image Store 7500. Agarose slices containing appropriate DNA fragments were 
excised with a scalpel from gels under long-wave UV transillumination and DNA was 
extracted and purified with a QIAquick gel extraction kit (28704, Qiagen) following the 
manufacturer's instruction. Briefly, the excised gel (no more than 400 mg) was mixed 
with 3 volumes (v/w) Buffer QG and incubated at 50°C for 10 minutes, then Ivolume of 
isopropanol was added to the mixture. The solution was applied to the QIAquick column 
and centrifuged for 1 minute at 8000rpm, then DNA was washed with 0.75 ml Buffer PE 
and centrifuged for 1 minute at I4000rpm. The column underwent additional 
centrifugation for 1 minute and the DNA was eluted by adding 50 III TE buffer and 
collected after 1 minute's incubation. 
2.2.6 DNA restriction enzyme digestion and linearised plasmid DNA 
dephosphorylation 
Restriction enzymes are sequence-specific endonucleases that cut DNA at specific sites. 
The digestion was assembled to 20/50 III containing 400-600 ng DNA and 10 units of 
restriction digest enzyme per Ilg of DNA in Ix enzyme-special buffer. The reaction was 
incubated at 37°C (or the temperature specified by the supplier) for 2-3 hours or 
overnight and agarose gel loading buffer was added prior to electrophoresis; the second 
digestion was carried out following the first digestion, DNA purified by phenol 
choroform extraction and ethanol precipitation. To prevent self-ligation of the digested 
plasmid, the DNA was treated with calf intestinal phosphatase (CIP) to remove the 
phosphate group from the 5' terminus. The total 50 III reaction contains digested DNA 
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and 1 unit ofCIP per 5 III of DNA in Ix CIP buffer, and the reaction was incubated at 37 
DC for 30 minutes. The linearised, dephosphorylated DNA was then purified by phenol 
choroform extraction and ethanol precipitation. 
2.2.7 peR mediated site-directed mutagenesis and recombinant DNA 
The human connexin 43 cDNA was cloned in to plasmid pcDNA3 and this plasmid 
(kindly provided by Dr D. Laird) was used as the template for PCR-mediated site-directed 
mutagenesis. The PCR primer sets: 
Forward primers: 5 '-CGACTCACTATAGGGAGACC-3 , 
Reverse primers: 5'-GGTCTGCTGCTGGCACGA -3' 
were used to generate a mutant human connexin 43 cDNA fragment, in which the last 
five amino acids of the C-terminus are deleted. The PCR reactions were carried out with 
pfu DNA polymerase (M7741, Promega) to reduce reading error probability and followed 
the product protocol with annealing at 62QC. The PCR was set up in 50 III volume 
containing: 1 III pcDNA-Cx43 plasmid (~0.3 ng), 0.5111 pfu polymerase (M7741, 
Promega),5 III pfu PCR buffer, and 1111 10 mM dNTPs. The PCR reaction was carried 
out under the following conditions: denatured the DNA at 95 QC for 3 minutes, and then 
thermal cycled at 94 QC for 30 seconds ( strand separation), 62 QC for 45 seconds (primer 
annealing) and 72 QC for 30 seconds (strand elongation) for 30 cycles before another 72 
QC for 10 minutes for a final extend step and then hold at 4 QC. The PCR mutant 
connexin 43 and the wild type connexin 43 fragment (isolated by digestion of pcDNA3-
Cx43 with Hind III and Barn HI) were sub cloned into the EcoR V/Hind III and Barn HI 
sites of p3X FLAG-CMVTM-14 expression vector plasmid (E4901, Sigma) to generate 
the pC-terminus 3XFLAG fused wild human Connexin 43 (pCFWCx43) and pC-
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terminus 3X FLAG fused with truncated human Connexin 43 (pCFTCx43). The 
recombined plasmids were sequenced to confirm correct introduction of the desired 
mutation. 
The HPY18 E6 wild type gene and E6 Thr156Glu mutation gene were cloned into 
pcDNA-3 plasmid by Dr Lawrence Bank's group and kindly provided by Dr Sally 
Roberts. The plasmids were sequentially digested with EcoRI and HindUI, then purified 
with phenol:chloroform extraction and ethanol precipitation. The vector p3x-FLAG-
CMyTM_10 expression plasmid (E4401, Sigma) was cut with EcoRI and HindUI and 
ligated to the wild and mutant HPY18 E6 DNA fragments. The constructs were 
transformed into DH5a and the positive colonies were selected and mini-preped to 
confirm the sequences. 
2.2.8 DNA ligation 
Digested and purified vector and insert DNA fragments were ligated in a 1:3 molar ratio. 
Reaction was carried out in 20 ~l volume containing 1 unit of T4 ligase and total DNA 
0.05-0.5 ~g in Ix ligase reaction buffer, and the reaction incubated at 14°C overnight 
before transformation of competent E.coli. All the recombinant DNA was sequenced 
(Glasgow University Molecular Biology Support Unit). 
2.2.9 Competent E.coli preparation 
To prepare the competent bacteria, a 1 ml overnight cultured E.coli strain DH5a was 
incubated into 100 ml L-Broth (lOg NaCl, 16g Bactopeptone, 5g yeast extract in 1 liter 
water, pH7.5). The cells were grown for 3-4 hours at 37°C in a shaking incubator until 
the ODsso was approximately 0.6. The culture was chilled on ice for 15-30 minutes and 
collected by centrifugation at 3000g for 15 minutes at 4°C. The cells were then 
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resuspended in 25 ml ice-cold 0.1 M CaCb and incubated on ice for 45 minutes. The 
cells were then pelleted and resuspended with 10 ml ice-cold 0.1 M CaCb and chilled on 
ice for 30 minutes followed by centrifugation. The pellet was re suspended in 3 ml of ice 
cold 0.1 M CaCb and 15 % glycerol, then aliquoted and stored at -70°C until use. 
2.2.10 Plasmid transformation and bacteria selection 
For each transformation, 100 III of competent DH5a cells was thawed on ice and 
approximately 15 ng of plasmid DNA was added and mixed gently and incubated 
together on ice for 30 minutes. The mixture was heat shocked by incubating at 42°C for 
45 seconds and chilled on ice for 2 minute. 1 ml L-Broth was added to the cells which 
were incubated in a 37°C shaker for 1 hour. After the incubation, the cells were spun 
down and plated onto LB plate containing 100 Ilg/ml ampicillin which were then 
incubated at 37°C overnight. Colonies were picked with a sterile toothpick and placed in 
5 ml L-Broth containing 100 Ilg/ml ampicillin and incubated in a 37°C shaker overnight. 
2.2.11 Quantification of oligonucleotides 
The spectrophotometer (Eppendorf BioPhotometer) was used to determine the 
oligonucleotide concentrations by measuring the absorbance at 260 nm. Double-stranded 
DNA: 1 A260 equals 50 Ilg/ml. 
Single-stranded DNA: 1 A260 equals 30 Ilg/ml. 
RNA: 1 A260 equals 40 Ilg/ml. 
The purity of oligonucleotides was determined by comparing readings at 260 nm and 280 
nm (A26o and A28o), assuming a ratio of no less than 1.80 indicating the samples were 
protein free. 
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2.2.12 RNA isolation 
Total RNA was extracted from 8x107 cells using an RNeasy mini kit (74119, Qiagen), as 
specified by the manufacturer's instruction. The pelleted cells were lysed and 
homogenised in 4 ml of RLT Buffer by passing the lysate through an 18-20-gauge needle 
fitted to an RNase-free syringe several times. 4 ml of 70% ethanol was added to the 
sample and the mixture was transferred to an RNase mini spin column where total RNA 
binds selectively to the silica-based membrane. After S minutes centrifugation at 
8000rpm, 4 ml of RWl Buffer to the column and repeated the centrifugation, washed the 
column with 2.S ml Buffer RPE twice and spun as previously described. The RNA was 
eluted in SO III RNase-free water and collected by centrifuging into a RNase-free tube 
and stored in -20°C. The whole process was RNase protected and all the materials were 
DEPC-treated before used. 
2.2.13 RT -peR 
For RT-PCR, the total RNA extract was treated with Rnase-free DNase to remove any 
potential contamination. 1 Ilg RNA was resuspended in IX DNase I Reaction Buffer to a 
final volume of20 III and 1 units of DNase I (M0303S, New England Biolab) was added, 
mixed thoroughly and incubated at 37°C for 10 minutes. 0.2 III of O.S M EDTA (to a 
final concentration of S mM) was added and heated inactivated at 7SoC for 10 minutes. 
The reaction was diluted to 100 Ill, stored at -70°C and used directly for RT-PCR. 
RT-PCR was performed using Superscript™ II Reverse Transcriptase Kit (18064-022, 
Invitrogen) and followed the manufacturer's protocol. A 12 III reaction containing 2.S Ilg 
total RNA, 1 Ill0ligo(dT)I2-18 (SOO Ilg/ml) (18418-012, Invitrogen), 1 III dNTP mix (10 
mM each) and DEPC-treated water was heated at 6SoC for S minutes and quick chilled 
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on Ice. This solution was mixed with 4 III 5x First-Strand Buffer, 2 III 0.1 M DTT and 
1111 RNasin® Plus RNase Inhibitor (N2661, Promega) and incubated at 42°C for 2 
minutes. 1 III Superscript™ II RT was added and the reaction was incubated at 42°C for 
50 minutes; then heating at 70°C for 15 minutes inactivated the reaction. To remove 
RNA complementary to the cDNA, 2 unit of RNase H (18021-014, Invitrogen) was 
added and incubated at 37°C for 20 minutes. cDNA was stored at 4°C. The PCR 
reaction was carried out with a final volume of 50 III containing 2 units of Taq DNA 
polymerase (M1661, Promega), 2 III dNTP mix (10 mM each), 3 III of25 mM MgCh, 1 
III of 10 IlM of each primers, 5 III of Taq DNA Polymerase Buffer and 1 III cDNA as 
template. The PCR cycle was started with a hot start (3 minutes at 95°C in which the 
DNA Polymerase was added, followed by 2 minutes at 72°C), and then consisted of 30 
cycles of denaturation at 94°C for 30 seconds, annealing at different temperature 
dependent on the different DNA primers for 45 seconds and elongation at 72°C for 30 
seconds. The PCR was completed with a final extension at 72°C for 10 minutes and 
held at 4°C. The product was checked after separation on a 1% agarose gel with 
ethidium bromide under the DV illumination. 
2.2.14 Cell culture 
W12GPXY, C33a, HaCaT, CaSki, HBF and J2 3T3 cells were cultured in Dulbecco's 
modified Eagle's medium (DMEM) supplemented with 10% FCS and L-glutamine 
(2mM); WI2E, WI2G and WI2GPX cells were cultured in serum-free keratinocyte 
growth medium (KGM) (cc-3IOI, Cambrex). All cells were maintained under 
humidified 5% CO2 95% air at 37°C and the medium changed every 3 days. 
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2.2.15 Preparation of cell stocks 
After trypsinisation and counting, the confluent cells were resuspended in the appropriate 
growth medium at lxl06 cells/ml with 15% DMSO in final concentration. 1 ml of cell 
suspension was aliquoted in vials and frozen at -70°C for 24 hours before transferred to 
in liquid nitrogen. 
2.2.16 Total cell extract preparation 
Confluent monolayer cells were washed with PBS twice and lysed in protein-loading 
buffer, 100~l1125 mm2 on ice. The cell lysate was passed through a 18-20-gauge needle 
8-10 times to shear the chromosomal DNA and collected in Eppendorf vials. The extract 
was boiled for 5 minutes and chilled on ice before centrifugation to pellet the cell debris. 
The cell lysate protein concentration was determined by the Bradford assay, and 
subsequently stored in -20°e. 
2.2.17 SDS page 
Proteins were separated on a vertical Polyacrylamide gel prepared with the Bio-Rad mini 
gel electrophoresis apparatus. The resolving gel and stacking gel (described as Table 7) 
were poured into the system and set one by one following the manufacturer's protocol. 
The gel assembly was submerged in Ix Tris-Glycrine buffer and 30 ~l of each protein 
samples was loaded into the wells with 5 ~l RainbowTM protein marker (RPN 756, 
Amersham Pharmacia biotech) in the first lane. The gel was run at 100 V until the dye 
front reached the end of the resolving gel. 
2.2.18 Western blotting 
Separated proteins were subsequently transferred to a nitrocellulose membrane (Hybond-
P, Amersham Biotech) using a Bio-Rad transblot cell, following the manufacturer's 
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instructions. The process was carried out at 250 mA for 2 hours or 30 mA overnight at 
4°C in Western blotting transfer buffer. The transferred membrane was preincubated for 
1 hour at room temperature with 5% dried milk in PBS-O.l %Tween, before overnight 
incubation at 4°C with diluted primary antibody in PBS-Tween 1 % dried milk on a 
rotating shaker. After 3xlO minute PBS-Tween washes, horseradish peroxidase (HRP)-
conjugated secondary antibodies were diluted 1 : 1000 in PBS-Tween and incubated for 1 
hour. The PBS-Tween washes were repeated 5 times and the membrane was developed 
with 1: 1 mixture of the two supplied reagents of Amersham enhanced 
chemiluminescence (ECL) (RPN 2209, Amersham Biotech) kit for 1 minute and exposed 
to Kodak X-OMAT film. Bound antibodies were removed from the membranes by 
shaking the developed membrane in stripping buffer (0.288mM p-Mercaptoethanol, 2% 
v/v SDS, 62.5mM Tris pH 6.8) at 50°C for 30 minutes followed by 3xlO minutes PBS-
Tween washes. The stripped membranes were stored at 4°C or reprobed with other 
antibodies. 
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Table 7: SDS-PAGE gel composition. 
12% Resolving gel 15% Resolving gel Stacking gel 
30% acrylamide 4.0ml 5.0 ml 650fll 
1.5M Tris pH8.8 2.5 ml 2.5 ml 
1M Tris pH6.8 2.5 ml 
10% SDS (w/v) 100 fll 100 fll 50 ~l 
10% APS* (w/v) 100 fll 100 fll 50 fll 
TEMED 20 fll 20 fll 10 ~l 
dH20 3.3 ml 2.3 ml 3 ml 
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2.2.19 Co-immunoprecipitation 
Confluent cells were washed twice with ice-cold PBS and scraped into 5 ml chilled IP 
buffer containing PBS, 1% Triton X-lOO, 0.5% CHAPS, 0.1% SDS with 15 % fresh 
protein inhibitor cocktail (Roche, UK). The cell lysates were incubated on ice for 15 
minutes and the solutions sonicated for 1 minute on ice. Celllysates were then cleared of 
cellular debris by centrifugation at 12000g for 10 minutes at 4 °C and the protein 
concentration determined by Bradford's assay. Primary antibodies were added to lOOllg 
protein of each cell lysate and incubated for 2 hours at 4°C under agitation. Subsequently 
40llg of reconstituted protein A-Sepharose was added (Amersham Biosciences, Inc) and 
the volume adjusted to 750ll1. The samples were agitated at 4 °C for 4-5 hours. 
Immunocomplexes were then harvested by centrifugation and washed four times with 
250111 ice-cold IP buffer and once with 25111 ice cold PBS. Proteins were solubilized by 
sonicating the complexes in PBS mixed with 5111 6x protein loading buffer (Ix buffer: 
125 mM Tris (pH 6.8), 4% SDS, 20% glycerol, 10% mercaptoethanol and 0.006% 
bromophenol blue, 15% (v/v) fresh protein inhibitor cocktail (Roche, UK)) for 5 minutes 
on ice and separated by SDS-PAGE. 
2.2.20 Transfection of cells 
1.5x105 cells were seeded in 35mm petri dishes in 2 ml appropriate medium and 
incubated at 37°C until the cells were 80% confluent. The following solutions were 
prepared for each transfection: Solution A, 2 Ilg DNA diluted in 100 III serum-free 
medium; Solution B, 3 III LipofectamineTM (18324-012, Invitrogen) reagent diluted in 
100 III serum-free medium. Two solutions were combined and incubated at room 
temperature for 30 minutes to allow the DNA-liposome complexes to form. For each 
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transfection, cells were rinsed with 2 ml of serum-free medium and 800 III of serum-free 
medium was added to the DNA-liposome mix which was applied to the pre-rinsed cells. 
Following 5 hours incubation at 37°C, 1ml of20% FCS medium was added and the cells 
were incubated for 18 hours and then replaced with 2 ml fresh medium. After 72 hours 
transfection, stable transfected cells were selected in medium supplemented with 500 
Ilg/ml G418 (A1720, Sigma) to obtain stably transfected cell lines. 
2.2.21 Iontophoresis (cell microinjection) 
90% confluent monolayer cells were washed twice with PBS and maintained in it before 
the iontophoresis. 4% Lucifer Yellow, a negatively charged fluorescent gap junction-
permeable dye, was microinjected into the focalised cell with a freshly prepared fine 
glass capillary using 0.5 second pulses of IOnA at 10 Hz for 2 minutes. The injected cell 
was left for 1 minute, and the extent of cell coupling was measured by counting the 
number of cells that had clearly taken up Lucifer Yellow. Pictures were taken using a 
digital camera. The whole process was carried out under an Inverted UV fluorescence 
microscope in the dark. 
2.2.22 Growth assay in vitro 
lx105 cells were seeded in 35mm culture dishes and maintained in appropriate medium 
for 48 hours. Cells from three dishes were independently trypsinized and counted 
(Coulter counter) at selected intervals. 
2.2.23 Organotypic raft culture 
The in vitro living skin model system consisted of two components: a dermal equivalent 
made up of fibroblasts in a collagen matrix that is contracted and modified by the resident 
cells, and an epidermis that develops from keratinocytes "plated" on the dermal 
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equivalent. Type I collagen is extracted from rat tail tendons in O.S M acetic acid, 
precipitated by the addition of an equal volume of 10% w/v NaCl, redissolved in 0.2SM 
acetic acid and extensively dialysed against 111000 acetic acid, with the final solution 
being adjusted to 2.Smg collagen/ml and stored at 4°C. The preparation of the dermal 
equivalent was carried out at 4°C and all the solutions were pre-chilled on ice. Collagen 
gel was prepared by mixing 8 volumes of collagen solution with 1 volume of 10x MEM, 
and 1 volume of 0.22 M NaOH, and the pH adjusted to 7.2 with NaOH. 1 volume of 
FCS containing7.Sxl05 human breast skin fibroblast/ml mixture was added and the gel 
was mixed thoroughly. The mixed gel was aliquoted as 3ml/dish into 3Smm petri dish 
and allowed to set at 37°C for IS minuets, after which 2 ml of DMEM containing 10% 
FCS was added and the gels detached from the dishes. The gels were incubated for 
approximately 10 days at 37°C in a humidified atmosphere of S% CO2 in air with 
medium changed every 2 days until the gels were contracted to fit 24 well multi well 
dishes. The gels were transferred into the 24 well dishes and seeded 1x104 cells seeded 
on the top of each gel and incubated for 24-48 hours until the cells on gel top were 
confluent. The gels were raised to the air-liquid interface on a stainless steel grid and 
incubated for 8-12 days with medium changes daily. The gels were harvested and fixed 
in 4% (v/PBS) formaldehyde overnight before being embedded into paraffin sets. 4flm 
sections were cut with Leitz ISO 1 rotary microtome and floated on a water bath at 4SoC, 
lifted and fixed onto glass slides, and dried completely on a hot plate. 
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2.2.24 Haematoxylin and Eosin (H&E) stain 
The slides with dried sections were incubated at 80°C for 1 hour and allowed to cool. 
The sections were deparaffinised and hydrated through a gradient of xylene for 5 minutes 
twice, absolute alcohol for 4 minutes twice and water 1 minute. The sections were 
stained with the following steps: immersed in haematoxylin for 4 minutes and washed in 
water, dipped in acid alcohol 5-10 second and rinsed with water, developed in Scott's Tap 
Water for 45 seconds and washed with water, stained in Putt's eosin for 5 minutes and 
washed in water to remove any remaining stain. The sections were dehydrated 
sequentially in alcohol for 4 minutes (2 change, 2 minutes each), and in xylene for 2 
minutes (2 change, 1 minutes each). Finally the dried slides were fixed with Pertex 
mounting solution (CellPath, UK) using a coverslip. Pictures were taken with a Zeiss 
Axiovert SI 00 microscope. 
2.2.25 Immunofluorescence staining of organotypic raft culture sections 
The 4 !lm paraffin-embedded sections were de-waxed and hydrated as described above. 
To retrieve antigen, the rehydrated sections were put into a pressure cooker, immersed in 
boiling citrate buffer, and microwaved at high power for 15 minutes, and left to cool for 
20 minutes. The slides were rinsed with PBS for 5 minutes twice prior to incubation with 
PBS containing 20% FCS for 1 hour. The blocking solution was removed and then the 
sections were incubated with appropriate primary antibodies in PBS containing 1 % FCS, 
0.1 % Tween, 1 % BSA and 0.01% SDS (BSA and SDS only present for connexin stain) at 
4°C in a humidified atmosphere overnight. The sections were washed with PBS 3xl0 
minutes and incubated with anti-mouse-fluorescein and anti-rabbit-texas-red-labelled 
secondary antibodies diluted 1: 100 in PBS containing 1 % FCS in a dark humidified box 
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for 1 hour. The slides were washed 4xl0 minutes with PBS and mounted with 
Vectashield mounting medium with DAPI and finally a coverslip was fixed using nail 
varnish. Negative controls (no primary antibody) were included in all experiments. 
Images were taken using a Zeiss LSM51 0 Meta confocal microscope. 
2.2.26 Immunofluorescence stain 
Cell were grown on sterile 18 x 18 mm coverslips until 90% confluent, washed three 
times with PBS and fixed with Fix Solution (20% sucrose, 5% formaldehyde in PBS) for 
10 minutes at room temperature. After three washes with PBS, the coverslips were 
permeabilised with 0.5 ml of a 70% acetone, 30% methanol solution for 5 minutes at -20 
cC. The coverslips were washed three times with PBS and incubated in PBS containing 
20% normal goat serum andlor 20% normal horse serum for 1 h at room temperature. 
Cells were incubated with primary antibodies diluted in 1 % goat serum and horse serum 
in PBS for 1 hour at room temperature. Coverslips were washed in PBS six times before 
incubation for 1 hour with secondary antibodies labelled with fluorescein or Texas-Red 
diluted 1:100 in PBS (Vector laboratories). After washing in PBS six times, the 
coverslips were mounted with Vectashield mounting medium (with DAPI or propidium 
iodide as a nuclear stain). Negative controls (no primary antibody) were included in all 
experiments. Images were taken using a Zeiss LSM51 0 Meta confocal microscope. 
2.2.27 Affymetrix arrays 
A goal of this project was to generate a list of candidate genes, which were involved in 
the progression to late stage carcinogenesis in HPV 16 positive cervical cancer cell lines; 
and the gap junction-related proteins changes during this process. 
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In this study, Two-GeneChip®-array sets from Affymetrix (HG-U133) were used which 
created the selected sequence clusters from GenBank®, dbEST, and RefSeq and 
contained 22,283 (Chip A) and 22,645 (Chip B) probe sets derived from approximately 
33,000 well-substantiated human genes. Affymetrix arrays are proprietary, based on 
direct photolithographic deposition of oligo probes on silicon wafers, which can give 
very reproducible results with high quality total RNA. In this array procedure, the 
biological noise was be accounted for with statistics using replicates of the conditions and 
the technical noise was modeled by the same research group in the same environment. 
Reproducibility of the chip set was examined by repeated tests on the same sample. The 
two duplicate chip sets (from two different manufacture lots) were tested on the same 
sample 6 months apart. All the array procedures were carried out following the 
manufacture's protocols. 
The prepared total RNA samples stored at -70°C once extracted (described in 2.2.12) 
were submitted to the Sir Henry Wellcome Functional Genomics Facility, Glasgow 
University, who organized the whole experiment. The RNA quality and quantity at this 
stage are detected using the following machines: NanoDrop ND-1000 (NanoDrop 
Technologies) for quantity and the BioAnalyzer (Agilent) for quality control. 
Briefly, following the recommendations from the manufacturers for each reaction, 10 Ilg 
total RNA was used to generate double-stranded cDNA by synthesising the first strands 
with T7-linked 0Iigo(dT)24 primers and Superscript II RT following the second strands 
synthesis. The double strand cDNA library was cleaned up according the protocol using 
the cDNA Cleanup spin column and cDNA Wash Buffer. The final labelling of the 
cRNA in vitro transcribed was performed with biotinyl-ll-CTP and 16-UTP 
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ribonucleotides using Enzo HighYield RNA Transcript Labeling Kit (Enzo Diagnostics) 
at 37°C for 6 hours and purified using Qiagen Rneasy mini columns. Before 
hybridization with the U133 array chips, the labelled cRNAs were fragmented (10 to 11 
~g/probe array) and maintained in a final hybridisation cocktail concentrated at 0.8 ~g/~l. 
Hybridizations were preformed to the GeneChip set at 45°C for 16 hours in a rotisserie 
oven set at 60 Lp.m. The cRNA samples were first hybridized to Affymetrix Test 3 arrays 
for quality control and subsequently to Affymetrix Human Genome U133 A and B arrays. 
Finally, the fragmented cRNAs are hybridized to the GeneChip set by way of multiple 20 
to 25 oligonucleotide probes specific for each gene, with each probe corresponding to a 
different region of the mRNA of interest. The probes specific for each mRNA are 
scattered across the surface of each GeneChip to control for technical issues that occur in 
each hybridization. 
Following hybridization, the chips were washed and stained using Affymetrix fluidics 
stations. Staining was performed using streptavidin-phycoerythrin conjugate (Molecular 
Probes, Eugene, OR), followed by the addition of biotinylated antibody to streptavidin 
(Vector Laboratories) and finally with streptavidin-phycoerythrin conjugate. Probe arrays 
were scanned using the Affymetrix GeneArray Scanner at 488 nm and 3 ~m per pixel. 
The scanned images were inspected and analyzed using established quality control 
measures. 
2.2.28 Microarray data analysis 
A fully automated analysis of Affymetrix GeneChips® is provided by the bioinformatics 
unit of MBSU in Glasgow University, which includes the raw data analysis, comparative 
data analysis and data automated annotation by iterative group analysis (iGA). 
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Raw data consists of files generated by the Affymetrix scanner and image-processing 
software: the image files (DAT) were converted to (eEL) files containing single intensity 
values for every probe (probe-level raw data). The files have then been taken for further 
analysis in three steps: 
1. Low-level data normalization was done using the Robust Multichip Average 
(RMA) method implemented in the statistical analysis of Affymetrix 
oligonucleotide array probe level data included in the Bioconductor microarray 
analysis software (http://www.bioconductor.org). RMA performs the following 
operations (Irizarry et al., 2003): 
• Probe-specific background correction to compensate for nonspecific 
binding using perfect match distribution rather than perfect match-
mismatch pro be values 
• Probe-level multichip quanti le normalization to unify perfect match 
distributions across all chips 
• Robust probe-set summary of the log-normalized probe-level data by 
median polishing 
2. To identify differentially expressed genes in W12G and W12GPXY cells, 
RankProducts (RP) (Breitling et al., 2004), a method developed in the University 
of Glasgow, sorts all the genes according to their expression changes and provides 
statistical confidence levels. The value of Fold change and False Discover Rate 
(parameter like p-value in this programme) in the microarray result Table 8. was 
derived from RP analysis. 
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3. IterativeGroupAnalysis (iGA) is a method for automated functional interpretation 
to identify differentially expressed functional gene-classes (Breitling et al., 2004). 
All the genes shown in the micro array result Table 8 which have significantly 
changed between W12G and W12GPXY cells were nominated with the iGA 
programme and sorted in functional groups. iGA is based on using elementary 
statistics to identify those functional classes of genes that are significantly 
changed in an experiment and at the same time determines which of the class 
members are most likely to be differentially expressed. iGA assigns each gene to 
functional classes, e.g. based on its GeneOntology assignments. Whether the 
functional class was nominated was determined with the probability of change 
(PC-value). The PC-values, number of group members and of significantly 
changed genes are indicated. All genes are sorted according to metrics of 
differential expression (fold-change, t-statistics ... ), the choice of the optimal 
sorting method will depend on personal preferences and details of the 
experimental design, but has relatively little influence on the iGA results. The 
classes with the lowest PC-value are most significantly changed. As the PC-
values are directly derived from p-values, they already give a good idea of the 
statistical significance of an observed change, after correcting for the effect of 
multiple testing, i.e. the fact that many hundreds of groups are tested for 
differential expression at the same time. At the same time, the PC-values are 
underestimating the true probability of changes, because they are based on 
determining the minimum p-value within each class. iGA yields a robust 
biological summary of transcriptional changes between W12G and W12GPXY 
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cells. The significance threshold for differentially expressed gene-groups in HG-
U133A chips was set at with P-value changed more than 2.4e-0.4 and the 
threshold value in HG-U133B chips was 4.1e-OA. In this thesis, all the individual 
genes nominated with iGA were sorted in functional groups although some of 
their false discovery rates were high. 
2.2.29 Real-time reverse transcription polymerase chain reaction 
Over recent years the employment of the method "real-time" reverse transcription 
polymerase chain reaction (RT-PCR) equipment has been widely used for the analyses of 
gene expression in a number of systems (Dhar et aI., 2001; 2002; Hiratsuka et aI., 2001). 
The objective of this study was to confirm the angiogenesis factors mRNA expression 
changes suggested from micro array analysis with SYBR Green RT-PCR using the 
GeneAmp 5700 Sequence Detection system. In contrast to other methods such as 
Northem hybridization, real-time RT-PCR is a technique with higher throughput and 
more quantitative capabilities. In quantitative RT-PCR, housekeeping genes are active 
references that are used to standardize between amounts of samples assayed. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as housekeeping genes 
for studies involving mRNA measurements in this case. 
Real-time PCR quantitative value was monitored with fluorescence after each of the 
repetitive cycles during the whole PCR process, which is especially sensitive during the 
early phase of the reaction. SYBR Green dye has a high affinity for double-stranded 
DNA (dsDNA) and exhibits enhancement of fluorescence upon binding to the dsDNA. 
The fluorescence spectrum resulted from the incorporation of SYBR Green I dye into the 
double-stranded DNA directly produced in PCR tubes during the PCR reaction, and 
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emission data were quantitated using the threshold cycle (CT) value. In the GeneAmp® 
5700 Sequence Detection System, the fluorescence of the SYBR Green dye is monitored 
at the end of the each cycle and CT readings obtained represent measurements on the log 
scale. A melting point dissociation curve generated by the instrument was used to confirm 
that only a single product was present (Ririe et aI., 1997). The major shortcoming of 
using SYBR Green in real time PCR is the dye can bind to all the double -stranded DNA 
which could leads to a false reading with undesired PCR products. To overcome this 
problem, it is vital to ensure that only one product is synthesised and no primer-dimer 
formed. To validate the specificity ofa primer set, RNA (1 Ilg) and the RT negative were 
analyzed in triplicate to confirm that there was no fluorescence resulting from either 
genomic DNA contamination or from the RT step. Each PCR run also included triplicate 
wells of no template control (NTC) where RNase-free water was added to reaction wells 
(PE Biosystem GeneAmp® 5700 User Manual, 1998). The PCR products were collected 
and run on a 3% (w/v) agarose ITAE gel to confirm only one product size around 105 
bp). 
2.2.30 Primer design 
The specific primers used for SYBR Green PCR are listed in Table (8). The primers were 
first designed using Primer Express Software version 1.0 (PE Applied Biosystems) on 
sequences attained from GenBank and primers were purchased from Sigma (Sigma 
Genosys, D.K). All primers were checked by running a virtual PCR, and the 
amplifications were analyzed for expected product. 
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Gene Primer name SYBR Green primer sequence (5'-3') Tm a QC Amplificati 
VEGF VEGF-For AGAGCGGAGAAAGCATTTGTTT 58 
VEGF-Re GCAACGCGAGTGTGTGTTTT 58 
FGF-2 FGF-2-For CCAGGTAACGGTTAGCACACACT 59 
FGF-2-Re CGACCCTCACATCAAGCTACAA 59 
IL8 IL8-For TTCTTTAGCACTCCTTGGCAAAA 59 
IL8-Re CTCTTGGCAGCCTTCCTGATT 59 
VPF VPF-For GGTGAGGTTTGATCCGCATAA 59 
VPF-Re ACGAGGGCCTGGAGTGTGT 
GAPDH GAPDH-For CCCACAGCCTTGGCAG 
59 
59 
GAPDH-Re ACCACAGTCCATGCCATCAC 59 






Table 8: Detail of the primers used for detection of angiogenesis factor genes by SYBR 
Green RT-PCR. 
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2.2.31 SYBR real- time quantitative PCR 
SYBR Green PCR amplifications were performed in a GeneAmp 9600 thermocycler 
coupled with a GeneAmp 5700 sequence detection system (PE Applied Biosystems). The 
reactions were carried out in a 96-well plate in a 25-f.ll reaction volume containing 12.5 f.ll 
of 2xSYBR Green Master Mix (PE Applied Biosystems), 0.75 f.ll of 10 pmol/f.ll of both 
forward and reverse primers and 1 f.ll of different concentration total cellular cDNA. The 
thermal amplification and detection were performed using the GeneAmp 5700 system 
with the following profile: 1 cycle of 50°C for 2 minutes, 1 cycle of 95°C for 10 minutes, 
and 40 cycles each of 95°C for 15 s, 60°C for 1 minutes, and finally stored at 4°C. For 
determining the gene expression quantitative change between W12G and W12GPXY 
cells, the amounts of cDNA of W12GPXY cells used per SYBR Green PCR varied from 
1.0 ng to 1.0 pg respectively. In each 96-well plate, a dilution series of the samples was 
run along with the control samples for the corresponding background and their GAPDH 
controls. Each sample was replicated two to three times. 
2.2.32 Real time quantitative RT-PCR Pilot study 
After SYBR Green PCR amplification, data acquisition and subsequent data analyses 
were performed using the GeneAmp 5700 sequence detection system (version 1.3). In 
the SYBR Green Master Mix, there is an internal passive dye, ROX, in addition to the 
SYBR Green dye. The increase in the fluorescence of SYBR Green against that of ROX 
is measured at the end of each cycle. A sample is considered positive when the change in 
the fluorescence of SYBR Green relative to that of ROX (ARn) exceeds an arbitrary 
threshold value. The threshold value is set at the midpoint of the ARn and the cycle 
number plot. For all the described amplifications, the threshold value of the ARn was 
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considered to be between 0.1-0.3. The peR cycle at which a statistically significant 
increase in the IlRn is first detected is called the threshold cycle (er). For data analyses, 
the er values were exported into a Microsoft Excel Worksheet for further statistical 
analyses. Regression analyses of the er values of cDNA dilution series were used to 
examine the amplification efficiencies of the genes. 
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Chapter 3. RESULTS 1 
GLOBAL GENE EXPRESSION CHANGES DURING PROGRESSION OF 
HPV-16 CARCINOGENESIS 
One goal of this project was to investigate gene expression changes during the 
progression of HPV-16 positive cervical carcinogenesis progression by comparing 
W12G and W12GPXY cell lines. 
In the cervix, early squamous cell carcinoma lesions are characterised as cervical 
intraepithelial neoplasia (CIN), graded from CINI (mild dysplasia) to CINIn 
(carcinoma in situ). In 1989, Stanley et aI. established the W12 cell line from an HPV 
16 positive cervical CINI epithelial biopsy. In these cells, the viral DNA is stably 
maintained as around 100 extrachromosomal episomal copies (Stanley et aI., 1989). 
In W12G cells, derived from W12 cells, HPV-16 DNA has integrated into the host 
cell chromosome in about 30 HPV-16 copies, but only E6 and E7 viral protein 
expression is detected. In W12G cells, the viral genomes are integrated as whole 
HPV 16 genome disrupted in the E2 open reading frame, which is quite similar to the 
integration in the HPV-16 positive cervical cancer cell line CaSki (Jeon et aI., 1995). 
Although there are fewer HPV-16 copies in W12 G cells, the oncoproteins E6 and E7 
are still expressed at higher levels than in any HPV -16 episomal containing cell 
popUlation (Jeon and Lambert., 1995). However, W12G cells are still capable of 
undergoing terminal differentiation and are unable to form colonies in soft agar in 
spite of the increased viral oncoprotein expression and cellular growth advantage 
(Jeon et aI., 1995). 
As previously reported, W12GPXY cells were developed from W12 G cells without 
feeder-layer and growth factor support, and form malignant tumours in nude mice, 
although they did not form colonies in soft agar (Aasen et aI., 2003). Giemsa staining 
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had shown in W12GPXY cells several chromosomal changes including nng-
chromosome formation (Aasen, 2003). 
3.1 Global mRNA expression changes between W12G and W12GPXY cells 
3.1.1 Microarray analysis 
From 1994, DNA microarrays have been utilized as a powerful tool in biomedical 
research as they can be used to determine the relative expression profiles of thousands 
of genes in given samples to predict genetic predisposition to disease, serve as a set of 
diagnostic markers, define better drug treatment options for existing diseases 
(pharmacogenomics), or mark the precise nature of disease progression. 
To understand more about gene expression changes involved in late stages ofHPV-16 
positive cervical carcinogenesis progression, Affymetrix human array HG-U133 chips 
were used to compare mRNA transcription levels between W12G and W12GPXY 
cells; each sample group including three individual mRNA extracts, i.e. three mRNA 
preparations from three cell cultures; and the whole experiment was repeated. 
After microarray analysis and hierarchical clustering, there were a total of 63 
functional genes nominated by iterative Group Analysis (iGA) (see page 88-89), 
whose transcription expression values differed significantly between W12G and 
W12GPXY cells and these genes were sorted in different cell function groups with 
PC-value thresholds (see page 88). Among these genes, 26 were more highly 
expressed in W12G cells and 37 were more highly expressed in W12GPXY cells. 
Most of the genes are functionally related to cell growth regulation, cell and tissue 
metabolism regulation, and to vascular angiogenesis promotion. The results are 
presented in Table 9. 
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Table 9: microarray report comparing expressed functional genes in W12G and 
W12GPXY cells 
• Genes more highly expressed in W12G cells are shown in red and genes more highly 
expressed in W12GPXY cells in green. 
• False Discovery Rate shows the expected percentage of false positives when the differentially 
expressed gene-list was cut at the particular position associated threshold. Although some of 
genes in the table have high false discovery rate, it is still worth to present their transcription 
changes, especially those nominated in gene function groups. 
Gene title 
Cell cycle regulator 
cyclin-dependent 
kinase inhibitor 1 C 
(p57, Kip2) 
insulin-like growth 
factor binding protein 
3 
interleukin 8 
Inhibin, beta A 










protein (Rho GTPase 
binding) 3 
poliovirus receptor-
related 2 (herpesvirus 
entry mediator B) 
neuregulin 1 


















Gene function Fold 
change 
G1 phase of mitotic cell cycle, cyclin- 29.71 
dependent protein kinase inhibitor 
activity, regulation of cyclin dependent 
protein kinase activity 
positive regulation of myoblast 211 .83 
differentiation, negative regulation of 
signal transduction, positive 
regulation of apoptosis, insulin-like 
growth factor binding, protein tyrosine 
phosphatase activator activity 
regulation of retroviral genome 1 ~ 127.87 
replication, interleukin-8 receptor 
binding, chemokine activity, neutrophil 
activation, neutrophil chemotaxis, 
induction of positive chemotaxiS, 11 
angiogenesis 
transforming growth factor beta 31.31 
receptor binding, activin inhibitor 
activity, negative regulation of follicle-
stimulating hormone secretion 
hepatocyte growth factor receptor 16.90 
activity 
oncostatin-M receptor activity 2.36 
cytoskeletal regulatory protein binding 5.67 
15026 - coreceptor activity 7.34 
receptor tyrosine kinase binding, 5.88 
transmembrane receptor protein 
tyrosine kinase activator activity 















follistatin FST activin inhibitor activity, negative 53.03 
regulation of follicle-stimulating 
hormone secretion 
transforming growth TGF A epidermal growth factor receptor 6.88 
factor, alpha activating ligand activity 
jagged 1 (Alagille JAG1 endothelial cell differentiation 6.19 
syndrome 
parathyroid hormone- PTHLH 
like hormone 

















motif) ligand 1 
Cell structure 
PTPRZ1 protein tyrosine/threonine 
phosphatase activity 
COK6 G1 phase of mitotic cell cycle, 
cytokinesis, regulation of cell cycle 
PLAUR U-plasminogen activator receptor 
activity 
IL 1 B interleukin-1 receptor binding 
OTR epidermal growth factor receptor 
binding 















TBC1 domain family, TBC101 




collagen, type XII, 
alpha 1 
microfibrillar 





a disintegrin-like and 
metalloprotease 










voltage-dependent anion channel 2.57 
porin activity 
microvillus 7.24 
hydrolase activity, acting on carbon- : 15.59 
nitrogen (but not peptide) bonds, in ~ 
linear amides, ceramide metabolism, 
Golgi membrane, endoplasmic 
reticulum membrane 
laminin-5 19.75 
collagen fibril organization, collagen 30.46 
type XII, extracellular matrix structural 
constituent conferring tensile strength, 
skeletal development 
Microfibril 606.35 
collagen catabolism I 370.63 
collagen catabolism ' 644.45 

























1 motif, 1 









nicotinamide N- NNMT 
methyl transferase 





squalene epoxidase SOLE 
UDP UGT1 
glycosyltransferase 1 
family, polypeptide A 






c reductase core 
protein, binding 
protein 















CGI-30 protein CGI-30 
biliverdin reductase A Bl VRA 
ARG99 protein ARG99 




cholestenol delta-isomerase activity, 62.42 
drug transporter activity, steroid delta-
isomerase activity 
nicotinamide N-methyltransferase 37.11 
activity 
fructose transport 15.20 
squalene monooxygenase activity, 6.71 
sterol biosynthesis 
bilirubin conjugation, estrogen 3.60 
metabolism, UDP-glycosyltransferase 
activity 
C-5 sterol desaturase activity, sterol 3.30 
biosynthesis 
oxidative phosphorylation 5.38 
protein repair 4.24 
FK506 binding, peptidyl-prolyl cis- 107.38 
trans isomerase activity, isomerase 
activity 
acetyl-CoA C-acetyltransferase 2.13 
activity 
peptidyl-diphthamide biosynthesis 4.99 
from peptidyl-histidine, diphthine 
synthase activity 
biliverdin reductase activity 4.75 
adenosylmethionine decarboxylase 10.79 
activity, spermine biosynthesis 
heparan sulfate proteoglycan 9.84 
metabolism, carboxy-Iyase activity 
glutamine biosynthesis, regulation of 12.06 
neurotransmitter levels, nitrogen 


























solute carrier family SLC7 A 11 
7, (cationic amino 
acid transporter, y+ 






kynureninase (L- KYNU 
kynurenine 
hydrolase) 
hypothetical protein FLJ1080 
FLJ10808 8 
dehydrogenaselreduc DHRS2 
tase (SDR family) 
member 2 
Cell development 
Pre-B-cell leukemia PBX1 
transcription factor 1, 
3 
stearoyl-CoA 9-desaturase activity 31.12 
cystine:glutamate antiporter activity, 15.56 
amino acid permease activity 
NAD(P)H dehydrogenase (quinone) 2.21 
activity 
gamma-glutamyltransferase activity , 7.49 
kynureninase activity, tryptophan 629.18 
catabolism 
ubiquitin activating enzyme activity 12.12 
epithelial cell differentiation, alcohol 74.22 
dehydrogenase activity, progesterone 
metabolism, androgen metabolism, 9-
cis-retinoic acid biosynthesis, - 3-
alpha( 17 -beta)-hydroxysteroid 
dehydrogenase (NAD+) activity, 
racemase and epimerase activity 





HMGCR gonad development, 6.11 
hydroxymethylglutaryl-CoA reductase 
A (NADPH) activity 
apolipoprotein 
drebrin 1 







vascular endothelial VEGF 
growth factor 
a disintegrin-like and FGF2 
metalloprotease 
(reprolysin type) with 
thrombospondin type 
1 motif 1, fibroblast 




nuclear factor I/A NFIA 





behaviour, regulation of bone 
mineralization 
vascular endothelial growth factor 8.49 
receptor binding, positive regulation of 
vascular endothelial growth factor 
receptor signaling pathway, 
extracellular matrix binding 
heparin binding, angiogenesis 16.27 
viral genome replication 






















A family, 7 
pancreatic ribonuclease activity, 
RNASE7 innate immune response, defense 
response to bacteria, ribonuclease 
activity 
3. Results 
11 .78 0.02 
Interestingly, it was noted there were several gene transcriptions having unusually 
very large fold changes between W12G and W12GPXY cells in the microarray result 
analysis, e.g. IGFBP3 (211.83 fold), MMP10 (370.63 fold) and MMP1 (644.45 fold). 
To make sure there was no mistake in programme running, the raw data from the 
scanned image with the Affymetrix GeneArray Scanner was checked with the data 
analysis result. It was found in these genes the raw scanned data is consistent with the 
calculated fold changes (appendix 4). 
We also selected out the connexins and PDZ containing protein gene expression data 
from the Rank Product analysis reports although some of their PC-value thresholds 
were higher than we defined in iGA analysis. In total 6 Connexins and 4 PDZ 
containing proteins were found expressed in the W12G and W12GPXY microarray 
lists. There were few apparent difference in connexin transcription levels between the 
two comparative cell lines except that Connexin 30, Connexin 26 and Connexin 45 
were upregulated around three fold inW1 2GPXY cells. The PDZ containing proteins, 
ZO-l and hDlg were around three fold more highly expressed in W12GPXY cells, 
while transcription of p55, a major human erythrocyte membrane protein also found 
in other tissues, was 7 fold higher in W12G cells than in W12GPXY cells. The 
results are presented in Tables lOa and lOb. 
3.2 Real-Time Reverse Transcriptase-PCR Confir med Differential Expression of 
Selected Genes in W12G and W12GPXY cells 
To assess the validity of the microarray approach to identifying differentially 
expressed genes, quantitative real-time RT-PCR was performed on the mRNA 
prepared for microarray experiments. Angiogenesis is a key step in progression from 
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in-situ carcinoma to malignant tumour; furthermore, there are accepted functional 
assays for testing the significance of transcriptional changes in these factors to 
confirm the microarray results. Quantitative real-time PCR was carried out with three 
angiogenesis-related factor genes, VEGFC, FGF-2 and IL8, identified by this cDNA 
microarray analysis as having significantly higher expression in W12GPXY than in 
W12G cells. As controls for the angiogenesis factor family, VPF (expression not 
changed in W12GPXY cells compared to W12G cells) and GAPDH were also 
studied. For all the three expressed genes with differential expression on microarray, 
the quantitative real-time RT-PCR patterns corroborated the microarray data although 
the precise expression-fold changes by microarray analysis was higher than by RT-
PCR. Moreover, the similarity in expression levels of mRNA for GAPDH and VPF 
between W12G and W12GPXY cells shown with quantitative real-time PCR were 
consistent with the microarray analyses. Quantitative real-time RT-PCR amplification 
was carried out with mRNA samples from W12G and W12GPXY cells (originally 
extracted at the same concentration): 1110 diluted W12G mRNA comparing with a 
gradient of diluted W12GPXY mRNA from 1~1II0000 and no mRNA (XY-EM) as 
negative control; the results are shown in Figures 9 (a-d) and Table 11 (a-d). 
Therefore, real-time quantitative PCR on selected representative genes demonstrated 
the functional integrity of our micro array in the appropriate identification of 
differentially expressed genes between W12G and W12GPXY cells, and highlighted 







Table 10 a: Microarray result ofConnexin change in W12GPXYv W12G. 
Gene bank Connexins Fold Change False 
accession discovery rate 
231771 at connexin 30 3.33 2.14 
223278 at connexin 26 3.16 1.39 
208460 at connexin 45 3.00 3.80 
206156 at connexin 31.1 2.20 22.64 
201667 at connexin 43 1.22 6.66 
215243 s at connexin 31 1.01 44.61 
Table 10 b: Microarray result ofPDZ proteins change in W12GPXY v W12G. 
Gene bank PDZ containing proteins Fold False discovery 
accession change rate 
202743_at phosphoinositide-3-kinase, 7.B7 3.62 
regulatory subunit 3 (p55, gamma) 
203230_at dishevelled, dsh homolog 1 1.56 4B.24 
(Drosophila) 
21416B_s_at tight junction protein 1 (zona 3.00 6.20 
occludens 1) 
202516_s_at discs, large homolog 1 ~- 3.62 4.0B 
(Drosophila) 
• Gene more highly expressed in W12G cells are shown in red and genes more highly 
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VEGF-
XY1/10000 
Figure 9 a: VEGF quantitative RT-PCR comparison of W12GPXY mRNA dilutions 
with W12G mRNA diluted in 1/10. 
Name Threshold c~cle Standard deviation threshold c~cle 
VEGF-G1110 28.96 ±0.61 
VEGF-G1110 28.1 ±0.61 
VEGF-XY 25.23 ±0.38 
VEGF-XY 24.7 ±0.38 
VEGF-XY1110 26.28 ±0.1 
VEGF -XY1I1 0 26.41 ±0.1 
VEGF-XY11100 29.17 ±0.49 
VEGF-XY1I1 00 28.48 ±0.49 
VEGF-XY1I1 000 35.47 ±3 .2 
VEGF-XY1/1000 34.80 ±3 .2 
VEGF-XY1I1 0000 36.24 ±0.83 
VEGF-XY1110000 35.07 ±0.83 
VEGF-EM 39.23 ±14.69 
VEGF-EM 40 ±14.69 
Table 11 a: Threshold cycle and Standard deviation Curve threshold cycle of VEGF 
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FCF-G1/10 FCF-XY FCF-XY1/10 FCF-XY1/100 FCF-XY1/1000 FCF-XY1/10000 FCF-EM 
mRNA dilution 
Figure 9 b: FGF-2 quantitative RT-PCR comparison ofW12GPXY mRNA dilutions 
with W12G mRNA diluted in 1/10. 
Name Threshold cycle Standard deviation threshold cycle 
FGF-GII10 31.05 ±0.12 
FGF-GII10 30.87 ±0.12 
FGF-XY 27.19 ±0.04 
FGF-XY 27.24 ±0.04 
FGF-XYII10 28.32 ±0.38 
FGF-XYII10 28.67 ±0.38 
FGF-XYlIlOO 31.98 ±1.03 
FGF-XYl/100 31.53 ±1.03 
FGF-XYlIlOOO 35.39 ±0.25 
FGF-XYII1000 35.04 ±0.25 
FGF-XYI/10000 40 0 
FGF-XYlIlOOOO 40 0 
FGF-EM 40 0 
FGF-EM 40 0 
Table 11 b: Threshold cycle and Standard deviation Curve threshold cycle of ofFGF-
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ILS-G1/10 I LS-XY ILS-XY1/10 ILS-XY1/100 ILS-XY1/1000 ILS-XY1/10000 IL8-EM 
mRNA dilution 
Figure 9 c: 1L8 quantitative RT-PCR comparison ofW12GPXY mRNA dilutions with 










































Table 11 c: Threshold cycle and Standard deviation Curve threshold cycle of of 1L8 in 




































VPF-G1/10 VPF-XY VPF-XY1/10 VPF-XY1/100 VPF-XY1/1000 VPF- VPF-EM 
XY1/10000 
mRNA dilution 
Figure 8 d: VPF quantitative RT-PCR comparison of W12GPXY mRNA dilutions 
with W12G mRNA diluted in 1110. 
Name Threshold c~cle Standard deviation threshold c~cle 
VPF-GlII0 25.96 ±0.37 
VPF-Gl 11 0 25.38 ±0.37 
VPF-XY 23 .72 ±0.14 
VPF-XY 23.92 ±0.14 
VPF-XYlIl 0 26.21 ±0.28 
VPF-XYl/lO 26.42 ±0.28 
VPF-XYII100 29.39 ±2.12 
VPF-XYlIl00 30.39 ±2.12 
VPF-XYII1000 33.52 ±0.4 
VPF-XYlI1000 34.08 ±0.4 
VPF -XYl/l 0000 40 0 
VPF-XYlIl 0000 40 0 
VPF-EM 40 0 
VPF-EM 40 0 
Table 11 d: Threshold cycle and Standard deviation Curve threshold cycle of VPF in 
W12G and W12GPXY samples in quantitative real-time PCR. 
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Table 12: Nominated angiogenesis-related genes abnormally expressed in W12GPXY 
cells confirmed by quantitative R T -PCR. 
Gene Fold change Fold change Note 
shown· from from quantity 













vascular endothelial growth factor receptor 
binding, positive regulation of vascular 
endothelial growth factor receptor signaling 
pathway, extracellular matrix binding 
angiogenesis, heparin binding 
Angiogenesis, regulation of retroviral 
genome replication, interleukin-8 receptor 
binding, chemokine activity, neutrophil 
activation, neutrophil chemotaxis, induction 
of positive chemotaxis 
Vascular endothelial growth factor A 
precursor (VEGF A), Heparin binding, 
extracellular matrix binding, Growth factor 
activity 
Glyceraldehyde-3-phosphate dehydrogenase 
(phosphorylating) activity, NAD binding 
Abbreviations: VEGFC, vascular endothelial growth factor C; IL8, interleukin 8; 




3.3 HPV-16 oncoproteins and expression of the binding proteins 
As W12GPXY cells were established from W12G cells, and W12GPXY cells showed 
more tumorigenic characteristics, the question arose of whether or not there is 
increased expression of viral oncogenes E6 and E7 in W12GPXY. To test this 
hypothesis, expression of HPV-16-E6, E7, p53 and pRb were analysed by Western 
blotting with whole celllysates of HaCaT (HPV negative epithelia, immortalised, not 
transformed), C33a (HPV negative p53 mutant cervical cancer cell line), W12E 
(HPV -16 genome maintained as episomes, immortalised, not transformed cervical 
epithelial cells), W12G (integrated HPV-16 genome, immortalised, not transformed 
cervical epithelial cells (Jeon et aI., 1995), WI2GPX, W12GPXY (integrated genome, 
fully transformed cervical epithelial cells) cells (Aasen et aI., 2003), and CaSki 
(HPVI6 positive cervical cancer cell line ). 
E6 expression was readily detected in WI2E, WI2G, W12GPX and W12GPXY cells 
as expected (Fig (10). E6). Notably, there was approximately 2.9±0.36 (S.D.) times 
more E6 in WI2GPXY than in WI2G cells (quantified from densitometric scanning 
of films from 3 independent experiments); higher even than in CaSki cells. p53 level 
was checked to confirm that increased E6 could raise p53 degradation in the cell lines. 
In C33a cells, the mutant p53 expression was higher than p53 in HaCaT cells; while 
in the HPV16 positive cell lines, p53 was significantly decreased from W12G to 
CaSki cells and WI2GPXY cells. 
As HPV E7 binds to another important tumour suppressor, pRb, leading to the latter's 
degradation, the levels of E7 and pRb were also studied by western blot in the HPV16 
harbouring cell lines. Consistent with a previous study (Jeon and Lambert, 1995), E7 
was more abundant in W12G cells than in W12E cells; while in W12GPXY and 
CaSki cells there was increased E7 compared to level in W12G cells (Fig (11). E7). 
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In contrast, pRb in W12E and W12G cells was more abundant than in W12GPXY and 
CaSki cell lines, consistent with the known effect ofE7 in down regulation ofpRb. 
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Figure 10: Western blot analysis of levels of HPV-16 E6, and p53 in epithelial cell 
lines. 
C33a WI2G WI2GPXY 
HaC aT WI2E WI2GPX Caski 
..- HPVI6E7 
..- pRb 




3.4 Monolayer proliferation and differentiation 
Ki67 is a marker for cell proliferation. It is a nuclear protein expresssed in 
proliferating cells and may be required for maintaining cell proliferation (as in HPV 
cervical neoplasia) (Isacson et aI., 1996). Involucrin is a keratinocyte cornified 
envelope protein precursor, which is formed beneath the inner surface of the cell 
membrane during terminal differentiation. Involucrin first appears in the cell cytosol, 
but ultimately becomes cross-linked to membrane proteins by transglutaminase. In 
cervical dysplasia, involucrin expression was normally decreased. We took these two 
markers to analyse the further different carcinogenesis characteristics between W12G 
and W12GPXY cells. 
Ki67 immuonofluorescence staining for the proliferative fraction was performed on 
W12G and W12GPXY after plating out for 60 hours. Positive stained cells were 
counted from three different fields under the microscope from each slide and for each 
sample two individual slides were checked. The percentage of Ki67 positive cells 
was assessed in each case and was found to be an average of 6 times more in 
W12GPXY (70%) cells than that in W12G (11%) cells Fig (12). Involucrin staining 
was analysed in monolayer cultured cells at 60 hours or 240 hours after plating out. 
The percentage positive cells were calculated as for Ki67. Involucrin 
immunostaining, was clearly increased after 240 hours in W12G cells; conversely, 
there was no significant change between 60 and 240 hours in cultured W12GPXY 
cells. Furthermore, in W12G raft culture sections, involucrin was mostly located in 
the upper and middle cell layers, but not in the basal cells. Involucrin was detected in 
all layers of W12GPXY cells on raft culture, although nearly all the cells invading 
into the collagen were negative Fig (13). Thus, W12GPXY cells appeared to have 





Figure 12: Ki67 immuonofluorescence staining of W12G and W12GPXY cells in 
monolayer. The average percentage ofKi67 positive cells was ~12 % in W12G cells, 








Figure 13 : Involucrin immuonofluorescence staining of W12G and W12GPXY cells 
after monolayer cultured 60 hours (A, B), 240 hours(C, D) and raft culture sections 
(E, F). The average percentage of involucrin positive cells was ~ 10 % in W12G cells, 
and ~5 % in W12GPXY cells at 60 hour; while was ~80 % in W12G cells and ~7 % 
in W12GPXY cells at 240 hours. The white lines in (E, F) show the interface 




3.5 Connexin expression in W12G and W12GPXY cells 
In previous experiments, it was demonstrated that, in contrast to the W12G parental 
cell line (Jeon et aI., 1995), W12GPXY cells have lost intercellular gap junctional 
communication (as measured by transfer of Lucifer Yellow-CH) concomitant with 
redistribution of Connexin 43 from intercellular junctions in the plasma membrane 
into the cytoplasm (Aasen et aI., 2003). To understand the mechanism regulating the 
redistribution of Connexin 43 and reduced cell coupling, firstly expression of 
Connexin 43 was analysed by Western blotting with whole cell lysates of WI2E, 
WI2G, W12GPX, and W12GPXY cells (Aasen et aI., 2003). Consistent with the 
result of the microarray analysis, Western blotting demonstrated there is no obvious 
change in total amount of Connexin 43 between W12G and W12GPXY cell culture 
Fig (14, A); moreover, Connexin 43 phosphorylation patterns were similar in both cell 
lines Fig (14, B). However, when W12G and W12GPXY cells, on coverslips were 
immunofluorescence stained, Connexin 43 was identified mainly at cell-cell contacts 
on cell membrane, and the staining pattern was consistent with the presence of gap 
junction plaques in W12G cells Fig (15). However, only 35% of W12GPXY cells 
showed Connexin 43 positive stain and most of this was in the cytoplasm around the 
perinuclear region. Connexin 43 gap junction plaques were absent and little cell 
membrane staining was found in these cells. Interestingly, in W12GPXY cells that 
did stain the individual cytoplasmic Connexin 43 level seemed much higher than that 
seen on W12G cell membrane contacts. This could explain the reason for similar 
total Connexin 43 levels shown in Western blotting between W12G and W12GPXY 
cells Fig (15 C, F). 
Although tried under different conditions with several other Connexin antibodies, it 
was difficult to detect the proteins in Western blotting of connexins other than 
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Connexin 43. However, immunofluorescence studies showed that in both cell lines, 
Connexin 26 was present in plasma membranes; with stronger staining at cell-cell 
contacts and larger membrane plaques in W12GPXY than in W12G cells (interesting 
in view of absence of LY-CH transfer between W12GPXY cells) Fig (15 A, D). 
Connexin 30 was also seen by immunofluorescence in both cell lines. Like the 
Connexin 26 pattern, it was present only on the plasma membrane and composed 
large plaques between the neighbouring cells Fig (15 B, E). 
3.6 Other cell membrane proteins in W12G and W12GPXY cells 
As HPV-16 E6 appears to target PDZ proteins and as ZO-1 (a PDZ protein) can 
associate with Connexin 43, hDlg and ZO-1 were analysed by Western blotting. ZO-
1 was decreased from W12G to W12GPXY cells, and was hardly detected in CaSki 
cells. However, there was 2-3 fold more hDlg in W12GPXY cells than in W12G cells 
(consistent with mRNA upregulation from Microarray analysis), while the amount 
was less in CaSki cells (Fig (16». More detailed study of hDlg will be described in 
the next chapter. 
In previous studies, adherens junction proteins E-cadherin and 13-catenin (also having 
been implicated in formation and stability of gap junctions) were reported to be 
reduced during cervical carcinogenesis (de Boer et aI., 1999; Carico et aI., 2001; Denk 
et aI., 1997). However, Western blotting suggested there was no significant 
difference in amount of these proteins in HaCaT, WI2G, W12GPXY and CaSki cells, 
although E-cadherin and 13-catenin were dramatically decreased in C33a cells Fig 
(17). It was found that 13-catenin located on plasma membranes especially at cell-cell 
contacts and there were no dramatic difference in staining between W12G, 
W12GPXY and CaSki cells, although there were more cytoplasm speckle staining 
11 n 
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noted in W12GPXY cells Fig (18). Furthermore, it was previously shown that there 
was little difference in E-cadherin pattern between these cells (Aasen, 2003). 
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WI2G W12GPX W12GPXY 
R 
.... 45kDa 
Figure 14: A, Western blot analysis of levels of Connexin 43 in epithelial cell lines; 




Cx26 Cx30 Cx43 
W12G 
W12GPXY 
Figure 15: Connexin 26, Connexin 30 and Connexin 43 immuonofluorescence 
staining of W12G and W12GPXY cells in monolayer. Nuclei were stained with 
DAPI. Bar =20)lm. 
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C33a WI2G WI2GPXY 
HaC aT WI2E WI2GPX CasKi 
ZO-l 
hDlg 
Figure 16: Western blot analysis oflevels ofZO-1and hDlg in epithelial cell lines. 








W12G W12GPXY CaSki 
B-catenin 
Figure18: ~-catenin immuonofluorescence staining ofW12G (A), W12GPXY (B) and 




3.7 Cell morphology changes between W12G and W12GPXY cells 
Previous studies have shown close links between cell junction complexes with the 
actin cytoskeleton: perturbation of cell junctions caused cellular actin cytoskeleton 
rearrangements (Watabe et aI., 1994). Gap junction intercellular communication can 
affect actin stress fiber co-ordination in cultured astrocytes (Yamane et aI., 2002). 
Phalloidin staining showed dramatic differences in actin filament distribution in 
addition to the cell junction changes between W12G and W12GPXY cells. In W12G 
cells, actin filaments were spread evenly in the cytoplasm. The cells were tightly 
associated with others, and were polygonal shape, quite similar to normal epithelial 
cells. In W12GPXY cells, actin filaments were concentrated on the cell edges and 
there were lots of projections around the cell membrane, where cells contacted less 
frequent and less organized. The cells were more elongated than W12G cells and the 
cell shape was more similiar to cancer cell morphology Fig (19, A). 
When W12G and W12GPXY cells were grown as organotypic raft cultures, typical 
histological features indicated that W12G cells formed a stratified epithelium 
differentiated from basal layer to upper layers; the cells had close associated contacts 
and there was no obvious invasion into the collagen; W12GPXY cells showed little 





I ~ . 
Wl?G W12GPXY 
Figure 19: A, Phalloidin staining of W12G and W12GPXY cells; B, H&E stain of 





Development of cervical cancer is closely associated with infection by high risk 
anogenital HPV and expression of its E61E7 oncogenes. A key event in cervical 
tumour progression is the integration of the viral episomal copies into the host 
genome. Usually, this results in repression of expression of all virus proteins except 
for the viral oncoproteins E6 and E7 that become overexpressed, leading (among 
other changes) to uncontrolled cell cycle progression and inhibition of cell 
differentiation and apoptosis (zur Hausen, 2002). Cervical cancer progression is 
tightly linked to the interaction between the function of the HPV oncoprotein and the 
local cellular microenvironments; where cell-mediated responses are central in 
progression of squamous intra-epithelial lesions to cervical carcinoma. However, 
cervical carcinoma progression implies a complex and not entirely understood 
interaction between HPV oncoproteins and host factors. The microenvironment inside 
and around tumors is complex, involving interactions between extracellular matrix 
(ECM), growth factors, cytokines and cells. This micro environment is modified by 
proteases produced by tumor or stromal cells (Wang and Hildsheim, 2005). These 
factors may influence the composition of the ECM around the plasma membrane and 
may also modulate gene expression of membrane components and future sequential 
cellular responses (Duffy, 1998). To investigate global gene expression changes 
during cervical cancer progression, micro array was employed to search for RNA-
based biomarkers to define these pathological changes between the HPV 16 genome 
integrated cervical epithelial cell line W12G and a malignant cell line established 
from W12G cells, the feeder-layer and mitogen-independent line WI2GPXY. 
Microarray and quantitative real-time PCR results indicated there were significant 
increases in VEGFC, lL8 and FGF-2 mRNA expression in W12GPXY cells 
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compared with W12G cells. Such changes could be correlated with ability of 
W12GPXY cells to invade into collagen in organotypic raft culture compared with the 
non-invasive W12G cells. The disorganisation of epithelial junctions can lead to 
defective cell-cell adhesion, loss of cell polarity and unregulated cell proliferation, and 
therefore may represent a crucial step in tumourigenesis. This study found that ZO-I, 
a key tight junction protein at cell membranes, was significantly increased 3 fold at 
the mRNA level but decreased at the protein level in W12GPXY cells compared to 
W12G cells. On the other hand, the related PDZ protein, hDlg was increased in both 
mRNA and protein levels in W12GPXY cells. These data suggest that in our model 
of cervical cancer invasion, changes in Connexin 43 gap junctions could be associated 
with changes in malignant cancer cell microvascular invasion and metastatic spread. 
Previous studies reported the downregulation or loss of GJIC in HPV positive cervical 
tumours and malignant cell lines (Tomakidi et aI., 2000; Faccini et aI., 1996). 
However, our Western blot data revealed no significant changes of total connexin 
contents between W12G and W12GPXY cells, although they are completely deleted 
in HeLa and Caski cells (Aasen et aI., 2003). However, immuonofluorescence 
staining of Connexin 43 demonstrated that Connexin 43 localization had transferred 
from plasma membrane gap junction plaques into the perinuclear cytoplasm 
concomitant with the loss of intercellular exchange of lucifer yellow. Interestingly, 
Connexin 26 and Connexin 30 still formed typical gap junction plaques at cell-cell 
contacts in W12GPXY cells; even though these cells could not transfer lucifer yellow. 
These results suggested that a specific change in permeability properties rather than a 
complete loss of gap junctions might be involved in the progression from W12G to 
invasive W12GPXY cells. Specific loss of Connexin 43 could be key to changing the 
signals exchanged between the cells in the later stages of cancer progression. 
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W12GPXY cells displayed many malignant tumour characteristics both in monolayer 
and organotypic raft culture such as hyperproliferation, hypodifferentation, lowered 
p53 and pRb levels. The multifunctional HPV-16 E6 oncoprotein seems to have roles 
in tumour progression that can facilitate malignant transformation of HPV -associated 
tumours (Song et aI., 1999; 2000). E6 is a shuttling protein that can move between 
the nucleus and cytoplasm. Our results showed that the amounts and intracellular 
locations of HPV-16 E6 were distinctly different between W12G and the tumour-
progressed W12GPXY cells (detailed study in next chapter). The increased amount of 
HPV -16 E6 in the latter cells was most pronounced in the cytoplasmic compartment 
suggesting the possibility of E6 actions in addition to the well-characterised E6-p53 
pathway during the later stages of malignant progression. Thus, we hypothesized and 
focused on the proposal that the increased E6 in W12GPXY cells is directlylindirectly 
involved in targeting Connexin43 for its loss from cell membrane and accumulation in 
cytoplasm (or complete loss from the cell) resulting in loss of Connexin 43 gap 
junction functions. There is evidence from mouse papilloma cells that E-cadherin 
junction formation is required to transport Connexins from the cytoplasm to the sites 
of cell-cell contact at membranes (Hemandez-Blazquez et aI., 2001). Altered E-
cadherin expression has been reported in cervical dysplasia and cancer (Vessey et aI., 
1995). However, both W12G and W12GPXY display large amounts ofE-cadherin in 
the membrane; in addition, the C33a cell line is E-cadherin negative (Vessey et aI., 
1995), yet it is very well coupled, and consistently displays large Connexin 43 
membrane plaques. Furthermore, re-expression of Connexins by transfection of 
cancer cells was normally sufficient to restore GJIC (Jou et aI., 1993; Trosko et aI., 
2001). In general, it seemed that loss of GJIC does not appear to be a necessary or a 
direct consequence of changes in cadherin based cell-cell adhesion. 
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Other candidate targets of E6 that might be involved in loss of gap junction are PDZ 
proteins. ZO-l is a tight junction (TJ)-associated protein that belongs to the MAGUK 
family in which presence of the characteristic MAGUK modules (PDZ, SH3 and GK) 
are key. The modular organization of these proteins allows them to function as 
scaffolds, which associate with transmembrane tight juction proteins, the cytoskeleton 
and signal transduction molecules. Previous studies have suggested ZO-l can bind to 
Connexin 43 and associate through its carboxyl cytoplasmic domain with the second 
PDZ domain of ZO-l which may play an important role in Connexin 43-containing 
gap junctions (Giepmans and Moolenaar, 1998; Toyofuku et aI., 1998). These 
conclusions were based largely on studies of cultured cells, and included 
coimmunoprecipitation, yeast 2-hybrid assays, transfection experiments, and co-
immunofluorescence staining of Connexin 43 and ZO-l. There is consistent growing 
evidence that other MAGUK proteins (eg, ZO-l, dIg, PSD-95 and PSD-93) are 
involved in processes of cell junction assembling to membrane subdomains and ion 
channel aggregation (Migaud et aI., 1998; Gonzalez-Mariscal et aI, 2000; McGee et 
aI., 2001). In this study, it was shown that the expression of both ZO-l and the 
related protein hDlg were changed in W12GPXY cells compared to W12G cells .. 
The tumour suppressor DIg and its human homologue hDlg, another membrane-
associated guanylate kinase (MAGUK) family protein, have been found to be closely 
associated with regulation of cell architecture and control of cell proliferation and cell 
polarity (Woods et aI., 1996; Goode & Perrimon, 1997; Bilder et aI., 2000; Ishidate et 
aI., 2000; Firestein & Rongo, 2001). In Drosophila, DIg is located at septate junctions 
(Woods and Bryant, 1991) and genetic mutation causes tumour development in the 
imaginal disc. However, the role of DIg as a tumour suppressor appears to be distinct 
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from its role in maintaining septate junctions and localising membrane proteins 
(Woods et aI., 1996). 
In view of the known interaction between ZO-1 and Connexin 43 and the tumor 
suppressor property ofhDlg ; it was decide to investigate further possible involvement 
ofhDlg and E6 in the loss ofConnexin 43 gap junctions in W12GPXY cells. 
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Chapter 4. RESULTS 2 
HPV-16 E6 CAUSES REDISTRIBUTION OF CONNEXIN 43 IN CERVICAL 
CANCER CELLS VIA AN INTERACTION WITH hDLG AND LEADS TO 
LOSS OF GAP JUNCTIONAL INTERCELLULAR COMMUNICATION 
In HPV -16 cervical carcinogenesis, the viral oncogene E6 inactivates the tumour 
suppressor p53, but also has p53-independent functions in tumour progression. E6 
has been reported to interact with several cytoplasmic proteins including the PDZ 
domain-containing proteins MAGI-I, ZO-I, MUPP-l, hScrib and hDlg. Such 
interactions might alter cell signalling cascades or cause changes in cell structure 
(Chen et aI., 1995; Tong et al. 1997; Nakagawa and Huibregtse, 2000; Gao et aI., 
2001; Thomas et aI., 2002; Watson et aI., 2003). 
hDlg (the human homologue of Drosophila Discs Large), is a tumour suppressor 
present in epithelial cells at sites of cell-cell contact which regulates cell polarity and 
attachment. It contains several protein-protein interaction domains including three 
PDZ domains, the second PDZ domain of which binds E6. With those protein 
interaction domains, hDlg can form protein scaffolds and comprise macromolecular 
complexes with the protein partners that are thought to be involved in cell signalling 
cascades and cell morphology organisation. Previous studies have identified several 
viral oncoproteins including high-risk HPV E6 and Adenovirus 9 E4-0RFl and Tax 
oncoprotein of HTLV-l (Lee et aI., 1997; Suzuki et aI., 1999) as hDlg targeting 
proteins, and E6 has been shown to target hDlg for proteasome-mediated degradation 
(Gardiol et aI., 1999; Kuhne et aI., 2000; Massimi et aI., 2004). Therefore, hDlg is 
proposed to be involved in oncogenic transformation processes of diverse viruses 
(Kiyono et aI., 1997; Lee et aI., 1997). In previous studies and this study, it was 
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shown hDlg relocalised from plasma membrane into cytoplasm in HPV positive 
cervical cancer (Watson et aI., 2002). 
Connexins, the proteins of vertebrate gap junctions, may also function as tumour 
suppressors, and Connexin 43, one of the most widely expressed connexins, also has a 
PDZ binding domain in its C-terminus, which can bind to several cell junctional 
MAGUK proteins such as ZO-l, ZO-2, and ZO-3). A body of evidence has 
accumulated to show that GJIC may be lost during malignant progression, eg: HPV-
positive cervical cancer (McNutt et aI., 1971; Krutovskikh and Yamasaki, 1997; King 
et aI., 2000; Aasen et aI., 2003). Connexin 43 relocates from the membrane to the 
cytoplasm in the novel HPV -16 E6-containing cervical epithelial cell line, 
W12GPXY, that is fully transformed and invasive and deficient in gap-junctional 
intercellular communication (Chapter 3 and Aasen et aI., 2003). Several studies have 
shown that Connexin 43 is involved in regulating cell proliferation and cell signalling 
cascades independently of GJIC functions. For example, Connexin 43 can be 
phosphorylated on tyrosine residues in the C-terminus by Src that can activate anti-
apoptotic progression through the SrclERK signalling pathway (Plotkin et aI., 2002), 
and Connexin 43 also promotes degradation of S phase kinase-associated protein 2 
(Skp2), the human F -box protein that regulates the ubiquitination and degradation of 
p27 (Zhang et aI., 2003). Therefore, the redistribution of Connexin 43 from cell 
membrane into cytoplasm may be a critical step in malignant progression in late 
stages of high risk HPV cervical carcinogenesis. 
Results shown in Chapter 3. confirmed that E6 does not directly regulate expression 
of Connexin 43 protein in HPV-16-containing cervical tumour cells. Next, the 
possible mechanisms of Connexin 43 redistribution from cell-cell junctions into the 
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cytoplasm of W12GPXY cells were investigated. In this chapter, it is now shown that 
the W12GPXY cells express increased levels of cytoplasmic E6, which co-localises 
with hDlg and that, concomitant with its relocation into the cytoplasm, Connexin 43 
also binds hDlg. Treatment of W12GPXY cells with Leptomycin B to trap E6 in the 
nucleus or siRNA knockdown of E6 abrogate the relocation and co-location of hDlg 
and endogenous wild type Connexin 43 and restore Connexin 43 gap junction at 
points of cell-cell contact. Further, when C33a cells (HPV -negative cervical tumour 
cells which normally retain large Connexin 43 gap junctions) are transfected with 
HPV -18 wild type E6, changes in localisation of connexin 43 and hDlg are consistent 
with those in W12GPXY cells. However, C33a cells transfected with a mutant E6 
lacking the hDlg binding site retain Connexin 43 gap junction plaques. Finally, 
Connexin 43 associates with hDlg through its PDZ-binding domain and this is 
required for its relocalisation to the cytoplasm in W12GPXY cells. These results 
suggest that increased cytoplasmic E6 associated with malignant progression of 
W12GPXY cells redistributes connexin 43 from membrane junctions into the 
cytoplasm by a mechanism involving binding of hDlg to the connexin 43 C-terminal 
tail. The findings have uncovered a new role for hDlg in trafficking of Connexin 43. 
They also provide a novel mechanism for the loss of gap junctional intercellular 
communication during malignant progression of squamous epithelial cells. 
4.1 hDIg can bind to both HPV-16 E6 and Connexin 43 
Structural analysis has demonstrated that the second PDZ domain in hDlg can bind to 
the X-S/T-X-V/L protein motif in high risk HPV E6 proteins (Kiyono et aI., 1997). 
In Connexin 43, the C-terminal sequence DLEI can bind to the second PDZ domain 
of the cell membrane protein ZO-l that has many structural and functional similarities 
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with hDlg (both proteins are in the same MAGUK proteins subgroup) (Toyofuku et 
aI., 1998; Giepmans and Moolenar, 1998). As expected, results showed that ZO-1 
was expressed in the Wl2-derived cell lines (Fig.l6, ZO-I) and immunoprecipitation 
confirmed that in W12G and in W12GPXY cells, ZO-1 was associated with Connexin 
43 (Fig. 20A). Immunoprecipitation was taken to investigate possible interactions 
between HPV-16 E6, hDlg and Connexin 43 in the W12G and W12GPXY cell lines. 
Connexin 43 and hDlg were co-immunoprecipitated from both W12G and W12GPXY 
cell extracts (Fig. 20C) even though Connexin 43 is mainly located in connexons in 
the cell membrane in W12G cells but is located largely in the cytoplasm in 
W12GPXY cells (Figs. 21 H, Nand K, Q). HPV-16 E6/ hDlg complexes were 
precipitated from both W12G and W12GPXY cells (Figure 20 B) but were much 
more abundant in the latter, probably as a result of the higher amounts of E6 in 
W12GPXY (Fig.ll E6 track 6). However, E6 precipitated Connexin 43 only in 
W12GPXY cells (Fig. 20 D). Thus it appeared that redistribution of Connexin 43 into 
the cytoplasm ofW12GPXY cells correlated with binding to both hDlg and E6. 
Next, I used immunofluorescence to investigate the subcellular location of these three 
proteins. HPV-16 E6 was abundant in the nucleus in W12G cells with some 
cytoplasmic staining (Fig. 21 B). In contrast, in W12GPXY cells the E6 stain was 
found not only in the nuclear but also in the cytoplasmic compartment (Figure 21 E). 
hDlg was mainly identified on the cell membrane and the cell margin in W12G cells 
(Fig. 21 A), but in W12GPXY cells most ofhDlg was relocated to the cytoplasm and 
displayed a speckle pattern of staining (Fig. 21 D). There was strong co-staining of 
E6 and hDlg in the cytoplasm in W12GPXY cells but not in W12G cells (Fig. 21 
compare C and F). 
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Connexin 43 was visualised mainly at positions of cell-cell contact, and the staining 
pattern was consistent with the presence of gap junction plaques on the plasma 
membrane in W12G cells (Fig. 21 H). However, in those W12GPXY cells, that 
retained Connexin 43, the protein was transferred into the cytoplasm and little cell 
membrane staining was found (Fig. 21 K) as observed previously (Aasen et aI., 2003). 
In W12GPXY cells, cytoplasmic Connexin 43 clearly co-localised with hDlg in large 
aggregates (Fig. 21 L) while there was no clear evidence of co-location in W12G cells 
despite both proteins locating in or near the membrane (Fig. 21 I). Finally, when we 
examined the locations of E6 and Connexin 43 in W12G cells there was no co-
localisation as each protein was detected in a different subcellular compartment (Fig. 
21 0). However, in W12GPXY cells E6 and Connexin 43 co-localised in some areas 
in the cytoplasm (Fig. 21 R). These findings further support the hypothesis that 
increased cytoplasmic E6 protein in W12GPXY cells might lead to redistribution of 




W12G extract extract 
I.P. western blottine: 
- Invol ZO-l CE ZO-l CE 
A: ZO-l connexin43 
- Invol E6 CE E6 CE 
B:E6 hDIg 
- Invol hDIg CE hDIg CE 
C: hDIg 4 ~. connexin43 
- Invol E6 CE E6 CE 
D:E6 connexin43 
Figure 20: Co-immunoprecipitation of Connexin 43, hDIg and HPV-16 E6. A. 
Precipitation with ZO-l antibody-linked beads and western blotting with an anti-
Connexin 43 antibody. B. Precipitation with E6 antibody-linked beads and western 
blotting with an anti-hDIg antibody. C. Precipitation with hDIg antibody-linked beads 
and western blotting with an anti-Connexin 43 antibody. D. Precipitation with E6 
antibody-linked beads and western blotting with an anti-Connexin 43 antibody. In 
each case the reverse experiment was also carried out, i.e. the antibody used for 
western blotting was linked to beads and the partner antibody used in western 
blotting, beads alone; Invol., involucrin antibody, CE, cell extract. 
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hDlg E6 merge 
W12G 
W12GPXY 
Figure 21: Co-immunofluorescence of W12G and W1 2GPXY cells. hDlg (A, D), 
E6(B, E), merge (C,F). Nuclei were stained with DAPI. Bars=lO fJlTI . 
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hDlg connexin 43 merge 
W12G 
W12GPXY 
Figure 21: Co-immunofluorescence of W12G and W12GPXY cells. hDlg(G, J), 




E6 connexin43 merge 
W12G 
W12GPXY 
Figure 21: Co-immunofluorescence of W12G and W12GPXY cells. E6 (M, P), 
Connexin 43(N, Q), merge (0, R). Nuclei were stained with DAPI. Bars=Q fllll. 
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4.2 Leptomycin B abrogates the relocation and co-localisation of hDlg and 
Connexin 43 into the cytoplasm of W12GPXY cells. 
Given the evidence that in W12GPXY cells with increased cytoplasmic E6, hDlg and 
Connexin 43 were also relocated together into the cytoplasm, it was interesting to 
investigate whether the upregulated endogenous E6 was the vital reason for this 
interaction and relocation. If the HPV -16 cytoplasmic E6 protein was responsible for 
the co-localisation of hDlg and Connexin 43 in the cytoplasm of W12GPXY cells, 
then inhibition of nuclear export of E6 into the cytoplasm should disrupt formation of 
the E6/hDlg/Connexin 43 complexes, possibly leading to relocation of Connexin 43 to 
the plasma membrane. W12G cells treated with Leptomycin B (5 ng/ml Leptomycin 
B for 8 hours to inhibit nuclear protein export) had no change in localisation of either 
hDlg or Connexin 43 compared to untreated cells (Fig. 22 A-C). However, in 
W12GPXY cells, drug treatment resulted in loss of the cytoplasmic speckles 
containing hDlg and Connexin 43 and reappearance of Connexin 43 at the cell 
membrane (Fig. 22 E) that was not found in the mock-treated cells. Furthermore, 
most of Leptomycin B- treated W12GPXY cells microinjected with Lucifer yellow 
transferred the dye to the second or third layers of neighbouring cells, showing that 
functional Connexin 43 gap junction plaques were reformed at contacting plasma 
membranes after Leptomycin B treatment (Fig. 23 A). In these cells E6 was clearly 
localised mainly in the nucleus instead of in the cytoplasm, which suggested the 
cytoplasmic E6 was the trigger for redistribution of hDlg and Connexin 43 in 
W12GPXY cells (Fig. 22 K). Leptomycin B treatment also had a marked effect upon 
the shape of W12GPXY cells but not upon W12G cells: W12GPXY cell membranes 
lost projections and a layer of actin filament bundles was observed underlying the 




hDlg connexin 43 merge 
W12G 
W12GPXY 
hDlg E6 merge 
W12G 
W12GPXY 
Figure 22: Co-immunofluorescence of Leptomycin B treated W12G and W12GPXY 
cells. hDlg (A, D), Connexin 43 (B, E), merge (C, F); hDlg (G, J), E6 (H, K), merge 
(1, L). Nuclei are stained with DAPI. Bars=20 Jll11. 
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hDlg E6 merge 
W12G 
W12GPXY 
Figure 22-Control: Untreated W12G and W12GPXY cells for comparison with cells 
treated with Leptomycin B. Untreated control cells were given aqueous methanol 
diluent only. hDIg (A,D), Connexin 43 (B,E), merge (C,F); hDlg (G,J), E6 (H,K), 





control Leptomycin B 
Figure 23 A: Leptornycin B treated and control W12GPXY cells were rnicroinjected 
with Lucifer yellow. The white arrows point out the rnicroinjected cells. 
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Figure 23 B: Phalloidin stain of Leptomycin B treated W12G and W12GPXY cells. 




4.3 siRNA knockdown of HPV16 E6 in W12GPXY cells redistributes Connexin 
43 and hDlg from cytoplasm to plasma membrane and restores connexin 43 gap 
junction plaques at points of cell contact 
To further confirm that elevated E6 protein caused relocation of Connexin 43 and 
hDlg from plasma membrane into cytoplasm, W12GPXY cells were transfected with 
siRNA directed against HPV16 E6. Western blots showed that siRNA against 
HPV16 E6 caused a marked decreased in total E6 protein in W12GPXY cells (Fig 
24). This was accompanied by reversal of cytoplasmic co-localisation of Connexin 
43 and hDlg, concomitantly with restoration of Connexin 43 gap junction plaques at 
points of cell-cell contact (compare Fig. 25 C, I). While mock transfection produced 
no change in cytoplasmic localisation of Connexin 43 and hDlg (Fig. 25 C), it was 
interesting to note that a control transfection with siRNA against BCR-ABL, while 
not restoring membrane localisation of Connexin 43 or hDlg, may have caused a 
subtle redistribution of the two proteins into smaller cytoplasmic aggregates (compare 








• HPV16 E6 
• GAPDH 
Figure 24. Western blot analysis of HPV 16-E6 in siRNA transfected W12GPXY 
cells. Track 1, W12GPXY cells treated with transfection reagents only; track 2, 
W12GPXY cells transfected with siRNA against BCR-ABL; track 3, W12GPXY 
cells transfected with siRNA against HPV-16 E6. Blots were reprobed with an anti-










W12GPXY transfected SiRNAHPV16E6 
Connexin43 merge 
Figure 25: Co-immunofluorescence of W12GPXY cells transfected with siRNA. 




4.4 Cervical keratinocytes transfected with wild type E6 display cytoplasmic 
relocalisation of Connexin 43 and hDIg. 
To confirm the finding that E6 could mediate hDlg-connexin 43 re-location to the 
cytoplasm in HPV -16-transformed cells and E6 binding to the second PDZ domain 
was the vital trigger for hDlg-Connexin 43 association and relocation, C33a cells (a 
HPV -negative, but pS3 mutant, cervical tumour line which displays large membrane 
Connexin 43 gap junction plaques) were transfected with empty vector (C33a-vec), a 
vector expressing HPV-18 wild type E6 (C33a-pNFWE6) and a vector expressing a 
mutant E6 lacking the hDlg binding site (C33a-pNFME6) (Gardiol et al., 1999). 
Firstly, in Western blot with the anti-flag antibody, it was shown there were amounts 
of HPV 18 wild/mutant E6 in the transfected cells (Fig. 26 A); then from IF A, it was 
suggested that the E6s were overexpressed both in nuclear and cytoplasm 
compartments (Fig. 26 B). In C33a and C33a-vec, transfected cells, most Connexin 
43 and hDlg was detected on the cell membrane and Connexin 43 was present as gap 
junction plaques between the adjacent cells. (Fig. 27 ABC, DEF). In HPV -18 wild 
type E6 transfected cells (C33a-pNFWE6 cells) changes in localisation of Connexin 
43 and hDlg were similar to those observed in W12GPXY cells. Most of Connexin 43 
and hDlg was redistributed into the cytoplasm and the two proteins co-stained in large 
cytoplasmic speckles (Fig. 27 GHI). In contrast, in C33a cells transfected with the 
vector expressing a mutant E6 lacking the hDlg binding site, Connexin 43 was 
localised in gap junction plaques in the cell membrane and hDlg was also found in the 









.... 30 kDa 
Figure 26 A: Western blot analysis of levels of flag fusion proteins in C33a, C33a-
vec, C33a-pNFWE6 and C33a-pNFME6 cell lines. Blots were reprobed with an anti-
GAPDH antibody to demonstrate equal loading in each track. 
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Figure 26 B: Immunofluorescence of C33a-pNFWE6 and C33a-pNFME6 stained 
with anti-flag to show cytoplasmic expression ofE6 (green). Nuclei are stained with 










Figure 27: Immunofluorescence of C33a cells transfected with C33a-pNF (N-
terminus flag empty plasmids), C33a-pNFWE6 (N-terminus flag-wild type HPV18 
E6) and C33a-pNFME6 (N-terminus-mutated HPV 18 E6). hDlg (A,D,G,J), Cx43 
(B,E,H,K), merge (C,F,I,L). Nuclei are stained with DAPI. Bars=10 f.1ill. 
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4.5 Wild-type and C-terminal mutant Connexin 43 are differently localised in 
W12GPXY cells 
To confirm that the last four amino acids DLEI in the C-terminus of Connexin 43 are 
key sites for binding to hDlg, mammalian expression plasmids for flag-tagged 
Connexin 43 and flag-tagged Connexin 43-Mu tr378-382 were constructed. These were 
transfected into W12GPXY cells and stable cell lines selected. Anti-flag antibodies 
were used to detect Connexin 43 expressed from the transfected constructs. In 
W12GPXY cells transfected with wild- type Connexin 43-flag (vector pCFWCx43), 
both Connexin 43-flag and hDlg were detected in the cytoplasm and there was no 
staining found on the cell membranes (Fig. 28), and the two proteins were partially 
co-localised consistent with our previous results. In W12GPXY cells transfected with 
the Mu tr378-382 Connexin 43-flag (vector pCFTCx43), the location of hDlg and 
Connexin 43 was quite different and there was no immunofluorescence co-stain of 
these two proteins. hDlg remained in the cytoplasm as in the cells transfected with 
a flag vector with no insert. Strikingly, most of Mu tr378-382 Connexin 43-flag localised 
to cell membrane junction plaques at cell contacts. These data suggest that without 
the four C-terminal amino acids, DLEI, Connexin 43 can no longer associate with 
hDlg. Thus hDlg could be involved in the trafficking process of Connexin 43 













Figure 28: Co-immunofluorescence of W12GPXY cells transfected with C-tenninal 
flag-tagged wild type and with C-tenninal flag-tagged, C-tenninal-mutated Connexin 
43 . hDlg (A,D,G), flag (B,E,H), merge (C,F,I). Nuclei are stained with DAPI. 




The disorganisation of epithelial junctions can lead to defective cell-cell adhesion, loss 
of cell polarity and unregulated cell proliferation, and therefore may represent a 
crucial step in tumourigenesis. Connexin 43 is the most common unit of stratified 
epithelial cell gap junctions and, in keratinocytes in culture, its loss from the plasma 
membrane leads to loss ofGJIC (Aasen et aI., 2003; Shore et aI., 2001). 
The tumour suppressor DIg and its human homologue hDlg, a membrane-associated 
guanylate kinase (MAGUK) family protein, have been found to be closely associated 
with regulation of cell architecture and control of cell proliferation and cell polarity 
and cell attachment (Woods et aI., 1996; Goode & Perrimon, 1997; Bilder et aI., 2000; 
Ishidate et aI., 2000; Firestein & Rongo, 2001). The modular organization of these 
proteins allows them to function as scaffolds, which associate to transmembrane TJ 
proteins, the cytoskeleton and signal transduction molecules. In Drosophila, DIg is 
located at septate juctions (Woods and Bryant, 1991) and genetic mutation causes 
tumour development in the imaginal disc. However, the role of DIg as a tumour 
suppressor appears to be distinct from its role in maintaining septate junctions and 
localising membrane proteins (Woods et aI., 1996). 
High risk HPV E6 associates with hDlg and this association is important in cell 
transformation (Kiyono et aI., 1997). The multifunctional HPV -16 E6 oncoprotein is 
known to have roles in tumour progression and can facilitate malignant 
transformation of HPV -associated tumours (Song et aI., 1999; 2000). E6 is a shuttling 
protein that can move between the nucleus and cytoplasm. Our data show that the 
amounts and intracellular locations of HPV -16 E6 were distinctly different between 
W12G and the tumour-progressed W12GPXY cells. The increased amount of HPV-
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16 E6 in the latter cells was most pronounced in the cytoplasmic compartment 
suggesting the possibility of E6 actions in addition to the well-characterised E6-p53 
pathway during the later stages of malignant progression. This agrees with the 
observation that in HPV -associated cervical tumour samples, hDlg displayed an 
increased cytoplasmic localisation (Watson et al., 2002; Cavatorta et al., 2004). 
Finally, overexpression of HPV-18 E6 in SV40-transformed human keratinocytes 
resulted in marked reorganisation of the actin cytoskeleton and a decrease in 
intercellular adherens junctions, suggesting that the E6 PDZ-binding motif might 
regulate hDlg protein scaffolding complexes (Watson et al., 2003). The results in this 
chapter have shown that these E6 proteins bind to the second PDZ domain of the 
human homologue of hDlg through the high risk HPV s specific C-terminal 
XS/TXV IL (where X represents any amino acid, SIT serine or threonine, and V IL 
valine or leucine) motif that is similar to the interaction between the adenomatous 
polyposis coli gene product and hDlg; furthermore, it was found E6 mutants losing 
the ability to bind to hDlg was no longer able to target E6-dependent hDlg-Connexin 
43 relocation from plasma membrane into cytoplasm. These results not only indicate 
the importance of E6 C-terminal region binding to the second PDZ site of hDlg in 
determining the binding specificity, but also imply that the E6 proteins of high-risk 
HPV s rather than low risk HPV s can bind hDlg through the common C-terminal 
motif. It suggested an intriguing possibility that interaction between the E6 protein 
and hDlg or other PDZ domain-containing proteins could be an underlying 
mechanism in the development of HPV -associated cancers. 
Previous work demonstrated binding between the Connexin 43 C- terminus and ZO-l 
(Geipmans and Moolenar, 1998). Now, our data has confirmed this association in the 
W12G and W12GPXY cell lines with LP evidence, although the co-staining of 
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Connexin 43-Z0-1 was no as strong as Connexin 43-hDlg in WI2GPXYcells. It is 
proposed there is competition between hDlg and ZO-1 for binding to Connexin 43 in 
W12GPXY cells, whether E6 could affect the competition and promote hDlg 
associated with Connexin 43 is interesting for further investigation. Recently hDlg 
was identified as a potential binding partner for the Connexin 43 C-terminal tail in a 
Tandem Mass Spectrometry (MS/MS) analysis screen (Singh & Lampe, 2003). Our 
studies now provide direct and indirect evidence that hDlg interacts with Connexin 43 
via the latter's C-terminal PDZ-binding domain. This suggests that, similar to its 
homologue ZO-I, hDlg could be involved in assembly or disassembly of Co nnex in 43 
gap junctions. The idea receives support from our finding that elevated amounts of 
cytoplasmic HPV-16 E6 in W12GPXY cells led to relocation of Connexin 43 from 
gap junction plaques into the cytoplasm in association with hDlg. Moreover, in 
W12GPXY cells, inhibiting E6 nuclear export by Leptomycin B or siRNA 
knockdown of E6 restored Connexin 43 to gap junction plaques on cell membranes. 
Furthermore, exogenous cytoplasmic expression of wild type HPV 18 E6, but not E6 
lacking the hDlg binding site, in C33a cells resulted in redistribution of Connexin 43 
from gap junctions into the cytoplasm in association with hDlg, demonstrating a 
causal relationship between E6 and redistribution of hDlg / Connexin and that the 
second PDZ ligand domain of high risk HPVs E6 is required for the induction of 
binding and relocation of hDlg-Connexin 43. Two other viruses, human T-cell 
leukemia virus (Rous set et aI., 1998) and adenovirus 9 (Glaunsinger et aI., 2000), 
encode oncogenes that bind PDZ domain-containing proteins. Interestingly, the PDZ 
ligand domain of adenovirus 9 oncoprotein, E4 ORF-l, has recently been found to be 
important for its oncogenic activities (Frese et aI., 2000). The MAGUK family 
proteins (hDlg, ZO-l, ZO-2, PSD-95/SAP 90, p55 and others) display similar 
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modular structure composed of 2-3 PDZ domains, an SH3 domain and guanylate 
kinase homology (GuK) domain but hDlg also contains an NH2-terminal domain, 
which is not found in other MAGUKs (Lue et aI., 1994; 1996). The precise 
arrangement of ternary complexes between E6, hDlg and Connexin 43 remains to be 
determined (Appendix 5, p261). These results and ours indicate that interactions 
between viral proteins and PDZ domain-containing proteins constitute a general 
mechanism for virus-induced oncogenesis. 
It is now clear that Connexin 43 can associate with both ZO-1 and hDlg within cells, 
but it remains to be seen whether or not it complexes with other MAGUK proteins 
having common second PDZ domains. Similarly, whether or not there is Connexin 43 
binding competition between hDlg and ZO-1 needs to be investigated. Although it is 
still unclear what role hDlg plays in the transport cycle of Connexin 43, our 
immunoprecipitation data show that Connexin 43 and hDlg associate in both W12G 
and W12GPXY cells and in C33a cells. Thus binding between the last four amino 
acids in the Connexin 43 C-terminus and hDlg does not disrupt Connexin 43 
trafficking from the ER to the cell membrane, and assembly into gap junctions when 
cytoplasmic levels of E6 are low. However, hDlg could play a key role in the 
relocation of Connexin 43 into the cytoplasm in W12GPXY cells when cytoplasmic 
E6 protein is abundant. In a scaffolding model, the different domains of hDlg serve as 
docking modules for the interactions with the different proteinlpolypeptides (Hung 
and Sheng, 2002). hDlg could function in the transport cycle of Connexin 43 by 
providing a docking platform for molecules involved in assembling or disassembling 
of gap junctions. DIg and hDlg are important for adherens junction assembly and 
maintenance of actin filament and microtubule networks (Firestein and Rongo, 2001; 
Laprise et aI., 2004; Watson et aI., 2003). It is therefore noteworthy that the 
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restoration ofConnexin 43 gap junction plaques in W12GPXY cells by Leptomycin B 
or siRNA knockdown of E6 was accompanied by changes in cell shape and 
rearrangement of the actin cytoskeleton. The present results suggest that binding with 
HPV -16 E6 may disrupt hDlg control of Connexin 43 trafficking, resulting in 
decreased formation of gap junctions on the cell membrane that may lead to tumour 
progression (Appendix 6, p262). 
In conclusion, these findings highlight a role for hDlg in Connexin 43 trafficking 
between the plasma membrane and the cytoplasm. It is likely that this will be a 
significant mechanism leading to loss of GJIC during malignant progression of 
keratinocytes. It will be of interest to see whether or not hDlg is involved in loss of 
Connexin 43 gap junctional communication in non-HPV -induced tumours. There may 
be parallels to be drawn between the loss of gap junctional communication which 
results from the E6 - hDlg - Connexin 43 interaction described here and the 
disruption of Connexin 43 -ZO-l interactions by Src (Toyofuku et aI., 2001). 
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Chapter 5. RESULTS 3 
THE TRAFFICKING AND DEGRADATION OF CONNEXIN 43 AND HDLG 
IN LATE STAGE OF HIGH RISK HPV POSITIVE CERVICAL 
CARCINOGENESIS 
During protein synthesis and processing, the cell has an elaborate quality control 
system that monitors the whole procedure and functions rapidly to degrade aberrant 
proteins through the proteasomal and/or lysosomal degradation pathway (Ellgaard et 
al., 1999). Connexins, the integral membrane protein constituents of gap junctions, 
are degraded with a half-life 1.5-5 hours, much faster than most other cell surface 
proteins. Connexins, misfolded or abnormally assembled, are frequently retained in 
the endoplasmic reticulum and subject to endoplasmic reticulum-associated 
degradation by the ubiquitin-proteasome system (Viviana et al., 2004). In addition to 
this, it was shown that post-endoplasmic reticulum quality control mechanisms could 
lead to some mutant or non-native connexins being transported to the Golgi complex 
and post-Golgi compartments before intracellular disposal (Musil et al., 2000; Qin et 
al 2003). In some instances, it was proposed that connexins, like other membrane 
proteins, may undergo retrograde transport back to the endoplasmic reticulum with re-
targeting to the endoplasmic reticulum-associated degradation pathway; or they are 
targeted directly into the endosomal system for vacuolar/lysosomal degradation and or 
may first be routed to the plasma membrane prior to their delivery to endosomal 
system for vacuolar/lysosomal degradation. It is also possible that a subset of newly 
synthesized connexins utilize early endosomes as a bio-synthetic intermediate during 
their first pass through the endomembrane system en route to the cell surface, and 
then undergo ubiquitination and proteasomal degradation in the plasma membrane 
(Laing and Beyer, 1995; Ellgaard et al., 1999; Benharouga et al., 2001; Tomas et al., 
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2003). This membrane protein quality control targeting is likely not only to involve 
recognition of commonly expressed mutant connexins, but also possibly in wild-type 
connexins, especially ones at the cell surface with perturbation of local 
micro environments essential for trafficking and stability of gap junction (Mazzoleni et 
al., 1996; Koval et al., 1997). One of the possibilities in connexin quality control 
system is postulated in Fig, 29. Although the degradation of connexin has been 
shown to be sensitive to inhibitors of either the lysosome or of the proteasome, the 
relative importance of proteasomal vs lysomal pathways in connexin degradation and 
how the processes are regulated to affect intercellular communication is not clear. 
Previous reports and evidence presented in this thesis have indicated that viral 
oncoproteins might play a role in tumour promotion by their influence on the 
regulation of gap-junctional intercellular communication (Fletcher et al., 1987; Oelze 
et al., 1995). This chapter now looks at mechanisms underlying the virus-induced 
aberrant trafficking and delocalization of Connexin 43 in W12GPXY cells. From 
earlier results presented, it is postulated that hDlg acts in a manner analogous to an 
itinerant vesicular protein; initial HPV 16 E6 associated hDlg targeting to intracellular 
membrane compartments may participate in cellular trafficking and assembly of gap 
junction proteins. 
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Figure 29: Model for the degradation pathways of connexins. Connexins are 
synthesised in ER and transmitted into the trans-Golgi network, subsequently 
targeting to cell surface or early endosome. Connexins are degraded through 
proteasomal and lor lysosomal pathways. 
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5.1 Both microtubules and microfilaments regulate relocation of the Connexin 43 
and hDlg complex into the cytoplasm in W12GPXY cells. 
Staining with Phalloidin-TRITC clearly revealed significant differences in actin 
filament distribution between W12G and W12GPXY cells (Figure 30 A). W12G cells 
appeared polygonal in shape and made extensive contacts with neighbouring cells 
while W12GPXY cells displayed an elongated phenotype with many cell projections 
and barbed points on the cell membranes; the overall level of cell-cell contact 
appearing much reduced in comparison with WI2G. Cytoplasmic actin filament 
bundles were evenly spread in W12G cells, but were more abundant in W12GPXY 
cells (refer to Fig. 19). After treatment with Cytochalasin B to distrupt actin 
filaments, actin concentrated into plaques and speckles in the cytoplasm, more 
obviously in W12GPXY cells (refer to Fig. 23). Immunofluorescence with an anti-
tubulin antibody revealed the microtubule network in the cytoplasm of untreated 
W12G and W12PXY cells. Nocodazole treatment resulted in aberrant accumulation 
oftubulin all through the cytoplasm (Figure 30 B). 
When Cytochalasin B was used to disrupt actin filaments in W12G cells, Connexin 43 
remained localised in well-defined membrane plaques although a little more 
cytoplasmic protein could be observed than in the untreated cells (Figure 31 A panel 
B). Little change in hDlg location was observed: most membrane staining remained 
with a little of the protein located as a diffuse stain in the cytoplasm (Figure 31 A 
panel A). There was no co-localisation of hDlg and Connexin 43 in Cytochalasin B 
treated W12G cells (Figure 31 A panel C). In Cytochalasin B treated W12GPXY 
cells, the cytoplasmic co-localisation of hDlg and Connexin 43 seen in untreated cells 
was retained, (Figure 31 A panels D-E). These data indicate that both Connexin 43 
and hDlg membrane targeting in W12G cells does not, or at least not completely, rely 
on functional microfilaments. Furthermore, redistribution of Connexin 43 and hDlg 
in W12GPXY cells does not result from rearrangement of the actin cytoskeleton. 
After treatment of W12G cells with Nocodazole, the most striking change was that 
most of cell surface Connexin 43 relocated to the cytoplasm in a perinuclear 
distribution (Figure 31 B panel H). In Nocodazole treated W12G cells, most hDlg 
could be detected in the cytoplasm rather than on plasma membrane (Figure 31 B 
panel G), although there was still no co-staining observed with Connexin 43. In 
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Nocodazole treated W12GPXY cells, hDlg showed some perinuclear localisation but 
was mostly located diffusely throughout the cytoplasm (Figure 31 B panel J). 
Furthermore, in W12GPXY cells treated with Nocodazole, Connexin 43 remained 
localised with hDlg (Figure 31 B panel K, L). Taken together, these findings 
indicated that microtubules are involved in the normal membrane localisation of 
Connexin 43 and hDlg in W12G cells but that the relocation of the two proteins into 
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Figure 30: Effect of disruption of the cytoskeleton ofW12G and W12GPXY cells. 
A: Phalloidin stain of Cytochalasin B treated cells. A, C, mock-treated W12G V 
W12GPXY cells; B, D Cytochalasin B treated W12G and W12GPXY cells. Nuclei 
are stained with DAPI. Bar=lOllm. 
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B: Immunofluorescence staining with an anti-tubulin antibody of Nocodazole treated 
cells. E, G., mock-treated W12G V W12GPXY cells; F, H Nocodazole treated W12G 


















Figure 31: Effect of disruption of the cytoskeleton on distribution of Connexin 43 and 
hDlg in W12G and W12GPXY cells. Nuclei are stained with DAPI. Bar=10llm. 
A: Effect of Cytochalasin B. Panel A-C, W12G cells, panel D-F W12GPXY cells; A, 
D hDlg stain; B, E Connexin 43 stain; C, F merged image of A, Band D, E 
respectively. Note lack of effect of Cytochalasin B in distribution of hDlg and 
Connexin 43. 
B: Effect of Nocodazole. Panel G-I, W12G cells, panel J-L W12GPXY cells; G, J 
hDlg stain; H, K Connexin 43 stain; I, L merged image of G, Hand J, K respectively. 
Note lack of effect ofNocodazole in distribution ofhDlg and Connexin 43. 
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5.2 hDIg and Connexin 43 were not blocked in the trans-Golgi network 
It is important to investigate where in the cytoplasm hDlg associated with Connexin 
43 to understand the mechanism of hDlg in the trafficking and degradation of 
Connexin 43. In different systems, Connexin 43 was reported to distribute into three 
main subcellular locations: plasma membrane-associated gap-junction plaques, a 
perinuclear population, and intracellular vesicles (Lampe and Lau, 2000; Defamie et 
aI., 2001). Previous studies demonstrated that perinuclear Connexin 43 probably was 
assembled in the trans-Golgi network, while intracellular vesicle-like distribution of 
Connexin 43 was probably involved in the lysosomal pathway (Das et aI., 2001; Qin 
et aI., 2003). My results showed there was les than 3% of total Connexin 43 staining 
on cell membrane in W12GPXY cells, but most of Connexin 43 (?: 97%) was in the 
cytoplasmic compartments. Therefore, it was important to know whether Connexin 
43 binding to hDlg occurred either prior to or post the trans- Golgi network. 
Co-staining with an anti-Golgi marker of both Connexin 43 and hDlg was used to 
define whether these proteins accumulated in the Golgi apparatus in W12GPXY cells. 
As shown in (Fig. 32 (B, E)), the Golgi maker stained compartments were perinuclear 
while the majority of either Connexin 43 or hDlg (Fig. 32 (A, D)) localized in other 
cytoplasmic regions. Not surprisingly, there was some co-localization of Golgi with 
both proteins (Fig. 32 (C, F)). These data indicated both hDlg and Connexin 43 
transited through the trans-Golgi network but suggested that the cytoplasmic 
association of the two proteins in W12GPXY cells happened not in the Golgi but in 
other cytoplasmic compartments. 
165 
5. Results 
Cx43 Golgi merge 
Cx43-Golgi 
hDlg Golgi merge 
hDlg-Golgi 
Figure 32: Co- immunofluorescene of either hDlg or Connexin 43 with Golgi maker 
(anti-GM 130) in W12GPXY cells. A, Band C, Cx43-Golgi co-stain of W12GPXY 
cells; D, E and F, hDlg-Golgi co-staining ofW12GPXY cells. A, Cx43 stain; D, hDlg 
stain; Band E, Golgi stains; C and F merge image of A, Band D, E respectively. 
Nuclei are stained with DAPI. Bar=20/-lm. 
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5.3 Sequestration of Connexin 43 and hDIg in endosome-lysosome compartments 
Next, to determine the subcellular localization of the hDlg-Connexin 43 complex, 
both Connexin 43 and hDlg were co-stained with an early endosome maker, EEAl, in 
W12GPXY cells and also in C33a-PCT3Xflag-HPV18WtE6 transfected cells. In 
W12GPXY and C33a-PCT3Xflag-HPV18WtE6 transfected cells, most of Connexin 
43 was found in cytoplasmic regions (Fig. 33 (B, H)) confirming our previous results. 
This coincided with the subcellular location of the early endosome maker (Fig. 33 (A, 
G)) and merging of Connexin 43 and EEA1 revealed strong co-localized 
immunofluorescence signals (Fig. 33 (C, I)). In contrast, in C33a-PCT3Xflag 
(control) and C33a-PCT3Xflag-HPV18MuE6 (LE. E6 lacking the PDZbinding 
domain) transfected cells, EEA1 remained in endocytosomal staining (Fig. 33 (D, J)), 
but Connexin 43 remained in gap junction plaques at the cell contact points on the cell 
surface as in untransfected C33a cells (Fig. 33 (E, K)). There was no co-stain of 
Connexin 43 and EEA1 in these cells (Fig. 33 (F, L)). Similarly, hDlg was 
intracellularly localized with EEA1 in both W12GPXY and C33a-PCT3Xflag-
HPV18WtE6 transfected cells, but not in C33a-PCT3Xflag and C33a-PCT3Xflag-
HPV18MuE6 transfected cells. Thus, it was shown that most ofhDlg and Connexin 
43 association accumulated in early endosomes and strongly suggested Connexin 43 
was intracellularly sequestered by high risk HPV E6 binding hDlg via a protein-
protein interaction Fig. (34). 
Subsequently, in order to determine the degradative route of the hDlg and Connexin 
43 complex, cells were co-stained with a late endosome- lysosome maker, mannose 6-
phospate receptor (MPR), and both hDlg and Connexin 43. Both Connexin 43 and 
hDlg co-localized with the late endosome-lysosome maker in both W12GPXY and 
C33a-PCT3Xflag-HPV18WtE6 transfected cells. Consistent with the early endosome 
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results, in the control C33a-PCT3Xflag and C33a-PCT3Xflag-HPV18MuE6 
transfected cells, hDlg and Connexin 43 were found on the plasma membrane and 
separated from the mannose 6-phosphate receptor staining (Fig.35 and 36). These 
results indicated most of intracellular hDlg and Connexin 43 complexes were 
degraded via the lysosomal pathway through endosome compartments as a result of 









early Enodosome Cx43 merge 
Figure 33 : Co-immunofluorescene stains of early endosome maker, EEAl, and 
Connexin 43 in W12GPXY and transfected C33a cells. Nuclei are stained with 
DAPI. Panel A-C, W12GPXY cells; panel D-F C33a-PCT3Xflag cells; panel G-I, 
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C33a-PCT3Xflag-HPV18WtE6 cells; panel J-L, C33a-PCT3Xflag-HPV18MuE6. A, 
D, G and J, EEA1 stain; B, E, Hand K Connexin 43 stain; C, F, and I L merged 













Figure 34: Co-immunofluorescene stains of early endosome maker, EEAl, and hDIg 
in Wl2GPXY and transfected C33a cells. Nuclei are stained with DAPI. Panel A-C, 
Wl2GPXY cells; panel D-F C33a-PCT3Xflag cells; panel G-I, C33a-PCT3Xflag-
HPVl8WtE6 cells; panel J-L, C33a-PCT3Xflag-HPVl8MuE6. A, D, G and J, EEAl 
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stain; B, E, Hand K hDlg stain; C, F, and I L merged image of AB, DE, GH and JK 
respectively. Nuclei are stained with DAPI. Bar= 1 Oflm. 
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Figure 35: Co-immunofluorescene stains of late endosome and lysosome maker, 
MPR, and Connexin 43 in W12GPXY and transfected C33a cells. Panel A-C, 
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HPV18WtE6 cells; panel J-L, C33a-PCT3Xflag-HPV18MuE6. Nuclei are stained 
with DAPI. Bar=10J..lm. 
A, D, G and J, MPR stain; B, E, Hand K Connexin 43 stain; C, F, and I L merged 










hDlg late Endosome merge 
Figure 36: Co-immunofluorescene stains of late endosome and lysosome maker, 




Panel A-C, W12GPXY cells; panel D-F C33a-PCT3Xflag cells; panel G-I, C33a-
PCT3Xflag-HPV18WtE6 cells; panel J-L, C33a-PCT3Xflag-HPV18MuE6. A, D, G 
and J, MPR stain; B, E, Hand K hDlg; C, F, and I L merged image of AB, DE, GH 
and JK respectively. 
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5.4 Most of hDlg-Connexin 43 complexes are degraded in the lysosomal pathway 
As previous studies demonstrated that both Connexin 43 and hDlg could be degraded 
via a proteasomal pathway in several cell models (Liang and Beyer, 1995; Mantovani 
et al., 2001), it was interesting to investigate whether or not the proteasome also 
played a role in E6 mediated targeting ofhDlg and Connexin 43. W12G, W12GPXY, 
C33a-PCT3Xflag-HPV18WtE6 and C33a-PCT3Xflag-HPV18MuE6 transfected cells 
were treated with proteasome inhibitors, MG 132 and ALLN with mock controls; 
Western blot revealed a slightly increased Connexin 43 and hDlg levels in both 
W12GPXY cells and C33a-PCT3Xflag-HPV18WtE6 transfected cells after MG132 
treatment, which was not obvious in W12G and C33a-PCT3Xflag-HPV18MuE6 
transfected cells (Fig (37)). However, when double stained with hDlg and Connexin 
43, the MG132 or ALLN treated W12GPXY cell showed besides the intrecellular 
staining, increased cell surface Connexin 43 gap junction plaques present on the 
plasma membrane Fig (38). This finding suggested a role for the proteasome in E6-
mediated targeting ofhDlg and Connexin 43 into the endosome/lysosome pathway. 
Next, it was interesting to examine whether or not the endosome/lysosome pathway is 
the major degradative pathway for cytoplasmic hDlg and Connexin 43 complexes in 
W12GPXYand C33a-PCT3Xflag-HPV18WtE6 cells. After lysosome inhibited with 
NH4CI, western blot showed there was a remarkable increase in Connexin 43 and 
hDlg in W12GPXY and C33a-PCT3Xflag-HPV18WtE6 transfected cells, which was 
not noted in W12G and C33a-PCT3Xflag-HPV18MuE6 transfected cells Fig (39). 
From the co- immunofluorescence staining results, it was found there was increased 
Connexin 43 and hDlg observed in the cytoplasm compared to the untreated 
W12GPXY cells but no restoration of Connexin 43 into gap junction plaques. It also 
seemed that lysosomal inhibitor (NH4CI) could not affect Connexin 43 stability on 
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cell membrane and gap junction formation in W12G cells Fig (40). In summary, 
these data suggested the possibility that high risk HPV E6 could act as the trigger for 
hDlg and Connexion 43 association, relocation from the cell membrane and 
degradation in endosome/lysosome compartments. At least in part, proteasome is 
involved in the process. 
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W12G-W12GPXY and C33a-WtE6-C33a-MuE6 cells treated with MG132 
W12GPXY W12G 
MG 132 treated MG 132 treated 
W12GPXY W12G 
-mock -mock 




C33a- MG 132 MuE6 
WtE6 treated C33a- MG 132 
-mock MuE6 treated 
-mock 
hDlg ·,1·n;··· 
..... 110KDa ..... 
Cx43 ~ 45KDa 
Figure 37. Western blot analysis of hDlg and Connexin 43 expression in W12G, 
W12GPXY, C33a-PCT3Xflag-HPV18WtE6 and C33a-PCT3Xflag-HPV18MuE6 
transfected cells treated with proteasome inhibitor MG 132. The sample loading 
between different cell types were not qualified. 
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hDlg Cx43 merge 
ALLN 
MG132 
Figure 38: Co-immunofluorescene stains of Connexin 43 and hDlg in W12GPXY 
cells treated with proteasome inhibitor ALLN or MG132. Panel A-C, W12GPXY 
cells treated with ALLN; panel D-F, W12GPXY cells treated with MG132. A and D, 
hDlg stain; Band E, Connexin 43; C and F merged image of A and B, D and E, 
respectively. Nuclei are stained with DAPI. Bar=lOJ..!m. 
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Figure 39: Western blot analysis of hDlg and Connexin 43 expression in WI2G, 
W12GPXY, C33a-PCT3Xflag-HPV18WtE6 and C33a-PCT3Xflag-HPV18MuE6 
transfected cells treated with lysosome inhibitor NH4Cl. The sample loading between 
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Figure 40: Co-immunofluorescene staining of Connexin 43 and hDlg in W12GPXY 
cells treated with lysosome inhibitor ~C1. Panel A-C, W12GPXY control cells; 
panel D-F, W12GPXY cells treated with ~C1. A and D, hDlg stain; Band E, 
Connexin 43; C and F merged image of A and B, D and E, respectively. Nuclei are 
stained with DAPI. Bar=lOf.!m. 
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5.5 Discussion 
Like other membrane associated proteins, both Connexin 43 and hDlg are synthesised 
in the ER and pass through the trans-Golgi network to the plasma membrane. 
Furthermore, connexins have assembled as connexons after exiting from the Golgi 
network but form gap junction plaques only in the plasma membrane. Previous 
studies suggested that Connexin 43 from the Golgi network was prevalent in vesicular 
carriers that traffic along microtubules and actin filaments to reach the plasma 
membrane (Paulson et al., 2000; Martin et al., 2001), while hDlg movement to the cell 
surface was more dependant on microtubules (Hanada et al., 2000). To investigate 
the mechanism underlying aberrant trafficking of cytoplasmic Connexin 43 and hDlg 
protein complexes in W12GPXY cells, I disturbed microtubules with nocodazole or 
actin filaments with Cytochalasin B. These results showed that neither Connexin 43 
nor hDlg trafficking was strongly affected by actin filament disruption, but was very 
sensitive to microtubule distribution. I also showed that cytoplasmic hDlg and 
Connexin 43 aggregates in W12GPXY cells were not blocked in the Golgi apparatus. 
These results suggested that while microtubules played a role in both Connexin 43 
and hDlg transport, the altered Connexin 43 and hDlg subcellular distribution caused 
by E6 did not result primarily from rearrangement of cytoskeleton. 
A remarkable pathology change in many invasive cancers and in malignant cell lines 
is the loss of connexin expression and GJIc. W12GPXY cells were developed as an 
HPV 16 positive primary cervical malignant cell line; in these cells, transferring of L Y 
by gap junctions was found deficient although Connexin 43, the most common gap 
junctions protein, mRNA and protein expression were still on average maintained at a 
high level. The reason for this paradox has now been shown to be the loss of 
Connexin 43 from gap junctions and targeting through binding hDlg into the 
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endosome/lysosome degradation pathway. These findings are consistent with a 
previous report in which retrovirally delivered connexins continued to be expressed in 
malignant breast tumor cells but gap junction plaques were absent (Qin et aI., 2002). 
It was proposed that in these connexin expressing tumour cells, GJIC deficiently 
could be due to the instability of connexins at the plasma membrane or defects in the 
secretory pathway involved in delivering connexins to the cell surface for gap junction 
assembly. Unlike other plasma membrane proteins, Connexin 43 undergoes rapid 
turnover with a half-life of only 1-2 h (Laird et aI., 1991). Previous studies showed 
that both the proteasome and lysosomes were involved in Connexin 43 degradation in 
tumor cells (Qin et aI., 2003); the lysosomal pathway was proposed to degrade 
endocytosed connexins and the proteasomal pathway was the route of cytosolic and 
misfolded protein degradation, however, the relative contribution of each pathway to 
Connexin 43 and hDlg turnover remains unclear. 
It was shown in both W12GPXY and C33a-PCT3Xflag-HPV18WtE6 cells that the 
majority of Connexin 43 associated with hDlg and co-localised in the early endosome 
and late endosome/lysosome compartments. After treatment with NH4CI to inhibit 
lysosomal degradation, both Connexin 43 and hDlg accumulated in the lysosomes but 
were not restored to cell membrane junctions. This suggested that Connexin and hDlg 
degradation occurred in the lysosomes, but that E6 worked on the protein complexes 
at an earlier step in Connexin 43 and hDlg trafficking. One possibility is that in these 
GJIC-deficient tumor cells, newly synthesized vesicular Connexin 43 transports from 
trans-Golgi network and interacts with high risk HPV E6/hDlg, the whole protein 
complex is directly targeted to the lysosomes for degradation via the endosomal 
system without firstly transporting to the plasma membrane. This may partly explain 
how some tumor cells could continue expressing Connexin 43 but could not form 
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Connexin 43 gap junction plaques on cell membrane. Consistent with this, it was 
reported that in MDA-MB-23I breast tumor cells the newly synthesized Connexin 43 
(as monomers or oligomers) may traffic from an early secretory compartment, e.g. 
Golgi network, directly to the endosome/lysosome for degradation without necessarily 
firstly reaching the plasma membrane, in a "by-pass" mechanism (Qin etal., 2003). 
Another group reported that prolonged treatment of bovine aortic endothelial cells 
with TGF-~1 causes increased expression, synthesis and accumulation of Connexin 
43 in a lysosomal compartment; interestingly, there were no internalized gap junctions 
observed within the cytoplasm or within lysosomes (Larson et aI., 2001). Thus, it is 
possible that in this case, Connexin 43 was also routed directly to lysosomes before 
reaching the plasma membrane through the proposed by-pass pathway. 
Another possibility is that the E6/hDlg complexes target isolated connexons ill 
cytoplasm or even cooperate with proteasome activity on the cell membrane for 
internalisation in the endosomes before the connexons can associate in gap junction 
plaques and form intercellular junctions. Interestingly, when W12GPXY cells were 
treated with proteasome inhibitors, there was modest recovery of gap junction plaques 
on the cell membrane and intercellular transferring of LY, and reduced Connexin 43 
accumulation in cytoplasm. This suggested involvement of proteasomal activity in 
Connexin 43 redistribution and degradation in these cells. Moreover, hDlg was 
reported as being a specific target of high risk HPV E6 for proteasome mediated 
degradation (Mantovani et aI., 1995). Together, these data would be consistent with 
the hypothesis that E6/hDlg associations could promote connexon internalisation via 
proteasome activity on the cell membrane that could destroy gap junction plaque 
stability and importantly result in Connexin 43 and hDlg association. Furthermore, 
this Connexin 43 proteasomal mediated degradation hypothesis was also supported by 
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data for other integral membrane proteins including the epithelial Na+ channel and 
growth hormone receptors going through proteasomal related degradation (Staub et 
aI., 1997; Gover et aI., 1997). 
It is important to note that although it was shown that Connexin 43 and hDlg 
complexes were found in the endosome/lysosomes, it is still not clear whether 
Connexin 43 and hDlg were cleaved and degraded there, because the antibodies 
available can not necessarily distinguish intact from cleaved peptides of Connexin 43 
and hDlg. It was noted in Chapter 3. that in W12GPXY cells, Connexin 26 and 
Connexin 30 still formed many gap junction plaques, in spite of the loss of Connexin 
43 from the cell membrane. In the contrast, from previous reports it seemed that 
whole gap junction plaque areas, no matter what connexin types, might be 
internalized to form gap junction annular vesicles that were transported and 
de gradated in the endosomal/lysosomal compartments (Bjorkman, 1962; Larsen et aI., 
1979). It will be interesting to investigate whether E6/hDlg specifically disassembled 
Connexin 43 from the whole gap junctions and only internalized Connexin 43 from 
the cell membrane that vitally affected gap junction component and functions. 
In summary, our study revealed that both lysosomes and proteasomes play distinctly 
important roles in Connexin 43 degradation and functional gap junction formation on 
the cell membrane, and it elucidated the complementary mechanism and co-operation 
of the two different degradation pathways in Connexin 43 degradation and gap 
junction assembly. 
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Chapter 6. DISCUSSION, CONCLUSION AND FUTURE WORK 
It has been reported that gap junctional intercellular communication was frequently 
decreased or absent in cells treated with tumor promoting agents. The observations were 
made on various cell types of wide range tissues and species using both in vitro and in 
vivo models (Kanno and Matsui, 1968; Jamakosmanovic and Loewenstein, 1968; 
Kivtovskikh et al., 1991). It was hypothesised that gap junctional intercellular 
communication may play a key role in carcinogenesis progression and the gap junction 
proteins, connexins, may act as tumour suppressors, since transfecting cells with an 
expression vector for wild type connexins can revert the phenotype of the tumor cells 
(Loewenstein, 1979, Peeble et al., 2003). Moreover, it was demonstrated that expression 
of viral oncogenes such as v-src, BPV -4 E8 and SV -40 large T -antigen could result in 
loss of gap junction intercellular communication (Loewenstein, 1985; Fitzgerald et al., 
1993; Faccini et al., 1996, NaHK et al., 2000). Gap junctional intercellular 
communication was also inhibited in HPV 16 related tumorigenesis (Campo, 2002). 
During HPV -associated carcinogenesis, loss of GJIC occurred in the late stage of the 
progression (Aasen et al., 2003). 
One of the main aims of this project was to investigate the mechanism of loss of gap 
junctional intercellular communication in the W12GPXY cell line, a model of later stages 
of high-risk HPV -induced cervical carcinogenesis. While, the microarray results 
presented have demonstrated there was no obvious connexin expression change at a 
transcription level between immortal W12G and malignant W12GPXY cells, 
immunofluorecence staining showed that Connexin 43 protein, was absent from many 
W12GPXY cells and redistributed into the cytoplasm in the remainder. This correlated 
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with the absence of L Y transfer between W12GPXY cells. Interestingly, in W12GPXY 
cells, immunofluorscence also showed that Connexin 26 and Connexin 30 could still 
form gap junctional plaques on the cell membrane, suggesting that as a result of the loss 
of Connexin 43, a change in gap junction properties rather than a complete loss of 
coupling has occurred. Connexin 26 and Connexin 30 can form gap junctions that are not 
permeable to L Y transfer (Brissette et aI., 1994; Marziano et aI., 2003), which was also 
shown in W12GPXY cells. 
Phosphorylation is one of the most common post-translational modifications for 
connexins, particularly of Connexin 43, primarily on serine and tyrosine amino acids. It 
was found that v-Src tyrosine kinase could phosphorylate Connexin 43 directly on two 
distinct tyrosine sites, Y247 and Y265, and the activated epidermal growth factor 
receptor acts indirectly through activated MAP kinase on three serine site (S255, S279 
and S282) to alter Connexin 43 phosphorylation (Crow et aI., 1992; Lau et aI., 1992). 
Furthermore, it has been shown that activation of several other kinases including protein 
kinase A, protein kinase C, p34( cdc2)/cyclin B kinase and casein kinase 1, can lead to 
phosphorylation at 12 of the 21 serine, and two of the six tyrosine, residues in the C-
terminal region of connexin 43 (Lampe and Lau, 2004). Previous studies demonstrated 
that Connexin 43 underwent several phosphorylation events that could affect a broad 
variety of Connexin 43-associated processes, such as the trafficking, 
assembly/disassembly, degradation, as well as the gating of gap junction channels 
(Kurata and Lau, 1990; Zhou et aI., 1994; Laird et aI., 1995; Lin et aI., 2001). 
Furthermore, it was found that phosphorylated Connexin 43 correlated with reduced gap 
junctions on the cell surface in Rous sarcoma virus transformed fibroblast cells and in ras 
transformed cells total Connexin 43 expression was found decreased and phosphorylated 
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level was increased (Crow et aI., 1990; Brissette et aI., 1991). In HPV-16 transformed or 
in cells overexpressing HPV -16 ES, it was shown that inhibited expression of Connexin 
43 was the main reason for a decrease in gap junction formation, although there was 
increased, virus-induced Connexin 43 phosphorylation (Ennaji et aI., 1994; Tomakidi et 
aI., 2000). In the latter case, it was proposed that ES contributed to Connexin 43 down-
regulation and phosphorylation. However, ES was overexpressed in these transformed 
cells while, in contrast, ES could not be detected in high risk HPV genome-integrated 
cervical cancer cell lines (Tanimoto et aI., 1992; Corden et aI., 1999). In contrast with ES 
causing a decrease in Connexin 43 expression, data from this project showed there was 
no change in Connexin 43 quantitative expression or phosphorylated isoform distribution 
between W12G and W12GPXY cells, suggesting that phosphorylation probably was not 
the central effector for Connexin 43 redistribution into the cytoplasm and the consequent 
loss of gap junctions on the cell membrane in W12GPXY cells. 
E6, one of the two major oncogenes expressed by high risk HPVs, displays multiple 
oncogenic properties besides interfering with the pS3 pathway, and it alone was sufficient 
to induce malignant carcinoma in transgenic animals (Song et aI., 1999; Liu et aI., 1999). 
Previous studies suggested a possibility by which E6 could affect Connexin 43 
accumulation in cytoplasm and loss from the cells. The finding that PDZ2 containing 
proteins could be targets of high risk HPV E6 suggested a possible mechanism for E6 
mediated loss of Connexin 43, as Connexin 43 had previously been shown to bind to the 
PDZ2 protein ZO-1. 
A special four amino acid motif in the C-termini of high risk HPV E6 was shown to 
interact with the second PDZ domain of proteins, such as hDlg, hScrib and SAP97, and 
the binding was required for E6 induced epithelial hyperplasia in vivo (Thomas et aI., 
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2001; Nguyen et al., 2003). Most of these proteins belong to the membrane-associated 
guanylate kinase homologue family (Thomas et al., 2001). MAGUK family members 
can also interact with cell adhesion molecules, cytoskeletal proteins and components of 
second message cascades (Garner et al., 2000; Hung and Sheng, 2001). 
Unlike other MAGUKs, hDlg contains a proline-rich amino-terminal domain with two 
potential SH3 domain binding sites (Ren et al., 1993; Lue et al., 1994). The presence of 
these consensus binding sites suggests that hDlg might participate in signaling pathways 
by forming protein complexes via the SH3 domains of other proteins. T lymphocytes 
p56lck, a known tyrosine kinase, was found to directly bind to the site within the amino-
terminal segment of hDlg containing the proline-rich domain. These results provide 
evidence of a novel function of hDlg in coupling tyrosine kinases in cell signalling 
pathways (Hanada et al., 1997). 
DIg, is required for the proper assembly and function of adherens junctions (Wood and 
Bryant, 1991; Wood et al., 1996). It has been shown recently that Dig is predominantly 
localized at the adherens junctions of the epidermis, intestine, and pharynx of embryos 
and adult nematodes (Firestein and Rongo, 2004). DIg-deficient embryos exhibited 
abnormal adherens junction formation and disorganization of the actin cytoskeleton 
without any change in E-cadherin localization (Firestein and Rongo, 2004). It was 
demonstrated that human intestinal epithelial cells express several forms of hDlg whose 
changes in phosphorylation state correlate with the initiation of differentiation. Moreover, 
by using an RNA interference approach, hDlg is shown to be necessary for adherens 
junction integrity and for functional differentiation of human intestinal epithelial cells. 
Finally, hDlg was shown to bind to p85/ phosphatidylinositol 3-kinase (PI3K) and both 
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proteins are part of a common macromolecular complex with E-cadherin at the sites of 
cell-cell contact (Laprise et aI., 2004). 
Recently, it was shown that hDlg might also act as a determinant in E-cadherin-mediated 
adhesion and signaling in mammalian epithelial cells (Laprise et aI., 2004). The 
reduction of hDlg expression levels by RNAi in intestinal cells not only severely alters 
adherens junction integrity but also prevents the recruitment of p85/PBK to E-cadherin-
mediated cell-cell contacts; and PBK and hDlg are associated with E-cadherin in a 
common macromolecular complex in living differentiating intestinal cells. The complex 
interaction requires the association of hDlg with E-cadherin and with Src homology 
domain 2 domains of the p85/PBK subunit. Phosphorylation of hDlg on serine and 
threonine residues prevents its interaction with the p85 Src homology domain 2 in 
subconfluent cells, whereas phosphorylation of hDlg on tyrosine residues is essential 
(Laprise et aI., 2004). There are several phosphorylated sites in the amino terminal 
region of hDlg and it was found that p38MAPK is involved in the phosphorylation 
process. When high risk HPV E6s target to hDlg, it was purposed that the binding could 
perturb hDlg phosphorylation process and consequently promote degradation ofhDlg. 
The cadherinlcatenin complex plays important roles in cell adhesion, signal transduction, 
as well as the initiation and maintenance of structural and functional organization of cells 
and tissues. ZO-1 works as a cross-linker between cadherinlcatenin complexes and the 
actin-based cytoskeleton through direct interaction with a-catenin and actin filaments at 
its amino- and carboxyl-terminal halves, respectively, and ZO-1 is a functional 
component in the cadherin-based cell adhesion system (Itoh et aI., 1997). There were 
reports that MAGUK proteins especially ZO-1 were involved in Connexin 43 assembly 
and targeting to the cell membrane to gap junction plaques and high risk HPV E6 seems 
191 
6. DisclIssion, Conclusions& Further work 
to target MAGUK proteins e.g. hDlg and hScrib. I propose that E6 can target Connexin 
43 via these junction-associated MAGUK proteins. Several reports have shown 
MAGUK proteins, such as ZO-I, could bind directly to Connexin 43 on the plasma 
membrane and the binding could influence membrane Connexin 43 assembly and 
stability (Toyofuku et aI., 1998; Baker et aI., 2002). Furthermore, chemical disruption of 
gap junctional intercellular communication could result in aberrant cytoplasmic co-
localised Connexin 43 and ZO-1 complexes (Defamie et aI., 2001). In this project, I 
found another membrane protein from the MAGUK family, hDlg, co-stained with 
Connexin 43 in the cytoplasm. Point mutation and co-immunoprecipitation studies 
clearly confirmed the association between hDlg and Connexin 43 via its second PDZ 
domain in W12GPXY cells. Moreover, Connexin 43 and hDlg were initially expressed 
on cell surface, but both of them were endocytosed and colocalised together when the 
cells were transfected with HPV 18 E6. Recently, it was reported that hDlg could 
interact with Connexin 32 and the binding was potentially involved In 
hepatotumorigenesis in Connexin 32 null mice (Dr David C. Spray, unpublished data, 
presented at the 2005 International Gap Junction Conference). All these data suggest that 
hDlg plays an important role in assembly and stability of Connexin 43 on the cell 
membrane during progression of some tumors. It would be important to explore whether 
other PDZ2 containing proteins from MAGUKs family also interact with connexins and 
regulate gap junction composition. 
Interestingly, it was noted that Connexin 43 and hDlg were localised on plasma 
membrane and there seemed to be no co-localisation of the two proteins in the cytoplasm 
in W12G cells, although the HPV16 genome also had integrated into the host cell 
genome and E6 and E7 oncoproteins were expressed. However, it was found that there 
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was around a three-fold increase in levels of E6 in W12GPXYcells and while E6 only 
appeared in the nucleus in W12G cells, but also translocated into the cytoplasm in 
W12GPXY cells. It was proposed that the majority of the cytoplasmic E6 binds to hDlg 
in W12GPXY cells and acts as a trigger for formation of a hDlg/Connexin 43 complex 
leading to their redistribution from the plasma membrane to the cytoplasm. SiRNA and 
Leptomycin B experiments confirmed this hypothesis. Furthermore, experiments with 
C33a cells showed that E6 mediated association and relocation of hDlg and Connexin 43 
is a general phenotype not specific to W12GPXY cells. 
Whether Connexin 43 and E6 interacted with hDlg via the same PDZ domain is still 
under investigation. It is possible that that Connexin 43 and E6 have different binding 
sites in hDlg. The binding between E6 and hDlg via the second PDZ domain could 
improve the binding affinity of hDlg associated with Connexin 43 through regulation of 
intramolecular interaction between multiple domains of hDlg; in the cytoplasm, hDlg 
could actually exist as a scaffold for the triple protein complex composed of E6, hDlg and 
Connexin 43. This idea is indirectly supported by observation that some MAGUK 
proteins' PDZ2 ligand binding could intramolecularly affect the binding affinity of other 
protein interaction domains (Wu et aI., 2000; Imamura et aI., 2002). 
Another hypothesis is that E6 and Connexin 43 could competitively associate with hDlg 
via the same binding site in its second PDZ domain and hDlg binding with Connexin 43 
is vital for the latter's cell membrane stability. So increasing cytoplasmic E6 could block 
hDlg composing a precise protein complex with Connexin 43 on the cell surface and 
subsequently result in Connexin 43 existing in an unstable environment and a failure to 
assemble on the cell membrane leading to retention in the cytoplasm. 
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A third idea is that hDlg probably associates with Connexin 43 when they traffic together 
from the post-Golgi network to the cell membrane, E6 binding to hDlg could disrupt the 
trafficking of the complex and activate cellular protein quality control systems causing 
hDlg associated with Connexin 43 to undergo an unusual alternative transport and 
degradation pathway, which is consistent the observation that most of Connexin 43 was 
degraded via the lysosomal pathway in tumor cells (Qin et aI., 2003). 
High risk HPV E6 can associate with paxillin, and overexpression ofHPV16 E6 can lead 
to actin filament cytoskeleton disruption that is a characteristic of many malignant tumor 
cells (Tong and Howley, 1997). It was noticed that drebrin, an actin associated protein 
also reported to bind with Connexin 43 (Butkevich et aI., 2004), was found increased in 
W12GPXY cells from the microarray analysis (details in Table 9). 
Establishment and maintenance of epithelial cell polarity relies on finely tuned protein 
networks comprising cell surface molecules, cytoplasmic adaptors, and enzymes 
connected to the actin cytoskeleton. hDlg is involved in cell polarity and is regarded as an 
important tumor suppressor, which could affect cellular molecular scaffolds to repress 
cell signalling pathways, and profoundly disrupt the epithelial cytoarchitecture to perturb 
cell shape and function. E6 binding to hDlg was found correlated with actin cytoskeleton 
disorganization and morphological transformation in human keratinocytes (Watson et aI., 
2003). It was also demonstrated that DIg could bind to dEB 1 (microtubule-binding 
protein--cytoskeletal), and disruption of the cellular microtubule network could cause 
aberrant hDlg distribution in MDCK cells (Brumby et aI., 2004; Iizuka-Kogo et aI., 
2005). This suggests that microtubules can influence hDlg cytoplasmic trafficking and 
membrane targeting. It was shown that disruption of the actin cytoskeleton could perturb 
connexin trafficking and cell membrane assembly (Thomas et aI., 2001; Hernandez-
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Blazquez et aI., 2001). Moreover, microtubules were required for gap junction assembly 
and connexin trafficking from several independent observations (Martin et aI., 2001; Lauf 
et aI., 2002). Thus, high risk HPV could indirectly disrupt cell membrane gap junction 
maintenance with binding to hDlg by affecting actin filament or microtubule network 
distribution. Results from this project confirmed the cytoskeleton disruption by increased 
levels of E6 and there was more influence of microtubules than actin filaments in 
transport ofhDlg and Connexin 43. 
Similar to other plasma membrane proteins, gap junction proteins are delivered to the cell 
surface through secretory pathways. Connexins are translated in the rough endoplasmic 
reticulum and most of them subsequently transit from the endoplasmic reticulum through 
the trans-Golgi network, during this procedure connexins are oligomerized into 
connexons (Musil and Goodenough, 1993; Sarma et aI., 2002). Interestingly, Connexin 
43 is degraded at a rate (half life only 1.5-5 h) much faster than most other cell surface 
proteins (Musil et aI., 1990; Beardslee et aI., 1998). Although the degradation of 
Connexin 43 has been shown to be sensitive to inhibitors of either the lysosome or of the 
proteasome (Hatanaka et aI., 2004), how connexins are targeted for degradation and 
whether this process can be regulated to affect intercellular communication is unknown. 
In tumor cells, it was reported that Connexin 43 undergoes both proteasome and 
lysosome degradation; lysosomes play a key role in degrading not only internalized 
Connexin 43 from the plasma membrane but also Connexin 43 delivered from early 
secretory compartments in breast tumor cells. Protesomal degradation regulates the 
stability of phosphorylated Connexin 43 and appears to promote the internalization of 
Connexin 43 from the cell surface (Qin et aI., 2003). My data suggest that reducing 
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Connexin 43 degradation with proteasome inhibitors (but not with lysosome inhibitor) 
was associated with a striking increase in gap junction assembly compared to control 
cells under basal conditions. Proteasome degradation seemed to be working on Connexin 
43 stability and assembly, and gap junction plaques could be restored by treatment with 
effective proteasome inhibitors in Connexin 43 assembly-inefficient cells. Interestingly, 
there was no obvious Connexin 43 degradation via the proteasome on the plasma 
memebrane in W12G and C33a-PCT3Xflag-HPV18MuE6 transfected cells (refer to Fig. 
35). In contrast, it was suggested that the major degradation of cytoplasmic Connexin 43 
happened in the endosome/lysosome degradation pathway. It seems possible that the 
proteasome works as a disessembling factor leading to an unusual trafficking of 
Connexin 43 from cell membrane to the lysosomes. These results were consistent with 
the observation that most Connexin 43 resided in endocytic vesicles/compartments and 
Connexin 43 gap junction plaques were lost from the cell membrane in high risk HPV 
positive tumor cells highly expressing E6. 
Formerly, it was reported that oncogenic human papillomavirus E6 proteins targeted 
hDlg for proteasome-mediated degradation and proteasome inhibitors could override the 
capacity ofE6 to degrade hDlg (Gardiol et al., 1999). Previous studies also indicated that 
PDZ containing proteins could mediate sorting of cell membrane proteins between 
recycling endosomes and lysosome degradation (Cao et al., 1999). My results are 
consistent with high risk E6 associating with hDlg and regulating its proteasomal 
degradation, but I also showed that in W12GPXY cells and C33a cells overexpressing 
HPV 18 E6, hDlg was transported to late endosomes and lysosomes from the early 
endosomes. Furthermore, it was consistent that the endogenous hDlg accumulated in the 
cytoplasm when the W12GPXY cells were treated with lysosomal inhibitor. More 
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importantly, due to most of hDlg co-localising together with Connexin 43 in endocytic 
compartments of Wl2GPXY cells, it would seem that lysosomal degradation was the 
major destination for hDlg in these cells. However, both the lysosome and the 
proteasome could be involved in the degradation of hDlg. The proteasome probably is 
mainly acting around the cell membrane, with E6-mediated ubiquitination of hDlg 
possibly resulting in membrane Connexin 43 disassembly and internalization. Most 
cytoplasmic hDlg interacted with Connexin 43 in vesicles and the associated complex 
was delivered to the lysosomal degradation compartments. 
There were several reports showing ZO-l, another PDZ containing MAGUK protein, 
frequently interacted with Connexin 43 on the plasma membrane and the binding was 
probably regulated by the c-Src signalling pathway (Sorgen et aI., 2004). From data 
generated in this thesis, I draw a novel hypothesis about ZO-l and hDlg in the loss of 
GJIC in high risk HPV -associated invasive carcinogenesis. hDlg may be more involved 
in Connexin 43 trafficking and internalization in endocytosis, but ZO-l is probably more 
important for Connexin 43 cell membrane stability and gap junction assembly. 
Immunoprecipitation of Connexin 43 with hDlg and ZO-l from different cellular 
compartments will explore whether there is competition between ZO-l and hDlg binding 
to Connexin 43 on the cell membrane and in the cytoplasm. 
To understand the details of the components of the cytoplasmic Connexin 43 complex, 
further, immunoprecipitation from cell extracts, which treated with RNA interference 
against hDlg, will highlight whether E6 is involved in the interaction via hDlg and forms 
a triple protein complex with hDlg-Connexin 43 in the cytoplasm, or if Connexin 43 
interacts with hDlg at the same binding site with E6. Moreover, it will help define the 
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mechanisms of hDlg suppression in tumorgenesis. It will be interesting to investigate the 
invasive characteristics of Wl2GPXY cells to understand the importance of cell 
membrane gap junctions in tumorgenesis progression in these cells because Connexin 43 
gap junction plaques were supposed to be back on the cell membrane once the cells 
treated with Leptomycin B or expressing si RNA against HPV -16 E6. 
The E6 oncoprotein together with E7 provides the major transforming activity of high 
risk HPV s. The combination of E6 and E7 genes is normally retained and expressed in 
cervical carcinomas, which is sufficient for transformation and causing carcinoma. It 
was found that expression of both E6 and E7 proteins alone without other viral gene 
products could lead to the transformation of rodent fibroblasts and human keratinocytes, 
however, the induction of transformation by E7 was much less efficiently and the 
presence ofE6 greatly enhanced the frequency (Bedell et al., 1989; Halbert et aI., 1991; 
Band et aI., 1991). However, HPV16 E7 was found associated with F-actin directly and 
disrupted actin cytoskeletal polymerisation (Rey et aI., 2000); furthermore, it was 
repOlied there was microtubule-associated morphological alteration in E7 targeted pRb-
deficient astrocytoma cells (Dirks et aI., 1997). 
Possibilities for further work 
In the future, there are several questions worth investigating: 
• It will be important to investigate whether the binding of E6, hDlg and Connexin 43 
is a triplex protein complex or there are other proteins also involved for the association. 
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• It will be important to investigate whether E7 cooperates with E6 to reorganize the 
trafficking and membrane targeting of Connexin 43 and whether the collaboration of the 
two oncoproteins results in a new model ofhDlg and Connexin 43 degradation. 
• E5 has been shown to be important in Connexin 43 down-regulation and 
phosphorylation, and it also can affect cell membrane protein trafficking. It is important 
to know whether E5 is a co-effector with E6 for the loss of Connexin 43 gap junction in 
W12GPXY cells. 
• The sequence of the PDZ2 domains between ZO-l and hDlg are quite similar. It will 
be interesting to know whether ZO-l is also associated with high risk HPV E6. It will be 
interesting to investigate whether other PDZ contain proteins from the MAGUK family 
are also involved in connexin trafficking and assembly like hDlg and ZO-l. 
• In this project, evidence showed that W12GPXY cells still have Connexin 26 and 
Connexin 30 gap junctions although Connexin 43 was lost from gap junctions. It will be 
interesting to investigate what molecules can no longer be transported between cells 
when Connexin 43 is deleted from the gap junction plaques. Such molecules will 
probably play important roles in cell proliferation control, cell apoptosis signal system 
and the cancer cell invasion process. 
• Using the abundant information from the microarray data analysis, it will be 
interesting to identify what are the key gene transcription changes during the late stages 
of HPV positive cervical cancer. 
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• From previous studies and this project, it was shown high risk HPV E6 can associate 
with hDlg in the PDZ2 domain. It will be interesting to investigate the binding capacity 
of E6 of other HPV types from the low risk group or the high risk HPV that infect either 
cutaneous or mucosal organs (e.g., HPV 5, HPV 6, HPV 1 and HPV 18), which maybe 
important in the different mechanisms of HPV positive lesions. 
• Although results in this project have shown the PDZ binding site mutated Connexin 
43 cannot associate with hDlg, it is still worth designing PDZ2 mutation to confirm the 
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Homo sapiens gap junction protein, alpha 1, 43kDa (connexin 43) (GJA1), 
mRNA. 
CX43 Forward primer (started from 2 amino acids ahead 
.-----I-.a.ll from HindIII site in pcDNA 3.0 plasmid) 
WtCX43: atg ggt gae tgg age gee tta gge aaa ete ett gae 
MuCX43: atg ggt gae tgg age gee tta gge aaa ete ett gae 
Amino acid sequence: start G D W SAL G K LLD 
WtCX43: aag gtt eaa gee tae tea act get gga ggg aag gtg 
MuCX43: aag gtt eaa gee tae tea act get gga ggg aag gtg 
Amino acid sequence: K V Q A Y S TAG G K V 
WtCX43: tgg etg tea gta ett tte att tte ega ate etg etg etg 
MuCX43: tgg etg tea gta ett tte att tte ega ate etg etg etg 




ggg aea geg gtt gag tea gee tgg gga gat gag eag 
ggg aea geg gtt gag tea gee tgg gga gat gag eag 
Amino acid sequence: G T A V E SAW G D E Q 
WtCX43: 
MuCX43: 
tet gee ttt egt tgt aae act eag eaa eet ggt tgt gaa 
tet gee ttt egt tgt aae act eag eaa eet ggt tgt gaa 
Amino acid sequence: S A F R C N T Q Q P GCE 
WtCX43: 
MuCX43: 
aat gte tge tat gae aag tet tte eea ate tet cat gtg 
aat gte tge tat gae aag tet tte eea ate tet cat gtg 
Amino acid sequence: N V C Y D K S F PIS H V 
WtCX43: 
MuCX43: 
ege tte tgg gte etg eag ate ata ttt gtg tet gta eee 
ege tte tgg gte etg eag ate ata ttt gtg tet gta eee 
Amino acid sequence: R F W V L Q I I F V S V P 
WtCX43: 
MuCX43: 
aea ete ttg tae etg get cat gtg tte tat gtg atg ega 
aea ete ttg tae etg get cat gtg tte tat gtg atg ega 






Amino acid sequence: K E E K L N K K E EEL 
WtCX43: 
MuCX43: 
aag gtt gee eaa act gat ggt gte aat gtg gae atg eae 
aag gtt gee eaa act gat ggt gte aat gtg gae atg eae 
Aminoacidsequence:K V A Q T D G V N V D M H 
WtCX43: 
MuCX43: 
ttg aag eag att gag ata aag aag tte aag tae ggt att 
ttg aag eag att gag ata aag aag tte aag tae ggt att 
Amino acid sequence: L K Q I ElK K F K Y G I 
WtCX43: 
MuCX43: 
gaa gag cat ggt aag gtg aaa atg ega ggg ggg ttg 
gaa gag cat ggt aag gtg aaa atg ega ggg ggg ttg 
Amino acid sequence: E E H G K V K M R G G L 
WtCX43: 
MuCX43: 
etg ega ace tae ate ate agt ate ete tte aag tet ate 
etg ega ace tae ate ate agt ate ete tte aag tet ate 




ttt gag gtg gee tte ttg etg ate eag tgg tae ate tat 
ttt gag gtg gee tte ttg etg ate eag tgg tae ate tat 
Amino acid sequence: F E V A F L L I Q W Y I Y 
WtCX43: 
Mu CX43: 
gga tte age ttg agt get gtt tae act tge aaa aga gat 
gga tte age ttg agt get gtt tae act tge aaa aga gat 
Amino acid sequence: G F S L S A V Y T C K R D 
WtCX43: 
Mu CX43: 
gat eee tge eea cat eag gtg gae tgt tte ete tet ege 
gat eee tge eea cat eag gtg gae tgt tte ete tet ege 
Amino acid sequence: D pep H Q V D C F L S R 
WtCX43: 
MuCX43: 
eee aeg gag aaa ace ate tte ate ate tte atg etg gtg 
eee aeg gag aaa ace ate tte ate ate tte atg etg gtg 
Amino acid sequence: P T E K T I F I I F M L V 
WtCX43: 
MuCX43: 
gtg tee ttg gtg tee etg gee ttg aat ate att gaa ete tte 
gtg tee ttg gtg tee etg gee ttg aat ate att gaa ete tte 




tat gtt ttc ttc aag ggc gtt aag gat cgg gtt aag gga 
tat gtt ttc ttc aag ggc gtt aag gat cgg gtt aag gga 
Amino acid sequence: Y V F F K G V K D R V K G 
WtCX43: 
MuCX43: 
aag agc gac cct tac cat gcg acc agt ggt gcg ctg 
aag agc gac cct tac cat gcg acc agt ggt gcg ctg 
Amino acid sequence: K SDP YHA T S GAL 
WtCX43: 
MuCX43: 
agc cct gcc aaa gac tgt ggg tct caa aaa tat gct tat 
agc cct gcc aaa gac tgt ggg tct caa aaa tat gct tat 
Amino acid sequence: SPA K D C G S Q K Y A Y 
WtCX43: 
MuCX43: 
ttc aat ggc tgc tcc tca cca acc gct ccc ctc tcg cct 
ttc aat ggc tgc tcc tca cca acc gct ccc ctc tcg cct 
Amino acid sequence: F N G C S S PTA P L S P 
WtCX43: 
MuCX43: 
atg tct cct cct ggg tac aag ctg gtt act ggc gac aga 
atg tct cct cct ggg tac aag ctg gtt act ggc gac aga 




aae aat tet tet tge ege aat tae aae aag eaa gea agt 
aae aat tet tet tge ege aat tae aae aag eaa gea agt 
Amino acid sequence: N N S S eRN Y N K Q A S 
WtCX43: 
MuCX43: 
gag eaa aae tgg get aat tae agt gea gaa eaa aat ega 
gag eaa aae tgg get aat tae agt gea gaa eaa aat ega 
Amino acid sequence:E Q N WAN Y S A E Q N R 
WtCX43: 
MuCX43: 
atg ggg eag geg gga age ace ate tet aae tee cat gea 
atg ggg eag geg gga age ace ate tet aae tee cat gea 
Amino acid sequence:M G Q A G S T I S N S H A 
WtCX43: 
MuCX43: 
eag eet ttt gat tte eee gat gat aae eag aat tet aaa 
eag ect ttt gat tte cee gat gat aae eag aat tet aaa 
Amino acid sequence: Q P F D F P D D N Q N S K 
WtCX43: 
MuCX43: 
aaa eta get get gga cat gaa tta eag eea eta gee att 
aaa eta get get gga cat gaa tta eag cea eta gee att 
Amino acid sequence: K L A A G H E L Q P L A I 
?~~ 
WtCX43: gtg gae eag ega eet tea age aga gee age 
MuCX43: gtg gae eag ega eet tea age aga gee age agt egt 
Amino acid sequence: V D Q R P S S R ASS R 
Mu CX43 Reverse primer 
~:'~'~~~L~~ 
, 
.' ..... ... 
WtCX43: egg eet gat gae etg gag ate 
MuCX43: gee age age aga eet egg eet gat gae etg gag ate 
Amino acid sequence:A S S R P R P D D L E I 
WtCX43: tag 
MuCX43: tag 
Amino acid sequence: Stop 
?'ih 
Sequence result of Mu Cx 43 (from MBSU): 
5' aae aat tet tet tge ege aat tae aae aag eaa gea agt gag eaa aae 
tgg get aat tae agt gea gaa eaa aat ega atg ggg eag geg gga age 
ace ate tet aae tee cat gea eag eet ttt gat tte eee gat gat aae eag 
aat tet aaa aaa eta get get gga cat gaa tta eag eea eta gee att gtg 
gae eag ega eet tea age aga gee age agt egt gee age age aga eet 
TCG GTA CCA GTC GAC TCT AGA GGA TCC CGG GCT 
GAC TAC AAA GAC CAT GAC GGT GAT TAT AAA GAT 
CAT GAC ATC GAC TAC AAG GAT GAC GAT GAC AAG 
TAG 3' 
Appendix 1: Homo sapiens gap junction protein, alpha 1, 43kDa (connexin 43) 
(GJA1), mRNA sequence. The forward primer for Mu Cx43 was started from the 
second amino acid ahead of HindIII site in pcDNA plasmid ( the vector containing 
wild type human Cx43), the reverse primer for Mu Cx43 was labelled with blue 
background in Cx43 sequence. The deleted sequence for the last 7 amino acids in C-
terminal were labelled with red. For more information see http:// 
www.ncbi.nlm.nih. gov/entrezlviewer.fcgi? db=nucleotide&val=4755136. 
The recombined Mu Cx 43 plasmid was sequenced. The small letter sequence was 
from Cx43 cDNA and the capital letter sequence was from p3X FLAG-CMVTM-14 
expression vector plasmid (E4901, Sigma). 
')".7 
Appendix 2 
p3xFlAG· CMV-13 (6. 3 kb) 
p 3xFlAG·CMV-14 (6.3 kb) 
=_- >- -i -g~~-=~ctQF 
._ 0 v ~ Cl v a..Q ~ 
::Z: Z LlJVCtl UJ :.!Xa> 
= > -~-;:;t<:-='E~-;;~ 







Multiple Cloning Site 
hGH poly A 
neor 
SV 40 poly A 
(p3xFLAG-C IVlV-13 * and p3XFLAG-CIVlV-14) 
Hind III Not I EcoR I CI~ I Bgl 11 
" IAG eT~ 
TTC GiH. 
GC~ OCO '-*Hc;. 
CG C CGG CGC TTA • GT 
T~ATA~TO 






AGC CAT GGT 
~t!!~l1tnnrft£ltm·ll~ 
Aop Ty r Lyo Aop B 1 0 Aop Gly Aop 
OH TICT AG
1
" OH TAe hAA Gh C CAT GAC GOT GAT 
CTG AGA T er TTT eTO OH CTO CCA CH 
Lyo Aop 810 Aop 118 Aop Tyr Lyo Aop Aop ADp Aop Lyo 
AA4i\ G .~ T CAT (l AC AT C G .~C V .C H G GAT GAC GAT OAC k .~ G TAO TG A 
TTT CB GT A CTO T P. G CTG ATG TTC CT A eTG eT A CTG TTC ATC ACT 








Appendix 2: p3X FLAG-CMVTM-14 expression vector plasmid (E4901 , Sigma) 
plasmid. Used for cloning and transfecting wild and Tr378-382 mutant Connexin 43 
constructs. For more information see http://www.sigmaaldrich.com. 
? 'iR 
Appendix 3 
p3xFLAG-CMV-9 (6.4 kb) 





pBR322 o rigin 
Multiple Cloning Site 
(p3xFLAG-C MV-9* and p3xFlAG-C MV-10) 
= > -
; er: er: 1j .£o8o-.8~~", 
:I:Z wcow ::.lXCXI 
= > -
:;:; er: = er: :I: 
c .... o-oCnle 
0 - 0 v 0\ v a....o I'1l 
:I:ZWC:OW~XCXI 
hGH poly A 
neo' 
SV 40 poly A 
~~~'I·I.(i( 
A.sp Tyr Ly D ADp B10 ADp Sly ADp 7yr Ly o ADp BiD ADp 11 
AT G GAC TAC AAA. GAC CAT GAC GGT GAT TAT AAA GAT CAT GAC ATC 
TAe CTG ATG TTT CTG GTA CTG ATA TTT CT.'\ GTA CTG TAG 
le t!i jI I' la liO:lI1'H;) J;I:r;:1 I'IIlS'! 
Not I &.:oR I 
GAT TAC AAG GAT GAC GAT GAC GC~ GCG '*iCA TCG ATA 
CTA ATG TTC CH CTO eT A eTG COC CGG CGC TTA AGT AGC TAT 
Hind III 
9gl11 &':oRV Xba l Bam HI 
~TG At TCG GTC OAC Tier Ay GIGA TC; eGG TG CT A At' TAT AGC CAG CTG AGA TeT CCT AG" cce hC 
"For pFLAG-CMV-9, the M t;! t-preprotJypsln Ie<lder sequ9nce (PPT LS) preClldll'S the FLAG COding sequence. 
Appendix 3: p3X FLAG-CMVTM-lO expression vector plasmid (E4401, Sigma) 
plasmid. Used for cloning and transfecting wild and PDZ2 binding site mutant HPV 
18 E6 constructs. For more information see http://www.sigmaaldrich.com. 
?"iQ 
Appendix 4 
MMPl 1204475 at 1644.45 14.095627 4.122086 12.04172 11.92974 
4.016399 11.39762 
MMPlO I 205680 at 1370.63 I 4.432889 4.459264 10.22319 10.37197 
4.483434 8.391109 
IGFBP3 1212143_s_at 1211.83 17.435301 7.904595 12.48461 12.17823 
7.782328 12.59369 
JAGl 1209098_s_at 16.19 18.728028 8.659485 10.56514 10.39518 
8.699817 9.939915 
DBNl 1 202806_at 1 3•63 1 8.7100688.625167 8.023017 8.056138 
8.846464 8.106846 
Appendix 4: Several raw scanned data samples of microarray results. MMP l, 
MMPlO and IGFBP 3 are the genes having huge fold change between W12G and 
W12GPXY cells, JAGl and DBNl are the genes have small huge fold change 
between W12G and W12GPXY cells. The scanned raw data was cauculated with In. 
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High risk HPV E6 
Appendix 5: Schematic diagram showing high risk HPV E6, and Connexin 43 binding 




















4) 4) 4) 4) 4) 4) 
W12GPXY \ nuclear 
Appendix 6: Schematic diagram showing different location ofHPV-16 E6, hDIg and 
Connexin 43 in W12G and W12GPXY cells. E6 is in nuclei, hdlg and Connexin are 
on the cell membrane in W12G cells; E6 is in nuclei and cytoplasm, hdlg and 
Connexin are associated with E6 in cytoplasm in W12GPXY cells. 
?F.? 
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